Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,retinoid binding (GO:0005501),-0.7687143326401525,-2.390822946679793,0.0,0.0,0.0,7/22,8.28%,ALDH1A2;RBP1;PTGDS;RBP4;CYP26B1;ABCA4;CRABP2
prerank,I-SMAD binding (GO:0070411),-0.7726567907605069,-2.1107989753300367,0.0,0.004965330826184041,0.01,5/13,4.03%,SMAD6;CTNNB1;SMAD7;SMAD9;TGFBR1
prerank,insulin-like growth factor I binding (GO:0031994),-0.707601239471323,-1.8245536636469197,0.0,0.1837172405688095,0.401,6/13,5.85%,IGF1R;IGFBP2;IGFBP3;ITGA6;IGFBP5;INSR
prerank,voltage-gated ion channel activity (GO:0005244),0.813538996591948,1.8143773503033136,0.0014684287812041115,0.5261894704504435,0.375,5/14,6.77%,KCNK15;CACNA1E;VDAC2;ANO6;KCND2
prerank,neuropeptide receptor activity (GO:0008188),0.6892091697532643,1.780515083569207,0.0026041666666666665,0.4690603279443954,0.549,4/29,2.34%,SSTR1;SORCS2;SORCS1;SORCS3
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),-0.4529203967573811,-1.774105899735956,0.0,0.23932894582207076,0.561,19/55,14.60%,SLC7A2;SLC13A3;SLC16A12;SLC16A6;SLC6A12;SLC6A6;SLC22A4;SLC6A13;SLC7A5;SLC38A11;SLC16A11;PDPN;SLC38A7;SLC16A2;SLC6A11;SLC38A5;SLC16A9;SLC38A10;SLC36A4
prerank,serine-type peptidase activity (GO:0008236),0.5943321146478001,1.767863662421409,0.0,0.37785415306631853,0.607,13/96,7.59%,HGFAC;KLK12;MMP2;FAP;HTRA3;CORIN;PARL;HTRA1;NAALAD2;PCSK4;PCSK6;KLK1;KLK6
prerank,ligand-gated ion channel activity (GO:0015276),0.6712009670333791,1.7676777788453288,0.0,0.28414231404323953,0.609,12/30,14.39%,GRIA1;GRIK3;GRIA3;CHRNA4;GRIN2B;GRIK5;GRIK2;GRID2;GRIK1;ANXA6;GRIN2D;GRIN2A
prerank,ligand-gated channel activity (GO:0022834),0.6738729383728569,1.767474406817064,0.0025906735751295338,0.22831611689259246,0.609,12/29,14.39%,GRIA1;GRIK3;GRIA3;CHRNA4;GRIN2B;GRIK5;GRIK2;GRID2;GRIK1;ANXA6;GRIN2D;GRIN2A
prerank,solute:anion antiporter activity (GO:0140323),-0.6342647478868784,-1.764628901372451,0.006472491909385114,0.20814666823363498,0.594,4/14,8.07%,SLC7A11;SLC26A7;SLC26A2;SLC4A3
prerank,insulin-like growth factor binding (GO:0005520),-0.6373698257716731,-1.7426927380119108,0.009174311926605505,0.2178125122419399,0.677,6/15,5.85%,IGF1R;IGFBP2;IGFBP3;ITGA6;IGFBP5;INSR
prerank,acetylcholine receptor activity (GO:0015464),0.6922039238446513,1.7299841860701515,0.008438818565400843,0.3290772243769441,0.811,3/22,4.08%,CHRM3;ANXA9;CHRNA4
prerank,pyridoxal phosphate binding (GO:0030170),0.7093507432557541,1.7164556085896168,0.012362637362637362,0.34091350452857305,0.867,9/20,13.40%,PYGL;CTH;CBS;PDXK;PSAT1;PNPO;PLPBP;OAT;SRR
prerank,ionotropic glutamate receptor activity (GO:0004970),0.7200716459939106,1.7067439950262115,0.011444921316165951,0.34051975730578704,0.895,9/17,14.39%,GRIA1;GRIK3;GRIA3;GRIN2B;GRIK5;GRIK2;GRIK1;GRIN2D;GRIN2A
prerank,serine-type endopeptidase activity (GO:0004252),0.5823392824686113,1.7022792195379974,0.0022271714922048997,0.3209477362620483,0.906,10/80,7.59%,HGFAC;KLK12;MMP2;FAP;CORIN;PARL;PCSK4;PCSK6;KLK1;KLK6
prerank,bicarbonate transmembrane transporter activity (GO:0015106),-0.5842637914245602,-1.6547184508205595,0.023411371237458192,0.3945310007890804,0.912,5/15,10.36%,SLC26A7;SLC26A2;SLC4A3;SLC39A8;SLC4A8
prerank,lipoprotein particle receptor binding (GO:0070325),0.6494763029897316,1.644000785395176,0.020604395604395604,0.5661798702046773,0.985,5/27,8.86%,RELN;HSPG2;LRP1;SYT1;ANKRA2
prerank,ephrin receptor binding (GO:0046875),0.6684377002934174,1.643608310409344,0.013477088948787063,0.5172601945882542,0.986,13/21,19.24%,EFNA4;EFNA5;CHN1;ANKS1B;FYN;PTPN1;CBL;EFNB1;ANKS1A;EFNB3;ABL1;EFNB2;GRB2
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",0.6718468430605372,1.638689380522266,0.010899182561307902,0.4977919434737529,0.989,8/23,8.72%,RAG2;PLEKHA4;PLEKHA5;SESTD1;WIPI1;MAPKAP1;GBF1;HIP1
prerank,NAD binding (GO:0051287),-0.4980056238296404,-1.6253429608472585,0.008264462809917356,0.4297493830062287,0.952,11/26,16.85%,ALDH1A1;ZC3HAV1;CRYL1;ME1;ALDH2;SIRT3;SORD;BDH2;HPGD;NNT;QDPR
prerank,tau-protein kinase activity (GO:0050321),-0.5387107460611116,-1.6249930506686132,0.04225352112676056,0.3831028584113553,0.953,8/20,10.39%,ROCK2;SIK3;MARK1;ROCK1;TTBK2;GSK3B;GSK3A;MARK2
prerank,sodium channel activity (GO:0005272),0.5884298134506206,1.6146396204971607,0.0231990231990232,0.5893322069044967,0.995,9/37,8.05%,SCN7A;SCN2A;GRIK3;KCNK1;GRIK5;GRIK2;SCN5A;SCN3A;GRIK1
prerank,steroid hydroxylase activity (GO:0008395),0.68962352097971,1.6142245069539964,0.02967359050445104,0.5495995326051775,0.995,5/16,14.24%,CYP2S1;CYP39A1;CYP1B1;CYP7B1;CYP27A1
prerank,telomerase RNA binding (GO:0070034),-0.5112747874836284,-1.6074753481485027,0.017064846416382253,0.38997708308849455,0.97,12/22,19.33%,XRN1;DCP2;NAF1;DKC1;SNRPD3;WRAP53;SNRPB;TERT;PINX1;EXOSC10;GAR1;TENT4B
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),-0.629547187044611,-1.6016496317405455,0.04603580562659847,0.36996228592185815,0.973,4/10,5.09%,SLCO3A1;SLCO2A1;SLCO1C1;SLC22A6
prerank,potassium channel regulator activity (GO:0015459),0.5611123489358971,1.590651592794754,0.013937282229965157,0.6453922660420107,1.0,15/49,14.36%,WNK2;SLC5A3;WNK3;RASA1;DPP10;ENSA;KCNMB2;KCNMB3;FLNA;SGK3;SGK2;KCNAB2;KCNIP4;NEDD4L;SUMO1
prerank,transcription corepressor binding (GO:0001222),0.626732855137387,1.582488510174797,0.025367156208277702,0.6509089032679237,1.0,9/27,14.17%,RORA;USP11;EED;ZBTB16;ESR1;HDAC6;PER3;PER1;LCOR
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),-0.49051572750916106,-1.570876987436675,0.028688524590163935,0.4212255650879461,0.99,9/25,16.88%,ZC3HAV1;PARP3;PARP4;PARP10;PARP1;SIRT3;PARP6;PARP14;SIRT4
prerank,glutamate receptor activity (GO:0008066),0.6482113876154467,1.5671867767817644,0.031117397454031116,0.7088966042236564,1.0,8/19,13.46%,GRIA1;GRIK3;GRIK5;GRIK2;GRID2;GRIK1;GRM5;GRIN2D
prerank,sterol binding (GO:0032934),0.545052770712849,1.5598667839243008,0.0166073546856465,0.7131120156676011,1.0,9/56,6.31%,APOD;RORA;PTCH1;VDAC2;ERLIN2;NPC1;OSBPL5;GRAMD1A;RORC
prerank,chemoattractant activity (GO:0042056),0.6153669025300671,1.5543163196566159,0.027450980392156862,0.7096568366887034,1.0,5/26,3.14%,LGALS3;CXCL10;FGF2;FGF10;VEGFA
prerank,alpha-tubulin binding (GO:0043014),0.5922839214990776,1.5503570567658334,0.02457956015523933,0.6998319956990899,1.0,13/31,16.43%,DLEC1;EFHC1;TBCE;FYN;PACRG;SETD2;HDAC6;CDK5R1;ARL8A;TRAPPC14;SNCA;WASHC1;DIP2B
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",-0.5422838206931752,-1.545143548337465,0.03514376996805112,0.4623104947702432,0.997,7/17,15.21%,LBR;PTGR2;BLVRA;BDH2;DECR2;PECR;DHCR24
prerank,ionotropic glutamate receptor binding (GO:0035255),-0.6307791016374074,-1.53515733941056,0.04419889502762431,0.4604989674798112,0.997,7/10,18.41%,SHANK3;SHISA6;NSF;SHANK2;SQSTM1;GNAS;SHISA7
prerank,tau protein binding (GO:0048156),-0.4204561610931622,-1.5265557204050262,0.02030456852791878,0.4546256904454108,0.998,19/40,22.86%,ROCK2;MARK1;MAP2;ROCK1;TTBK2;STUB1;GSK3B;GSK3A;MARK2;DCTN1;PPP2CB;LGMN;HSP90AA1;TAOK2;APOE;HSP90AB1;MARK3;CLU;BRSK2
prerank,protein tyrosine kinase activator activity (GO:0030296),0.6362684724232763,1.5261811980484885,0.03835227272727273,0.8170374190150697,1.0,5/19,9.79%,ERBB3;EFNA5;NRG3;ALKAL2;GRM5
prerank,sodium channel regulator activity (GO:0017080),0.5713490128683938,1.525765845890217,0.03201970443349754,0.7826783638388416,1.0,12/37,16.80%,FXYD3;FGF13;FGF12;FGF14;SGK3;SGK2;FXYD6;FXYD1;NEDD4L;PKP2;GPLD1;SGK1
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),0.7168615136369376,1.5182793459892925,0.047692307692307694,0.7957989324526709,1.0,1/11,0.09%,ROR2
prerank,translation elongation factor activity (GO:0003746),-0.564427134439722,-1.5168340438596948,0.046012269938650305,0.4537071042425667,0.999,9/14,16.83%,GTPBP2;GTPBP1;EEF1A1;GFM2;GFM1;EIF5AL1;EIF5A;TSFM;EEF1B2
prerank,sodium:proton antiporter activity (GO:0015385),-0.5976899540083865,-1.509052541995066,0.05352112676056338,0.4498005571954954,0.999,6/11,11.85%,SLC9A6;SLC9A2;SLC9A8;SLC9B2;SLC9A9;SLC9A7
prerank,intracellular chloride channel activity (GO:0061778),0.649983540308199,1.503450550075201,0.04227405247813411,0.8206150301447717,1.0,6/16,18.44%,ANO2;ANO6;TTYH3;TTYH1;ANO10;TTYH2
prerank,intracellular calcium activated chloride channel activity (GO:0005229),0.649983540308199,1.503450550075201,0.04227405247813411,0.8206150301447717,1.0,6/16,18.44%,ANO2;ANO6;TTYH3;TTYH1;ANO10;TTYH2
prerank,transaminase activity (GO:0008483),0.7122542571031671,1.5021360631030642,0.06042296072507553,0.7973023309396722,1.0,4/11,10.46%,AADAT;PSAT1;GOT2;OAT
prerank,microtubule plus-end binding (GO:0051010),-0.5180955073595208,-1.4998632429479837,0.041811846689895474,0.4483142032619057,0.999,9/20,14.34%,CLIP4;TTBK2;CLIP3;CLIP1;PAFAH1B1;DCTN1;NUMA1;STIM1;KIF18A
prerank,death receptor binding (GO:0005123),0.6640621641968004,1.4996137657674922,0.049926578560939794,0.7834376560039937,1.0,3/15,2.66%,EDA;NGF;FADD
prerank,heme binding (GO:0020037),0.511115033150997,1.4992756243969285,0.026106696935300794,0.7578560182569245,1.0,11/65,8.37%,CYP2S1;CYB561D2;STEAP4;SUOX;CBS;PXDN;PGRMC2;CYP1B1;PTGES2;SDHC;RSAD1
prerank,ion gated channel activity (GO:0022839),0.5948983192103927,1.4889324765546257,0.04862023653088042,0.7945547406013594,1.0,7/24,13.35%,ANO2;TMEM63A;ANO6;TTYH3;TTYH1;KCNT2;ANO10
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),0.6007084533199123,1.4884465669265112,0.057103064066852366,0.7713102415421835,1.0,4/21,9.79%,GRIA1;ANXA9;CHRNA4;GRM5
prerank,CXCR chemokine receptor binding (GO:0045236),0.6881552209324214,1.4844070892686414,0.06437125748502993,0.7705483041011012,1.0,2/11,12.47%,CXCL10;YARS1
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",-0.5025778248924289,-1.4784638279251598,0.05333333333333334,0.484250422153633,0.999,7/18,13.70%,ALDH1A2;ALDH1A1;ALDH2;FAR2;ALDH3A2;ALDH9A1;ALDH18A1
prerank,deoxyribonuclease activity (GO:0004536),0.6536327202726147,1.4771034108127208,0.06360946745562131,0.7877808071886641,1.0,4/14,5.66%,ZRANB3;MBD4;ERCC5;ERCC4
prerank,carbohydrate:cation symporter activity (GO:0005402),0.6893714160573607,1.4733182739772197,0.0736196319018405,0.7852295855137528,1.0,2/11,2.62%,SLC5A3;SLC17A5
prerank,endodeoxyribonuclease activity (GO:0004520),0.6088115235033004,1.472875112531658,0.059474412171507604,0.7644928698409975,1.0,6/20,10.47%,ZRANB3;MBD4;ERCC5;ERCC4;SETMAR;ENDOV
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.6479460420889932,1.4673729658872159,0.060561299852289516,0.7708281994876212,1.0,8/15,20.49%,KMT2A;SETD3;CXXC1;SETMAR;PRDM9;ASH2L;SETD4;KMT2D
prerank,peptidase inhibitor activity (GO:0030414),0.5579618514299151,1.4662720448686901,0.051833122629582805,0.755931031834415,1.0,5/33,6.24%,GPC3;A2M;RECK;CSTB;UCHL5
prerank,LRR domain binding (GO:0030275),-0.545615688499419,-1.464488994031349,0.062111801242236024,0.5015977200611118,1.0,2/14,0.37%,PAWR;ROBO1
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.6477009665449733,1.4615255816448303,0.06762589928057554,0.7601236926800461,1.0,3/14,9.94%,CAPN5;CAPN1;CAPN6
prerank,amino acid transmembrane transporter activity (GO:0015171),-0.39055861173612594,-1.4589621572076246,0.018518518518518517,0.4928445511475245,1.0,16/47,14.60%,SLC7A11;SLC7A2;SLC47A1;SLC6A6;SLC22A4;SLC6A13;SLC7A5;SLC38A11;PDPN;SLC38A7;SLC16A2;SLC66A1;SLC38A5;SLC6A1;SLC38A10;SLC36A4
prerank,potassium channel activity (GO:0005267),0.4883897564460172,1.4586361599928945,0.02682403433476395,0.7566578209665326,1.0,17/89,10.11%,KCNK15;KCNA2;KCNH8;GRIK3;KCNK1;KCNA1;KCNA6;GRIK5;GRIK2;KCND1;KCND2;KCND3;GRIK1;KCNMB2;KCNMB3;TMEM38B;KCNT2
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",-0.5653553671962943,-1.4563425133314272,0.05263157894736842,0.47919956409790704,1.0,6/12,23.07%,AOX1;SDHB;ISCA1;XDH;FXN;CIAPIN1
prerank,chemokine activity (GO:0008009),0.557446409516829,1.4495462778866208,0.044642857142857144,0.7867528424112271,1.0,4/31,9.38%,CCL11;CXCL10;CCL4;CKLF
prerank,chemokine receptor binding (GO:0042379),0.5460141102557966,1.4422977629124742,0.049681528662420385,0.80664845820053,1.0,4/35,9.38%,CCL11;CXCL10;CCL4;CKLF
prerank,active ion transmembrane transporter activity (GO:0022853),-0.40985564437001687,-1.4403757467610654,0.03431372549019608,0.5030527778771327,1.0,18/37,24.40%,SLCO3A1;SLC22A8;SLCO2A1;SLC22A4;SLCO1C1;COX6B1;SLC22A6;COX6A1;COX4I1;UQCR11;COX5B;COX5A;SLC16A7;UQCR10;UQCRH;SLCO5A1;UQCRFS1;UQCRC1
prerank,microtubule minus-end binding (GO:0051011),-0.5590510112301348,-1.439437829221969,0.08630952380952381,0.48469904414933207,1.0,7/13,16.76%,MACF1;TUBGCP4;TUBGCP3;TUBGCP6;NUMA1;HAUS7;TUBGCP2
prerank,mitogen-activated protein kinase binding (GO:0051019),0.5529487284778684,1.4314992903530148,0.08118556701030928,0.8463766799259329,1.0,12/29,20.05%,DUSP4;MAPK7;MAPKAPK3;MAPKAPK2;DUSP6;PTPRJ;MAPK14;PRMT1;ABL1;NBR1;DUSP16;DUSP1
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.694133795939142,1.426405869207754,0.08497723823975721,0.8534530712557671,1.0,2/10,2.40%,KAT2B;CDKN2B
prerank,cholesterol binding (GO:0015485),0.5101968256679367,1.4260257466223647,0.07334963325183375,0.8360061012910767,1.0,7/47,5.51%,APOD;PTCH1;VDAC2;ERLIN2;NPC1;OSBPL5;GRAMD1A
prerank,monocarboxylate:sodium symporter activity (GO:0140161),-0.5703564782850575,-1.4259983382462988,0.10057471264367816,0.5028092607827006,1.0,4/10,12.22%,SLC6A12;SLC6A13;SLC6A11;SLC6A1
prerank,peptidase activator activity (GO:0016504),-0.4543502121686761,-1.4169345497104362,0.06538461538461539,0.5084116817487366,1.0,14/22,33.17%,PSMD14;MAL;PCOLCE2;APH1B;CAV1;PCOLCE;PINK1;PSENEN;CASP8AP2;ADRM1;VCP;PSME3;VSIR;PSME2
prerank,symporter activity (GO:0015293),0.6667945164541543,1.4094741427252377,0.10849056603773585,0.907187093080492,1.0,1/10,0.36%,SLC28A1
prerank,ADP binding (GO:0043531),-0.437598639805833,-1.406343676665717,0.052845528455284556,0.5168357686632454,1.0,8/25,15.16%,PRKAG2;MYH9;ME1;PGK1;ABCG1;ATP5F1D;MYH10;ERN1
prerank,phosphatase binding (GO:0019902),0.4650922527054705,1.4042243729679815,0.03648068669527897,0.9166721708075726,1.0,42/105,22.90%,LGALS3;ANK1;ERBB2;EGFR;PTPRT;EIF2AK3;MAST2;SH3YL1;SPRED1;PDLIM4;SHOC2;RCAN3;ANAPC7;PIK3R1;MAPK14;MAPK1;MAGI2;FBXL2;TBK1;PPP1R3F;HSP90B1;RPA2;CRY1;IQGAP1;MET;ELL;JUP;SYTL2;TP53;TERF2IP;VRK3;KIF3A;STX17;STAT3;CDC27;SIRPA;ANAPC4;PXN;DLG4;ANAPC5;STAT6;KIFAP3
prerank,solute:sodium symporter activity (GO:0015370),0.5474488806904516,1.402376183748565,0.08718626155878467,0.906919690187547,1.0,2/27,2.53%,SLC28A1;SLC5A3
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),0.6045402823784826,1.400447099730976,0.10028653295128939,0.8986057992020766,1.0,2/15,1.57%,SLC1A3;SLC1A5
prerank,platelet-derived growth factor binding (GO:0048407),0.6610790097433381,1.4004316520520963,0.10248447204968944,0.8799683671902001,1.0,4/11,14.63%,PDGFRA;COL3A1;COL1A2;COL1A1
prerank,pentosyltransferase activity (GO:0016763),-0.3909127283034531,-1.395419114516793,0.05699481865284974,0.5292333327737018,1.0,12/36,21.08%,ZC3HAV1;PARP3;PARP4;PARP10;PARP1;SIRT3;PARP6;PARP14;SIRT4;QTRT2;QPRT;LARGE1
prerank,mechanosensitive ion channel activity (GO:0008381),0.6363045196119471,1.3937486924215134,0.11160714285714286,0.8993391112445132,1.0,2/12,2.96%,PIEZO2;TMEM63A
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),-0.48996732993450276,-1.384470773376235,0.10175438596491228,0.5236437889293689,1.0,4/16,0.62%,PTPRK;PTPRM;PTPRB;PTPRG
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),-0.48996732993450276,-1.384470773376235,0.10175438596491228,0.5236437889293689,1.0,4/16,0.62%,PTPRK;PTPRM;PTPRB;PTPRG
prerank,growth factor receptor binding (GO:0070851),0.45646696696906325,1.3838615885645102,0.05326086956521739,0.9340915479436273,1.0,19/95,11.99%,EFEMP1;PDGFRA;GLMN;FGF2;PYCARD;FGF10;VEGFA;PSEN1;ATXN2;FYN;HIP1;BTC;TRIP6;ERBB4;PTPRJ;NCSTN;ARF4;IL6ST;FGF7
prerank,intracellular ligand-gated ion channel activity (GO:0005217),-0.5455117518847517,-1.3816645156129805,0.11452513966480447,0.5140558952759697,1.0,3/11,9.86%,ITPR1;RASA3;MCOLN1
prerank,single-stranded DNA binding (GO:0003697),0.44704156377725945,1.3805307106341151,0.0565410199556541,0.9347797703621212,1.0,31/93,21.96%,DDX11;RAD23B;SSBP2;MEIOB;APTX;ERCC5;ERCC4;STN1;RPA3;SETMAR;REXO4;TDP1;FBH1;MCM4;RPA2;POLR2G;RAD52;BLM;HNRNPU;FAM111A;FUBP1;PARK7;TOP1;HMCES;FUBP3;HSPD1;SSBP1;CTC1;MLH1;TOP3A;RBMS1
prerank,potassium:proton antiporter activity (GO:0015386),-0.5645405480955124,-1.3796563452765467,0.10684931506849316,0.5026776795158069,1.0,5/10,11.85%,SLC9A6;SLC9A2;SLC9A8;SLC9A9;SLC9A7
prerank,aspartic-type endopeptidase activity (GO:0004190),0.6282011965776241,1.3784059547760639,0.1187214611872146,0.9288496985522829,1.0,3/12,4.32%,BACE2;HM13;PSEN1
prerank,low-density lipoprotein particle binding (GO:0030169),-0.4832970495700745,-1.375520173287284,0.09210526315789473,0.4983386574642892,1.0,5/16,11.93%,CDH13;PLTP;THBS1;SCARF1;STAB1
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.4566117181501401,1.374621549483586,0.046052631578947366,0.9327311141429372,1.0,15/91,8.72%,STXBP6;RAG2;PLEKHA4;PLEKHA5;SESTD1;GSN;ANXA9;PLCB1;WIPI1;MAPKAP1;LAPTM4B;FZD7;GBF1;RPH3A;HIP1
prerank,WW domain binding (GO:0050699),0.5317332254140406,1.3717883772235537,0.09274193548387097,0.9301767725253767,1.0,5/26,15.93%,ENAH;KIF20B;TRAF4;NDFIP1;TCEAL8
prerank,transmembrane receptor protein kinase activity (GO:0019199),0.47635458586133295,1.369696159205612,0.07674943566591422,0.9241982747485609,1.0,13/60,7.80%,ROR2;ROR1;PDGFRA;ERBB3;NTRK3;EPHB6;ERBB2;EGFR;ACVR1;EPHB2;NTRK2;TGFBR2;FGFR1
prerank,methylated histone binding (GO:0035064),0.47435787856084727,1.366785747765558,0.07249712313003452,0.9234804182415641,1.0,20/62,18.96%,RAG2;LRWD1;KDM8;CXXC1;KAT8;SPIN1;ATRX;MBTD1;CDYL;MSH6;ING4;PHF8;TAF7;MSL3;PYGO1;PHF19;ING1;ZMYND11;TAF1;KMT2E
prerank,methylation-dependent protein binding (GO:0140034),0.47892168750053676,1.3611471147344518,0.07916181606519208,0.9378920689843344,1.0,18/57,18.96%,RAG2;LRWD1;KDM8;CXXC1;KAT8;SPIN1;ATRX;MBTD1;CDYL;MSH6;ING4;PHF8;MSL3;PYGO1;PHF19;ING1;ZMYND11;KMT2E
prerank,voltage-gated anion channel activity (GO:0008308),0.580903233310443,1.3609911611212515,0.13848396501457727,0.9223263315540878,1.0,3/15,3.47%,VDAC2;CLCN5;ANO6
prerank,ubiquitin-specific protease binding (GO:1990381),0.5646564348091316,1.3589241808013992,0.11408450704225352,0.917463790801858,1.0,7/19,14.36%,PTEN;PRKN;RHBDD2;DERL2;SELENOS;LCOR;SUMO1
prerank,protein phosphatase 2A binding (GO:0051721),-0.43300785936364017,-1.3564137261798805,0.08873720136518772,0.5307938653190739,1.0,14/23,26.05%,MFHAS1;PTPA;PPME1;STRN4;CTTNBP2NL;ARPP19;MAPT;IGBP1;SPHK1;MASTL;GRIN3A;BOD1;SMG5;BOD1L1
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.5442627047747111,1.3562825118545763,0.11709286675639301,0.9159538804193388,1.0,7/25,8.72%,RAG2;PLEKHA4;SESTD1;NCF1;MAPKAP1;GAB2;HIP1
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),-0.417627826934261,-1.35395469621659,0.09504132231404959,0.5223244295955543,1.0,12/26,12.64%,ABCG2;SLC16A12;SLC16A6;SLC6A12;SLC6A6;SLC6A13;SLC16A11;SLC16A2;SLC6A11;SLC6A1;SLC16A9;SLC5A6
prerank,G protein-coupled serotonin receptor activity (GO:0004993),0.5541468258091269,1.3518550287688,0.11724137931034483,0.894784597914278,1.0,3/22,9.86%,CHRM3;HRH1;HTR2C
prerank,G protein-coupled amine receptor activity (GO:0008227),0.5541468258091269,1.3518550287688,0.11724137931034483,0.894784597914278,1.0,3/22,9.86%,CHRM3;HRH1;HTR2C
prerank,serotonin receptor activity (GO:0099589),0.5541468258091269,1.3518550287688,0.11724137931034483,0.894784597914278,1.0,3/22,9.86%,CHRM3;HRH1;HTR2C
prerank,glucuronosyltransferase activity (GO:0015020),0.560209628381311,1.3498868770274288,0.12861271676300579,0.8912960571790639,1.0,3/19,8.61%,EXT1;CSGALNACT1;CHSY1
prerank,leak channel activity (GO:0022840),0.5685649258748599,1.3477664216190253,0.12033195020746888,0.8880536314037332,1.0,2/18,3.10%,KCNK15;KCNK1
prerank,filamin binding (GO:0031005),-0.538562944639623,-1.346608872041368,0.138328530259366,0.5258561196641465,1.0,4/11,20.87%,NEBL;SYNPO2;CEACAM1;RFLNA
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.47163743239424205,1.3454221232267736,0.09038238702201622,0.8865950895615654,1.0,11/60,4.52%,ROR2;ROR1;EFEMP1;PDGFRA;ERBB3;NTRK3;EPHB6;ERBB2;EGFR;EPHB2;NTRK2
prerank,potassium ion leak channel activity (GO:0022841),0.5809113891481605,1.3387882361877823,0.15494978479196556,0.90725984913572,1.0,2/15,3.10%,KCNK15;KCNK1
prerank,nucleosomal DNA binding (GO:0031492),0.5465348335120451,1.335057822199583,0.13286713286713286,0.912312315195269,1.0,11/21,20.79%,MTA2;MBD2;HDAC2;RCC1;SMARCC2;RBBP4;SMARCC1;SMARCE1;SMARCA4;HNRNPC;GATAD2B
prerank,endonuclease activity (GO:0004519),0.47527030705306156,1.3346729467058418,0.10419161676646707,0.9008915706502956,1.0,10/49,10.78%,ZRANB3;INTS11;MBD4;ERCC5;ERCC4;NOB1;SETMAR;ZC3H12B;REXO4;RCL1
prerank,phospholipid transfer activity (GO:0120014),-0.4306423388633005,-1.334202319611431,0.12686567164179105,0.5432877112627964,1.0,10/21,19.91%,PITPNM2;ABCA3;PLTP;PITPNA;GLTP;OSBPL2;TNFAIP8L3;C2CD2L;PRELID2;CERT1
prerank,endopeptidase activity (GO:0004175),0.41795972743838417,1.3282934321555133,0.010121457489878543,0.9196216954582609,1.0,68/257,21.23%,HGFAC;KLK12;MMP2;ADAMTS12;ADAM19;ADAMTS20;FAP;BACE2;HTRA3;CORIN;USP35;USP11;PARL;KDM8;MIPEP;PSEN1;PCSK4;PCSK6;MMP15;CTSK;CTSO;ADAMTS1;CASP6;KLK1;KLK6;CTSB;PSMB7;UCHL1;ADAMTS4;USP46;PMPCB;THOP1;MMP16;USP33;ADAMTSL1;USP48;GZMM;MALT1;MMP19;TYSND1;USP40;ADAM33;PSEN2;USP14;CASP2;ADAMTS2;THSD4;USP1;USP25;PSMB2;USP2;ADAMTSL4;USP37;PIK3IP1;CASP7;ADAMTS14;MASP2;USP5;KLK2;SENP1;CPNE1;MBTPS1;PCSK7;USP13;PSMA8;PLAT;FURIN;RHBDD1
prerank,anion channel activity (GO:0005253),0.45932619632467414,1.3274377938508057,0.10783200908059024,0.911059483122768,1.0,7/61,6.83%,FXYD3;ANO2;VDAC2;CLCN5;ANO6;LRRC8D;TTYH3
prerank,phospholipase A2 activity (GO:0004623),0.5305891953625044,1.326756320717761,0.10818307905686546,0.9018302868553435,1.0,6/26,13.50%,PRDX6;PLA2G7;PLA2G12A;PLAAT5;PLAAT3;PNPLA8
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),0.5254757406032765,1.323595575527025,0.13112582781456952,0.9041671905156937,1.0,3/28,4.68%,EDA;FADD;TRAF4
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.45284025826289,1.321524563296106,0.08295454545454546,0.9023912395941119,1.0,11/72,8.72%,STXBP6;RAG2;PLEKHA4;SESTD1;GSN;ANXA9;PLCB1;MAPKAP1;FZD7;RPH3A;HIP1
prerank,poly(A) binding (GO:0008143),0.5570763524350469,1.3145813586248731,0.13428943937418514,0.9239820283399256,1.0,5/21,4.57%,PABPC5;RBMS3;HNRNPDL;ELAVL4;PABPC1
prerank,lipoprotein particle binding (GO:0071813),-0.4399217839490651,-1.313618707656073,0.13454545454545455,0.5836615719578649,1.0,8/20,21.77%,CDH13;PLTP;THBS1;SCARF1;STAB1;MAPT;LPL;COLEC12
prerank,voltage-gated cation channel activity (GO:0022843),0.43805477500790413,1.3120356776962039,0.09337676438653637,0.9237724317321471,1.0,31/97,22.89%,CACNA1E;KCNA2;KCNH8;CACNA2D1;CACNG7;KCNK1;NCS1;KCNA1;CACNA1A;GRIN2B;KCNA6;KCND1;CACNB4;KCND2;KCND3;TPCN2;GRIN2D;GRIN2A;KCNH2;CACNA2D4;KCNMA1;CACNA2D2;KCNA5;HCN1;KCNS3;KCNH7;LRRC55;PKD2;KCNQ3;KCNA4;KCNC1
prerank,gated channel activity (GO:0022836),0.5792911066881985,1.3091708695447268,0.17101449275362318,0.9257550406277415,1.0,2/14,2.96%,PIEZO2;TMEM63A
prerank,metalloendopeptidase activity (GO:0004222),0.44444687716072667,1.306896100093215,0.09410430839002268,0.924076087117061,1.0,18/76,18.60%,MMP2;ADAMTS12;ADAM19;ADAMTS20;MIPEP;MMP15;ADAMTS1;ADAMTS4;PMPCB;THOP1;MMP16;ADAMTSL1;MMP19;ADAM33;ADAMTS2;THSD4;ADAMTSL4;ADAMTS14
prerank,chloride transmembrane transporter activity (GO:0015108),-0.4593790284221325,-1.3053203615695468,0.1423487544483986,0.5908998315509069,1.0,7/16,30.82%,SLC26A7;SLC26A2;SLC4A8;SLC26A6;SLC26A8;SLC1A1;CLCN6
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),0.5075393266837234,1.3046036438601685,0.1461836998706339,0.9230866710187782,1.0,10/28,21.02%,GRIK3;CHRNA4;GRIK5;GRIK2;GRID2;GRIK1;GABRG2;GABRA3;GABRA2;GRID1
prerank,monocarboxylic acid binding (GO:0033293),0.5331448919672355,1.2992500568898997,0.17342657342657342,0.9365796724396146,1.0,1/18,0.79%,PYGL
prerank,neuropeptide binding (GO:0042923),0.5449127534401368,1.298140759982068,0.1717612809315866,0.9302510144259692,1.0,3/18,16.76%,SSTR1;GPR37;OPRK1
prerank,epidermal growth factor receptor binding (GO:0005154),0.5070736193237857,1.2953336330568495,0.17018469656992086,0.9322904032196884,1.0,12/25,24.53%,EFEMP1;ATXN2;HIP1;BTC;ERBB4;ARF4;SNX1;HBEGF;GRB2;CCDC88A;SNX4;LINGO1
prerank,protease binding (GO:0002020),0.428890137044581,1.294378033679445,0.09803921568627451,0.9252723346826113,1.0,27/99,16.11%,A2M;FAP;PYCARD;PTEN;BCL2;PRKN;FADD;ANXA9;RHBDD2;NTRK2;PRNP;CSTB;BIN1;ADAMTS4;COL3A1;DERL2;SELENOS;COL1A2;NFRKB;TYSND1;LCOR;SUMO1;COL1A1;ITGB1;CRADD;TP53;POLG
prerank,actin monomer binding (GO:0003785),-0.4112567403734206,-1.2932845479363524,0.14336917562724014,0.6081785462451522,1.0,10/22,27.66%,MTSS1;NOS3;ABL2;PFN2;TMSB4X;LIMA1;ABITRAM;TMSB10;MYL4;TWF2
prerank,sulfuric ester hydrolase activity (GO:0008484),0.6001797934013123,1.2923222178279579,0.19659442724458204,0.9235042817096117,1.0,6/12,22.31%,SULF1;GALNS;IDS;SGSH;ARSK;SULF2
prerank,tropomyosin binding (GO:0005523),-0.4516517403716132,-1.2919685098465286,0.12012987012987013,0.5968085441813403,1.0,3/16,0.81%,NEBL;CALD1;TMOD3
prerank,dipeptidyl-peptidase activity (GO:0008239),0.6151396729825472,1.2902458365524085,0.19969742813918306,0.9218839522291772,1.0,3/10,7.13%,FAP;NAALAD2;DPP10
prerank,phosphoric diester hydrolase activity (GO:0008081),-0.3686296022766328,-1.2854660279395225,0.1,0.5984169422851995,1.0,4/35,3.34%,GPCPD1;MPPED2;PLCL1;PLCB3
prerank,CCR chemokine receptor binding (GO:0048020),0.5058164688817521,1.2845569647043458,0.1576158940397351,0.9388548737545355,1.0,6/28,15.86%,CCL11;CCL4;CCR2;NES;CCL14;CNIH4
prerank,protein tyrosine kinase activity (GO:0004713),0.4196231883447879,1.2787750207783548,0.11051502145922747,0.954986367651012,1.0,19/108,10.96%,ROR2;ROR1;PDGFRA;ERBB3;NTRK3;PKDCC;PEAK1;EPHB6;ERBB2;EGFR;EPHB2;TEC;NTRK2;CSK;FGFR1;FYN;ERBB4;TYK2;STYK1
prerank,calcium ion binding (GO:0005509),0.39848814168957425,1.2762149653283503,0.03006012024048096,0.9560703226729876,1.0,67/323,16.38%,DCHS1;CDH19;PCDHA4;ASTN2;S100A4;DHH;PLSCR4;GSN;LRP1;C2CD5;EFHD1;ANXA9;NCS1;LETM1;CAPN1;CD320;HPCA;NUCB1;DSG2;CDH10;NRXN1;PRNP;CDH22;EML1;CABCOCO1;CDH8;AOC1;SYT1;PPP3CB;ITSN1;RCN1;S100A6;RPH3A;PPP3CA;S100A16;ANXA11;RCN3;SPARC;FKBP9;SYT11;SYT12;CDH20;CDH7;MCTP1;GLCE;ANXA6;CALU;ADGRL3;SLC25A23;CDK5R1;HSP90B1;OTOF;CCDC47;SRR;SMOC2;KCNIP4;SNCA;SCUBE1;PVALB;CALM1;GALNT3;IQGAP1;IDS;CALM2;CDH18;LRP2;SLC25A24
prerank,transcription coactivator binding (GO:0001223),0.5270841105184211,1.2759793384188858,0.18446601941747573,0.9463527479786629,1.0,2/20,2.29%,RORA;VGLL4
prerank,"DNA binding, bending (GO:0008301)",-0.46250323984414643,-1.2748605982758494,0.17034700315457413,0.6128372967610217,1.0,6/14,24.49%,LEF1;FOXL1;HMGA2;HHEX;HMGB2;FOXD1
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.5174314303491168,1.2746017136320824,0.16689466484268126,0.9415283591259935,1.0,7/22,14.90%,RBMS3;ELAVL4;EXOSC8;CPEB3;ZFP36L2;CPEB1;KHSRP
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),-0.47359953515953906,-1.272678208312883,0.16725978647686832,0.6046193068302013,1.0,5/15,12.61%,ALDH1A2;ALDH1A1;ALDH2;ALDH3A2;ALDH9A1
prerank,metalloendopeptidase inhibitor activity (GO:0008191),0.5547724997993347,1.2676862070334993,0.216793893129771,0.9633975755054055,1.0,3/14,3.46%,LXN;NGF;RECK
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),0.5927857908289293,1.2663925132835048,0.22429906542056074,0.9487468272736169,1.0,4/10,20.05%,DUSP4;DUSP6;DUSP16;DUSP1
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),0.5927857908289293,1.2663925132835048,0.22429906542056074,0.9487468272736169,1.0,4/10,20.05%,DUSP4;DUSP6;DUSP16;DUSP1
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.5276745057186155,1.2627341446672586,0.17289073305670816,0.955095197671103,1.0,10/20,23.18%,MAGI3;DTYMK;DLG2;AK1;AK3;AK6;AK2;AK8;CARD11;CMPK1
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),0.5309017693201814,1.26181114630647,0.1935933147632312,0.9491561282916211,1.0,9/19,21.02%,GRIK3;GRIK5;GRIK2;GRID2;GRIK1;GABRG2;GABRA3;GABRA2;GRID1
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.5152713959882089,1.2603475365450785,0.19328859060402684,0.9364674341848718,1.0,6/21,8.84%,CDK8;CDKL3;CDK13;CDK6;CDK15;CDK19
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.5152713959882089,1.2603475365450785,0.19328859060402684,0.9364674341848718,1.0,6/21,8.84%,CDK8;CDKL3;CDK13;CDK6;CDK15;CDK19
prerank,metal ion transmembrane transporter activity (GO:0046873),0.49689765239790695,1.2589506007982005,0.20184696569920843,0.9335286428230521,1.0,9/27,13.79%,SLC12A3;MRS2;KCNA1;ATP2B3;SLC12A2;SLC8A2;MAGT1;ATP2B1;TUSC3
prerank,phosphatidylglycerol binding (GO:1901611),-0.4808078015392512,-1.2587372277441848,0.1935483870967742,0.6287653595539362,1.0,7/13,29.59%,PLTP;PITPNA;STOML2;GSDMD;GSDME;UQCC3;MME
prerank,mRNA 5'-UTR binding (GO:0048027),-0.390504079609541,-1.2583680576988174,0.13385826771653545,0.6159816715804749,1.0,9/24,24.71%,RPS14;RPL5;MYH10;IGF2BP3;UTP23;RPL26;MRPS11;RPL41;IGF2BP2
prerank,ion channel activity (GO:0005216),0.423134931174471,1.2581997756449121,0.12956810631229235,0.9270451141731048,1.0,16/80,14.39%,PIEZO2;GRIA1;TMEM63A;GRIK3;CALHM6;GRIA3;CHRNA4;GRIN2B;GRIK5;GRIK2;GRID2;GRIK1;ANXA6;TMEM120A;GRIN2D;GRIN2A
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),0.46654580220015546,1.2546083289620324,0.17875,0.9333498713567067,1.0,7/38,9.31%,PLEKHA4;PLEKHA5;SESTD1;WIPI1;BBS5;HIP1;LANCL2
prerank,aspartic-type peptidase activity (GO:0070001),0.6002302855570338,1.253513162989581,0.2313546423135464,0.9290109541655752,1.0,2/10,4.32%,BACE2;PSEN1
prerank,ligand-gated cation channel activity (GO:0099094),0.4179117225244022,1.2524441520894052,0.15706214689265538,0.9245114604345636,1.0,14/75,16.10%,GRIA1;GRIK3;KCNK1;GRIA3;CHRNA4;GRIN2B;GRIK5;GRIK2;GRIK1;GRIN2D;KCNJ3;GRIN2A;KCNJ10;KCNH2
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.4742101656998728,1.2491598653930625,0.17829457364341086,0.9298689929957352,1.0,12/30,23.13%,DPEP1;MT3;CSTB;UBE2Z;PRDX3;SNCA;UBE2O;XIAP;CAST;PTTG1;RPS6KA3;CARD16
prerank,transcription coregulator binding (GO:0001221),0.44317703242664364,1.2490692258144198,0.15745192307692307,0.9212748830985458,1.0,12/50,15.33%,RORA;USP11;VGLL4;EED;ZBTB16;ESR1;HDAC6;PER3;PER1;AHR;LCOR;MED25
prerank,syntaxin-1 binding (GO:0017075),-0.4084041196828957,-1.2486427754777794,0.17712177121771217,0.6282728175173722,1.0,6/22,10.71%,DAPK1;UNC13C;STXBP1;NSF;CPLX1;UNC13B
prerank,cAMP response element binding (GO:0035497),0.5952373962624214,1.2461856681446075,0.21864951768488747,0.9249384761392748,1.0,3/10,10.51%,CREB3L1;CREB3L2;ATF2
prerank,histone acetyltransferase activity (GO:0004402),0.4811432137323179,1.242802148232935,0.18513689700130379,0.9311520729647661,1.0,11/30,18.83%,KAT2B;BAZ1A;HAT1;KAT8;MCM3AP;ATF2;TAF9;EPC1;NCOA3;EPC2;TAF1
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),-0.515749002950748,-1.240621068518852,0.2026315789473684,0.636700234065891,1.0,5/10,20.87%,PML;ANKRD13B;LAPTM5;ANKRD13A;FAAP20
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.5859139374598457,1.240178346089576,0.23511450381679388,0.9338118502562638,1.0,6/10,12.67%,SETD3;SETMAR;PRDM9;SETD2;NSD2;SETD5
prerank,H4 histone acetyltransferase activity (GO:0010485),0.5970267128930717,1.2400443955695406,0.22626582278481014,0.9257593794401137,1.0,4/10,15.62%,HAT1;KAT8;ATF2;MSL3
prerank,transition metal ion transmembrane transporter activity (GO:0046915),-0.3759448077783835,-1.2374358656939564,0.1826086956521739,0.6321575474707454,1.0,7/30,9.03%,SLC30A10;SLC31A1;ATP7A;SLC40A1;SLC39A8;SLC39A6;SLC30A1
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.5500950356322665,1.2365362934645512,0.2,0.9324288903630794,1.0,2/14,4.89%,AASS;ALDH1L1
prerank,protein tyrosine phosphatase activity (GO:0004725),0.42204750488050835,1.2333911419408374,0.16610549943883277,0.9373279548683718,1.0,20/71,15.42%,PTPRH;UBASH3B;PTPDC1;PTEN;PTPN22;DUSP4;PTPRT;PTPN2;PTPN13;PTPN1;DUSP11;PTPRJ;PTPN11;CDC25B;PTPRA;PTPN18;PTPRZ1;PTPN21;PTPRF;CDC14A
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",0.5876966083909008,1.2312935877675655,0.24461538461538462,0.9378858909598896,1.0,1/10,1.91%,DPEP1
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.4204768679162033,1.2308961259132825,0.1870748299319728,0.9313195674952135,1.0,15/73,21.44%,SORCS2;SORCS1;SORCS3;PTH2R;LGR5;TSHR;MAS1;GPR37;GLP2R;OPRK1;APLNR;S1PR2;VIPR2;ADCYAP1R1;MC5R
prerank,cytokine activity (GO:0005125),0.39594797292153533,1.229986133561343,0.13631633714880334,0.9269538199292946,1.0,11/131,5.52%,BMP5;CCL11;CXCL10;IL16;FGF2;CRLF1;VEGFA;TGFB1;CCL4;GDF9;WNT5A
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.4769882002217294,1.2285652065953525,0.20434227330779056,0.9250824105307622,1.0,13/31,21.71%,UBE2T;UBE2E2;UBE2K;UBE2Z;UBE2J2;AKTIP;UBE2O;UBE2Q1;TAF1;UBE2L3;UBE2G1;UBE2E1;UBE2D3
prerank,phosphatidylcholine transporter activity (GO:0008525),-0.43072326498824365,-1.2283009399195297,0.19281045751633988,0.6436459043365848,1.0,12/17,20.42%,ATP10A;PITPNM2;ABCA3;ABCA1;PLTP;PITPNA;ABCG1;ATP8B2;ABCB4;ATP10B;ABCA7;PCTP
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),0.48395875669305805,1.2280144564186408,0.22776280323450135,0.919426222528688,1.0,2/23,4.92%,CHRM3;PLCB1
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.5025091409635913,1.2267659707293492,0.21368715083798884,0.9164769018086864,1.0,6/22,18.00%,HSPG2;SYT1;ANKRA2;HSP90B1;APBB3;DNAJA1
prerank,fibroblast growth factor receptor binding (GO:0005104),0.5074490275674655,1.2242311733229103,0.23661971830985915,0.9191547057450825,1.0,2/21,1.62%,FGF2;FGF10
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),0.5839552142508497,1.223564644674833,0.23244929797191888,0.9142446494087876,1.0,3/10,9.77%,NCF1;NOX1;NCF2
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),-0.47542154605978726,-1.2228572577446595,0.20783132530120482,0.6459992764293402,1.0,4/12,10.79%,PIK3R3;PIK3C2A;PIK3C2B;PIK3R6
prerank,G protein-coupled photoreceptor activity (GO:0008020),0.5602331309721711,1.2218956471766758,0.2525697503671072,0.9135356688660641,1.0,2/12,11.20%,RHO;GPR88
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.4443176741952228,1.2209771645769723,0.20372670807453416,0.9096229023463,1.0,19/44,21.45%,PRDM16;SUV39H1;KMT2A;SETD3;CXXC1;EED;SETMAR;MEN1;PRDM9;SETD2;NSD2;SETD5;ASH2L;SETD4;KMT2E;N6AMT1;SETDB1;KMT2D;NSD1
prerank,sodium ion transmembrane transporter activity (GO:0015081),-0.36392516340391934,-1.2193179587942804,0.18410041841004185,0.6426856857445058,1.0,11/27,14.85%,SLC8A3;SLC41A1;SLC8B1;SLC9A6;SLC9A2;SLC9A8;SLC9B2;SLC4A8;SLC9A9;SLC9A7;CNNM4
prerank,voltage-gated sodium channel activity (GO:0005248),0.4969378217649472,1.2170051792866512,0.22905027932960895,0.9186303162749396,1.0,4/22,6.94%,SCN7A;SCN2A;SCN5A;SCN3A
prerank,GTPase inhibitor activity (GO:0005095),0.5465349620738984,1.21688830040023,0.23816568047337278,0.9114866783212601,1.0,5/13,14.88%,RTKN;IQGAP2;ARL2;RHOH;IQGAP1
prerank,receptor ligand activity (GO:0048018),0.38298039414439794,1.2155548522373436,0.09644670050761421,0.9093890403594332,1.0,32/245,12.11%,LGALS3;BMP5;CCL11;EDA;CXCL10;IL16;CRH;FGF2;FGF10;SEMA3E;CRLF1;NGF;SEMA6C;NRG3;VEGFA;PTHLH;SEMA3A;TGFB1;CCL4;GDF9;WNT5A;TAFA4;TAFA1;IL18;BTC;AMELX;GDNF;DAND5;BMP7;EDN3;FGF7;GRN
prerank,chloride channel regulator activity (GO:0017081),0.5403087688494945,1.214479119121513,0.24063400576368876,0.9064199630607318,1.0,5/14,16.80%,WNK2;WNK3;SGK3;STX8;SGK1
prerank,sulfotransferase activity (GO:0008146),-0.34605942114690397,-1.213790569229803,0.1872146118721461,0.6449871057725782,1.0,15/33,22.81%,HS3ST3A1;HS3ST1;CHST15;CHST11;TPST1;GAL3ST1;CHST2;UST;CHST3;CHST12;HS3ST2;CHST10;CHST1;SULT4A1;GAL3ST2
prerank,basic amino acid transmembrane transporter activity (GO:0015174),-0.46648777382627327,-1.2127079007895294,0.22865853658536586,0.6357094666649256,1.0,4/13,11.83%,SLC7A2;SLC38A7;SLC66A1;SLC38A5
prerank,poly(U) RNA binding (GO:0008266),0.5120824087892224,1.208309632645423,0.23328785811732605,0.9237922660420107,1.0,9/20,21.96%,PABPC5;RBMS3;PABPC1;DAZAP1;PNPT1;SSB;MCRS1;HNRNPC;RBMS1
prerank,chloride channel activity (GO:0005254),0.41804597162587526,1.2072253225688923,0.2190034762456547,0.9210344127666811,1.0,14/59,20.51%,FXYD3;ANO2;CLCN5;ANO6;TTYH3;TTYH1;FXYD1;CLIC1;CLCN2;GABRG2;TTYH2;GABRA3;GLRB;GABRA2
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),0.5449229398403538,1.2062812636954172,0.248868778280543,0.9176333988165846,1.0,5/12,11.41%,CDK8;CDK13;CDK6;CDK19;MAPK1
prerank,voltage-gated potassium channel activity (GO:0005249),0.40785355966725023,1.2053255863181112,0.19094922737306844,0.9143168465112707,1.0,28/80,26.22%,KCNA2;KCNH8;KCNK1;KCNA1;KCNA6;KCND1;KCND2;KCND3;KCNT2;KCNJ3;KCNJ10;KCNH2;KCNMA1;KCNA5;HCN1;KCNS3;KCNH7;LRRC55;PKD2;KCNQ3;KCNK6;KCNA4;KCNC1;KCNJ13;KCNQ5;KCNN2;HCN2;HCN3
prerank,nucleotidase activity (GO:0008252),0.518737423328316,1.2046655649170837,0.22627737226277372,0.9099095969414956,1.0,6/15,18.58%,NT5DC2;NT5C2;BPNT1;BPNT2;NT5C3B;NT5C
prerank,acid-thiol ligase activity (GO:0016878),0.540685203274089,1.2040011529991317,0.27134146341463417,0.9055316025321017,1.0,3/13,7.11%,ACSS2;ACSS3;ACSS1
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),-0.4660781908596759,-1.2030491119473485,0.2305084745762712,0.649772219788673,1.0,5/13,12.61%,ALDH1A2;ALDH1A1;ALDH2;ALDH3A2;ALDH9A1
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),0.5110518485067681,1.1998194755736058,0.2571428571428571,0.9151680072322829,1.0,4/18,6.44%,STXBP6;PAK4;CNN3;BAIAP2
prerank,leucine zipper domain binding (GO:0043522),-0.49475706513219164,-1.1986722531403273,0.24661246612466126,0.6487914057384617,1.0,1/10,0.14%,PAWR
prerank,semaphorin receptor activity (GO:0017154),-0.4661669966256572,-1.1980230198275543,0.25833333333333336,0.6393603882782524,1.0,5/11,13.22%,PLXNA2;NRP1;PLXNB1;PLXNA1;PLXNA4
prerank,cytokine receptor activity (GO:0004896),0.39921631231652666,1.1976317140593586,0.1951219512195122,0.9167921389696666,1.0,14/83,17.15%,GFRA1;IL2RA;CRLF1;IL20RB;GFRA4;CCR2;IL1RL2;CSF3R;IL6ST;PRLR;ACKR4;GFRA2;IL1RAP;CD74
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.37810827323588153,1.1971343643553287,0.15195071868583163,0.9118884246444229,1.0,30/173,15.14%,OSR2;CREB3L1;PRDM16;MYC;ZNF25;ZBTB20;OTP;ZBTB37;SATB1;NFX1;FOXP2;ZEB1;ZBTB16;RORC;MLX;TRPS1;E2F6;LRRFIP1;TBX18;ZBTB6;NFATC3;ZGPAT;PATZ1;FOXP4;ZBTB1;GATA3;ZBTB39;NACC2;CREM;ZEB2
prerank,potassium ion transmembrane transporter activity (GO:0015079),0.4659201779195368,1.1957059808047046,0.24083769633507854,0.9106406258328571,1.0,7/31,11.15%,KCNA2;SLC12A3;KCNK1;KCNA1;SLC12A2;TMEM38B;SLC12A4
prerank,poly-purine tract binding (GO:0070717),0.4805136740678887,1.192026249516611,0.24337957124842372,0.91791201054747,1.0,5/27,4.57%,PABPC5;RBMS3;HNRNPDL;ELAVL4;PABPC1
prerank,chloride channel inhibitor activity (GO:0019869),0.5780449539316443,1.1905632710160412,0.27217125382262997,0.9167856626541405,1.0,2/10,3.54%,WNK2;WNK3
prerank,NAD+ binding (GO:0070403),-0.4584346002337143,-1.190481136765556,0.2215568862275449,0.6480955256300632,1.0,4/12,14.79%,ZC3HAV1;CRYL1;SIRT3;HPGD
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.4535154199918413,1.1899484461803522,0.25156445556946183,0.91239827593601,1.0,12/33,17.41%,WAC;ZNF326;ERCC5;RPRD1A;URI1;DRAP1;GTF2B;ELP2;ELP4;HNRNPU;CDC73;NCOA3
prerank,metal ion binding (GO:0046872),0.3686512822204173,1.1893569291961608,0.065,0.9081035257111277,1.0,92/477,15.79%,DCHS1;CDH19;PCDHA4;ASTN2;S100A4;DHH;IDH2;PLSCR4;GSN;PSPH;LRP1;C2CD5;EFHD1;ANXA9;NCS1;PDXK;IRAK3;LETM1;SIK2;CAPN1;CD320;MAST2;HPCA;DXO;NUCB1;DSG2;CDH10;NRXN1;PRNP;GSS;MT3;PGM1;CDH22;EML1;CABCOCO1;UBA2;ACVR1C;CDH8;AOC1;SYT1;HMGCLL1;PPP3CB;ITSN1;NUDT22;POSTN;RCN1;S100A6;RPH3A;CSGALNACT1;PPP3CA;S100A16;RPE;ANXA11;RCN3;SPARC;FKBP9;SYT11;SYT12;CDH20;CDH7;MCTP1;ENDOV;GLCE;PI4K2A;MSH6;ANXA6;CALU;ADGRL3;SLC25A23;CDK5R1;NUDT3;GNAI1;HSP90B1;OTOF;CCDC47;SRR;EXD2;SMOC2;KCNIP4;SNCA;SCUBE1;PVALB;IDH3A;CALM1;GALNT3;IQGAP1;OPA1;IDS;ABL1;CALM2;PAPOLA;CDH18
prerank,amyloid-beta binding (GO:0001540),0.39469318673654324,1.1880685007167426,0.22185792349726777,0.9066898932756562,1.0,20/79,18.26%,HSPG2;LRP1;GRIA1;EPHB2;GRIA3;CACNA1A;PRNP;GRIN2B;NLGN1;APBB2;GSAP;CRYAB;NGFR;APBA1;CLSTN1;GRIN2A;TM2D1;CD74;APBB3;PGRMC1
prerank,RNA polymerase core enzyme binding (GO:0043175),0.4522156415155828,1.1880027808410047,0.22824716267339218,0.9004426261883733,1.0,12/33,17.41%,ERBB2;WAC;ZNF326;ERCC5;RPRD1A;URI1;GTF2B;ELP2;ELP4;HNRNPU;CDC73;NCOA3
prerank,bHLH transcription factor binding (GO:0043425),-0.4021265786960638,-1.1879672501603693,0.21895424836601307,0.643035589435712,1.0,6/19,19.58%,FHL2;KDM1A;LMO2;TCF12;CREBBP;TWIST1
prerank,receptor tyrosine kinase binding (GO:0030971),0.4169354153951588,1.1869673587815062,0.21993127147766323,0.8982717106494096,1.0,12/56,10.65%,SHC4;LRP4;CBLB;PTPN2;NRG3;SOCS5;ALKAL2;GAB2;GRB14;PTPN1;PIK3R1;CBL
prerank,ankyrin binding (GO:0030506),0.5102839279467247,1.1853684739732337,0.26382978723404255,0.8976771191257988,1.0,4/19,6.45%,NRCAM;SCN5A;SPTBN1;PLEC
prerank,heparan sulfate sulfotransferase activity (GO:0034483),-0.4263821601528174,-1.1835879180533508,0.2415902140672783,0.6433579151486661,1.0,6/15,14.93%,HS3ST3A1;HS3ST1;NDST3;NDST1;HS3ST2;HS3ST3B1
prerank,frizzled binding (GO:0005109),-0.34302143077450564,-1.1821058114306333,0.22660098522167488,0.6364902928239915,1.0,12/34,21.39%,WNT4;WNT5B;ZNRF3;WNT6;WNT9A;RYK;FZD1;RNF43;CCDC88C;WNT16;DVL2;WNT11
prerank,hexose transmembrane transporter activity (GO:0015149),0.5349849488962336,1.18209897013868,0.26905829596412556,0.9037562606357968,1.0,3/12,10.56%,SLC5A3;MFSD4A;SLC2A2
prerank,poly-pyrimidine tract binding (GO:0008187),0.4882781576383349,1.1809854285899455,0.2550607287449393,0.901600600975385,1.0,10/23,21.96%,PABPC5;RBMS3;PABPC1;DAZAP1;PNPT1;HNRNPU;SSB;MCRS1;HNRNPC;RBMS1
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),-0.440751167918478,-1.1783758961366366,0.25766871165644173,0.6348736063143768,1.0,4/13,15.84%,PIK3C2A;PIP5K1B;PIK3C2B;PIP4K2B
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.5507761381274096,1.1778256562624434,0.3003048780487805,0.9072301370915095,1.0,1/11,0.66%,SLC22A3
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.374451709129171,1.1768865479556554,0.17227319062181448,0.904709512344338,1.0,58/188,21.36%,SOX6;KLF15;CREB3L1;PRDM16;ZBTB20;SUV39H1;SOX11;GLI1;RFX3;CREB3L2;GATA6;TBX18;MEN1;CHD3;ATMIN;TFAM;BRCA1;SOX12;SOX5;CARM1;ARID4B;PRDM9;ERBB4;NFE2L2;SP1;TAF9;SFPQ;TAF2;CREBZF;PER3;XRCC6;ATF5;PER1;GATA3;AHR;SNCA;TAF7;RUNX1;TP53;KCNH2;FOXJ1;PAX2;GABPB1;GABPB2;RNF10;ASH2L;EGR1;BCOR;PPARG;JUN;STAT3;TFE3;KMT2D;PBX1;ZBED4;HNRNPL;NFKB1;THRA
prerank,ubiquitin protein ligase binding (GO:0031625),0.3654360954530354,1.1739723162505324,0.1305668016194332,0.909736765179556,1.0,69/253,20.00%,PRDX6;UBE2T;ERBB3;GLMN;PTPN22;BCL2;CBS;HM13;PRKN;EGFR;ERLIN2;FBXW7;BLZF1;TRAF4;SCN5A;SPOP;FBXO7;YWHAZ;LAPTM4B;RALB;NAE1;PACRG;BAG5;BRCA1;UBE2K;ANKRA2;UCHL1;CASC3;HIF1A;SYT11;CUL3;GPR37;SLF2;NGFR;UBE2J2;HDAC6;PATZ1;PRKACA;PER1;DET1;RPA2;NEDD8;SUMO1;RTN4;JKAMP;WASHC1;GABARAPL2;CCDC50;UBB;UBOX5;TP53;KCNH2;USP25;DBT;USP2;CUL4B;RIPK1;DNAJA1;HSPA9;MDM2;MID1;POLR2A;MAGEC2;NKD2;BCL10;UBE2L3;JUN;RRAGA;UBE2G1
prerank,FAD binding (GO:0071949),0.4688584244839878,1.1736465926867252,0.2782956058588549,0.904788550695006,1.0,4/24,8.75%,STEAP4;SQLE;DAO;MTRR
prerank,inorganic anion transmembrane transporter activity (GO:0015103),-0.3545861242106377,-1.1720578796508958,0.2237442922374429,0.6400547879276285,1.0,9/27,13.06%,SLC22A8;SLC26A7;SLC26A2;ANO1;SLC22A6;SLC5A5;SLC39A8;SLC25A30;LRRC8A
prerank,methyl-CpG binding (GO:0008327),0.4735241014531855,1.1715643101222106,0.2662162162162162,0.9065593775844956,1.0,6/22,16.09%,LRWD1;MBD1;MBD2;ZBTB38;PRMT1;TET3
prerank,phosphate ion binding (GO:0042301),0.5590934910724613,1.1674548278042438,0.299079754601227,0.9157567681732653,1.0,2/10,7.66%,ADSS1;RPH3A
prerank,alkali metal ion binding (GO:0031420),-0.45528798854777053,-1.1647965341274948,0.28938906752411575,0.6473239731460806,1.0,5/13,11.44%,ATP1A2;DRG1;ATP1A1;IMPA1;HDAC4
prerank,transmitter-gated ion channel activity (GO:0022824),0.44937940663310966,1.163570559789945,0.2777053455019557,0.9241420368440902,1.0,10/29,21.02%,GRIK3;GRIK5;GRIK2;GRID2;GRIK1;GRIN2D;GABRG2;GABRA3;GABRA2;GRID1
prerank,ubiquitin-dependent protein binding (GO:0140036),-0.48804817779944665,-1.1635624562230826,0.2736842105263158,0.6403443412856975,1.0,5/10,20.87%,USP15;ANKRD13B;LAPTM5;ANKRD13A;FAAP20
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),0.5590592542357256,1.162760998520516,0.3059210526315789,0.9210491704377104,1.0,4/10,19.51%,KDM8;KDM4B;PHF8;RIOX2
prerank,organic cation transmembrane transporter activity (GO:0015101),0.48833695940109295,1.160217940977886,0.2821637426900585,0.9251108546025838,1.0,3/16,11.78%,SLC22A3;SLC44A2;SLC7A8
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),-0.4717006086821063,-1.1582758484561475,0.28370786516853935,0.6445902199809828,1.0,3/10,10.29%,PIK3R3;PIK3C2A;PIK3C2B
prerank,calcium activated cation channel activity (GO:0005227),0.4919169916227404,1.1564443393887562,0.28910614525139666,0.9333631481225659,1.0,6/17,17.39%,TMEM63A;ANO6;KCNMB2;KCNMB3;ANO10;KCNMA1
prerank,CoA-ligase activity (GO:0016405),0.5080604399093913,1.1536100770077196,0.3093841642228739,0.9383275752504426,1.0,3/14,7.11%,ACSS2;ACSS3;ACSS1
prerank,carbohydrate kinase activity (GO:0019200),0.5334789596146812,1.151025147930845,0.3354330708661417,0.9422646388978327,1.0,6/11,22.84%,NAGK;FGGY;GNE;GALK2;HK2;HK1
prerank,tubulin binding (GO:0015631),0.35790890149568905,1.1506934416958825,0.1529175050301811,0.9374184315424208,1.0,76/295,19.60%,DLEC1;SGIP1;SAXO2;DNM1;FGF13;EFHC1;KIF20B;PRKN;KIF19;TTLL5;MAP4K4;MAP1B;GAS2L3;ARL3;TBCE;MAST2;TTLL11;STARD9;PRNP;EML1;PAK1;NDE1;MACO1;KIF21A;CCDC170;FYN;PACRG;BRCA1;CEP57;SETD2;CAPN6;DYNC1I1;TUBGCP5;VAPA;MID2;AGBL4;KIF5C;CLASP1;TTLL4;HDAC6;EMD;STMN4;AGBL1;CEP295NL;APC2;CDK5R1;UNC5C;KATNB1;RMDN2;ARL8A;ATF5;CKAP5;TRAPPC14;SNCA;MDM1;KIF22;TPGS1;WASHC1;OPA1;GABARAPL2;MAP6D1;EML5;NAV3;DIP2B;DCX;KIF21B;HTT;KIF3A;MAPRE3;CAMSAP1;MID1;KIF2A;HOOK2;IFT81;MAP6;CCDC66
prerank,purinergic nucleotide receptor activity (GO:0001614),0.5047461409477999,1.1501235320414505,0.3008720930232558,0.9335406824389387,1.0,5/15,21.51%,P2RY14;P2RY12;P2RY1;PTAFR;P2RX7
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",-0.28875426422988176,-1.1480061849990368,0.2109375,0.6608040126082478,1.0,21/54,25.72%,HDAC8;ACER2;TGM2;UPB1;NTAQ1;ASPG;NIT1;HDAC4;HINT3;ASAH2;AMDHD2;ASRGL1;SIRT4;HDAC11;HDAC3;HDAC5;SUDS3;MIER2;SIRT7;FAAH;HDAC10
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),0.5043703087750524,1.1462578468034723,0.32794117647058824,0.942463807073461,1.0,3/15,9.31%,PLEKHA5;SESTD1;LANCL2
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.5094592409721141,1.146143432768695,0.31343283582089554,0.9370244278253524,1.0,2/14,8.30%,RDH10;DHRS3
prerank,retinoic acid binding (GO:0001972),-0.4394095945570873,-1.1450739810239474,0.2845303867403315,0.6585489066939504,1.0,2/12,19.29%,CYP26B1;RARA
prerank,receptor antagonist activity (GO:0048019),0.4863125495997354,1.143989958741444,0.31,0.9393034538702825,1.0,2/17,9.21%,PXDN;DKK3
prerank,cell-cell adhesion mediator activity (GO:0098632),0.4168171922477232,1.1430993524264046,0.28465346534653463,0.9369265986542588,1.0,11/42,11.59%,STXBP6;PAK4;CNN3;LRRC4C;BAIAP2;NTNG1;CNTN6;CNTN2;DSCAM;PALLD;PPP1CA
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.4388941396630151,1.1413383380416295,0.28865979381443296,0.9375426621964467,1.0,17/34,27.09%,UBE2T;UBE2E2;UBE2K;UBE2Z;UBE2J2;AKTIP;UBE2O;UBE2Q1;TAF1;UBE2L3;UBE2G1;UBE2E1;UBE2D3;UBE2Q2;UBE2I;UBE2R2;UBE2J1
prerank,protein kinase C activity (GO:0004697),0.504004280026387,1.1405722473420679,0.33186490455212925,0.934789955988727,1.0,3/14,5.78%,PRKCA;PRKCQ;PKN1
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),0.3996151378267354,1.1404427931590646,0.28670520231213875,0.9296408809883715,1.0,18/57,19.89%,CYB561D2;UQCRQ;CYBRD1;NDUFS5;NDUFA4;NDUFB2;NDUFA8;NDUFS8;COX10;NDUFV3;NDUFS6;NDUFV2;NDUFA13;NDUFA6;NDUFA12;NDUFC1;CYB5A;NDUFA5
prerank,FMN binding (GO:0010181),0.5325592417198425,1.1402890623960136,0.33070866141732286,0.9245840317608517,1.0,3/11,8.75%,POR;PNPO;MTRR
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),0.528214927547374,1.13827861700469,0.3123076923076923,0.9260874664020141,1.0,5/13,19.01%,AGPAT2;AGPAT5;GPAT3;GPAT4;LPCAT2
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.3539302024165123,1.1377018190455406,0.18163471241170534,0.92256167472173,1.0,69/268,20.00%,PRDX6;UBE2T;ERBB3;GLMN;PTPN22;BCL2;CBS;HM13;PRKN;EGFR;ERLIN2;FBXW7;BLZF1;TRAF4;SCN5A;SPOP;FBXO7;YWHAZ;LAPTM4B;RALB;NAE1;PACRG;BAG5;BRCA1;UBE2K;ANKRA2;UCHL1;CASC3;HIF1A;SYT11;CUL3;GPR37;SLF2;NGFR;UBE2J2;HDAC6;PATZ1;PRKACA;PER1;DET1;RPA2;NEDD8;SUMO1;RTN4;JKAMP;WASHC1;GABARAPL2;CCDC50;UBB;UBOX5;TP53;KCNH2;USP25;DBT;USP2;CUL4B;RIPK1;DNAJA1;HSPA9;MDM2;MID1;POLR2A;MAGEC2;NKD2;BCL10;UBE2L3;JUN;RRAGA;UBE2G1
prerank,metallopeptidase activity (GO:0008237),0.37011846899711165,1.136896336246477,0.2540192926045016,0.9197596234794971,1.0,21/113,16.43%,MMP2;ADAMTS12;ADAM19;ADAMTS20;DPEP1;ADAM23;MIPEP;MMP15;ADAMTS1;ADAMTS4;PMPCB;LNPEP;THOP1;MYSM1;MMP16;ADAMTSL1;MMP19;ADAM33;PAPPA2;ADAMTS2;THSD4
prerank,transcription cis-regulatory region binding (GO:0000976),0.3529508532312037,1.1367461580229905,0.14714714714714713,0.9149447364676067,1.0,77/406,17.15%,RORA;OSR2;SOX6;KLF15;LHX5;CREB3L1;PRDM16;MYC;HOXB8;ZNF25;ZBTB20;SOX9;SUV39H1;OTP;SATB1;TFCP2;NFX1;SOX11;RFXANK;GLI1;E2F2;PHOX2A;HOXD3;RFX3;MLX;TRPS1;CREB3L2;XRN2;TWIST2;DRAP1;E2F6;GATA6;TBX18;MEN1;FOXM1;CHD3;ATMIN;TFAM;BRCA1;SOX12;SOX5;CARM1;BBX;HIF1A;ARID4B;PRDM9;ERBB4;ATF2;NFE2L2;SP1;TAF9;SFPQ;RBAK;TAF2;CREBZF;PER3;XRCC6;ATF5;PER1;GATA3;AHR;SALL2;POLRMT;SNCA;TAF7;CREM;RUNX1;PURG;TAF4;TP53;SP3;KCNH2;FOXJ1;PAX2;GABPB1;GABPB2;RNF10
prerank,sequence-specific mRNA binding (GO:1990825),0.5343594519177496,1.13325106567848,0.3574730354391371,0.9222016294143446,1.0,3/10,25.03%,ETF1;SSB;FMR1
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",0.5264331677093735,1.131652900394664,0.3203732503888025,0.9227720062191732,1.0,6/11,19.96%,GNPTAB;PTDSS1;PIGN;SGMS2;DPAGT1;PIGO
prerank,delayed rectifier potassium channel activity (GO:0005251),0.4330452349488834,1.1296983326381302,0.3,0.9241179038923281,1.0,10/32,24.78%,KCNA2;KCNA1;KCNA6;KCNH2;KCNA5;KCNS3;KCNQ3;KCNA4;KCNC1;KCNQ5
prerank,cysteine-type endopeptidase activity (GO:0004197),0.38375582477105663,1.128151848911045,0.2810098792535675,0.9240082946123421,1.0,26/78,19.11%,PYCARD;CAPN5;USP35;USP11;CAPN1;CTSK;CTSO;CASP6;CTSB;UCHL1;USP46;CAPN6;USP33;CASP12;USP48;MALT1;USP40;USP14;CASP2;USP1;USP25;USP2;USP37;CASP7;USP5;CAPN11
prerank,DNA binding (GO:0003677),0.34631507952670376,1.1280971453933613,0.117,0.9189229731138261,1.0,157/694,20.71%,RORA;OSR2;RAG2;SOX6;NKX6-2;MEOX1;MEOX2;TSHZ3;GLI2;SOX8;DDX11;PRDM16;CRLF3;MYC;RAD23B;BCL2;BANF2;CBFB;SOX9;SSBP2;HMGN1;MEIOB;EGFR;C1D;OTP;HOXA7;SATB1;APTX;MBD4;TFCP2;FOXP2;CHTF18;KDM5B;RFX2;ERCC5;TIPIN;EZH1;MBD1;GLI1;E2F2;ERCC4;TIGD2;MPG;DDB2;STN1;RFX3;ZBTB16;RPA3;MLXIPL;MLX;SETMAR;DRAP1;DEDD;LRRFIP1;MEN1;CHD3;TFAM;RARG;BRCA1;XPA;RARB;SOX12;REXO4;HIF1A;TDP1;NHEJ1;ZBTB6;CHD2;PRDM9;HDAC2;HUWE1;PSIP1;ENDOV;FBH1;NFE2L2;MCM4;LIN9;SP1;TAF9;MSH6;SFPQ;ZMYM6;CREBZF;ZGPAT;PATZ1;NR6A1;XRCC6;ATF5;GATA3;AHR;DDB1;POLRMT;RPA2;ORC1;POLR2G;PAX3;PDS5B;CRY1;ZNF638;POLG2;CREM;SLTM;ZEB2;GTF3C1;CGAS;POU3F1;ABL1;MEIS3;MSL3;RAD52;TAF4;BLM;TP53;TAF4B;PHF19;POLG;TRNP1;HNRNPU;QRICH1;FOXJ1;FAM111A;PAX2;CUL4B;FUBP1;WRN;NR5A1;PCID2;CSRNP3;AIFM1;MLF1;IRF3;ZNF496;ZMYND11;RNF4;PARK7;BATF;TAF1;CGGBP1;POLR2A;EGR1;CNBP;TOP1;CENPC;FOXJ3;PPARG;JUN;STAT3;PRDM2;HMCES;HP1BP3;MBD6;SMARCA4;FUBP3;KMT2D;SPO11;PBX1;MEIS1
prerank,flavin adenine dinucleotide binding (GO:0050660),0.40119233135779453,1.1263915486678608,0.3045507584597433,0.9196470775106387,1.0,8/53,8.75%,STEAP4;GCDH;POR;SQLE;DAO;ETFA;ACOX1;MTRR
prerank,sequence-specific DNA binding (GO:0043565),0.3472703555131543,1.1254991052661605,0.129,0.9174354782126491,1.0,88/590,16.44%,RORA;OSR2;RAG2;ETV1;NKX6-2;KLF15;MEOX1;ETV4;MEOX2;LHX5;TLX3;GLI2;CREB3L1;SOX8;PRDM16;TGIF2;BCL2;CBFB;HOXB8;ZBTB20;LRWD1;SOX9;HIVEP1;ZBTB37;HOXA7;KMT2A;SATB1;TFCP2;EGR3;FOXP2;UPF3A;KDM5B;RFX2;ZNF276;MBD1;E2F2;PHOX2A;CXXC1;HOXD3;STN1;RFX3;RORC;MLX;GATA6;TBX18;TFAM;RARG;MBD2;XPA;RARB;SOX12;BBX;KLF5;HIF1A;PRDM9;HDAC2;ZBTB38;NFATC3;ATF2;ESR1;NFE2L2;SP1;PRMT1;UPF1;KLF13;ZGPAT;NR6A1;XRCC6;ATF5;GATA3;AHR;ZNF250;POLRMT;PAX3;CREM;SLTM;IRX5;HOXB7;ZEB2;POU3F1;ABL1;MEIS3;SP3;TET3;SMG6;SREBF2;TERF2IP;HNRNPU
prerank,cysteine-type peptidase activity (GO:0008234),0.3836563322222838,1.1253758674726826,0.2778993435448578,0.9127599563178032,1.0,25/73,19.07%,USP50;USP35;USP11;OTUD7B;CTSK;CTSO;CASP6;OTULIN;CTSB;UCHL1;USP46;USP33;USP48;MALT1;USP40;USP14;CASP2;USP1;USP25;USP21;ATG4C;USP2;USP37;CASP7;USP5
prerank,TBP-class protein binding (GO:0017025),0.46183627176196296,1.1246446930554455,0.3394109396914446,0.9101356069575716,1.0,10/21,21.36%,DRAP1;GTF2B;ESR1;TAF11;AHR;PSMC1;TAF1;RUVBL2;YEATS2;THRA
prerank,protein phosphatase binding (GO:0019903),0.3660874519687851,1.122723158848615,0.2701271186440678,0.911755500940824,1.0,39/117,22.90%,LGALS3;ANK1;ERBB2;EGFR;PTPRT;EIF2AK3;PPP1R15A;PPP3CB;ENSA;PDLIM4;SHOC2;ANAPC7;PIK3R1;MAPK14;FBXL2;TBK1;PPP1R3F;HSP90B1;STRN;RPA2;AKAP11;IQGAP1;MET;JUP;TP53;SLC9A1;VRK3;KIF3A;STX17;STAT3;CDC27;ADCY8;SIRPA;ANAPC4;PXN;DLG4;ANAPC5;STAT6;KIFAP3
prerank,MAP kinase phosphatase activity (GO:0033549),0.5038655193571595,1.1226489918593705,0.324773413897281,0.9070670326287424,1.0,4/12,20.05%,DUSP4;DUSP6;DUSP16;DUSP1
prerank,cation channel activity (GO:0005261),0.3757960115848223,1.122607382968501,0.28618421052631576,0.9021767660548813,1.0,10/94,4.32%,PIEZO2;CACNA1E;KCNA2;TMEM63A;KCNK1;ANXA9;ANO6;KCNA1;CALHM6;PSEN1
prerank,calcium channel inhibitor activity (GO:0019855),-0.44705860962772725,-1.1220866910509033,0.2740112994350282,0.70948100987701,1.0,3/11,9.13%,ITPR1;SLC30A1;MCUB
prerank,GDP-dissociation inhibitor activity (GO:0005092),0.501734715358671,1.12184699154348,0.32983508245877063,0.8997278566396872,1.0,2/13,8.12%,GPSM2;GDI2
prerank,gamma-tubulin binding (GO:0043015),-0.3666741991246344,-1.1217366508045146,0.2873134328358209,0.7003528197035073,1.0,6/21,8.62%,NDRG1;DIXDC1;TUBGCP4;TUBGCP3;TUBGCP6;BRCA2
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),-0.449532472392679,-1.118789854564468,0.3324538258575198,0.6982933563302485,1.0,4/11,8.81%,UBE4B;PPIL2;STUB1;UBE4A
prerank,monovalent cation:proton antiporter activity (GO:0005451),-0.4346645928522902,-1.1182717149779553,0.3275862068965517,0.6898361701988743,1.0,6/12,11.85%,SLC9A6;SLC9A2;SLC9A8;SLC9B2;SLC9A9;SLC9A7
prerank,four-way junction DNA binding (GO:0000400),0.48569048634531636,1.11598485131212,0.34978843441466856,0.914774402572532,1.0,6/17,17.24%,MEN1;MSH6;XRCC3;ABL1;BLM;WRN
prerank,anion:anion antiporter activity (GO:0015301),-0.38234899613025153,-1.1154692316465236,0.3298245614035088,0.6876779139573409,1.0,3/17,8.07%,SLC26A7;SLC26A2;SLC4A3
prerank,phosphatidylinositol phosphate binding (GO:1901981),0.36623653153714936,1.115434545629037,0.3188720173535792,0.9117366896484442,1.0,17/100,9.31%,RAG2;PLEKHA4;PLEKHA5;SESTD1;IQGAP2;OSBPL5;WIPI1;MAPKAP1;LAPTM4B;GBF1;RPH3A;ARHGAP9;BBS5;GAB2;HIP1;DENND1C;LANCL2
prerank,G protein-coupled receptor binding (GO:0001664),0.3578145810094191,1.1132571469650592,0.2800829875518672,0.9138669046701788,1.0,21/132,15.49%,PTCH1;PTCH2;GNA14;BICD1;PRKN;GPRC5B;GPRASP2;NPB;WNT5A;FZD7;ARHGEF11;PACRG;FLNA;USP33;DVL1;MYOC;GNAI1;HOMER2;PENK;PDCD6IP;HOMER1
prerank,tRNA-specific ribonuclease activity (GO:0004549),0.49434499027987544,1.1090846261687828,0.34110787172011664,0.923520807480265,1.0,8/14,27.33%,RPP38;PRORP;TSEN2;POP1;RPP21;TSEN34;RPP30;RPP14
prerank,actin binding (GO:0003779),-0.24076840389300902,-1.1090451122792124,0.13513513513513514,0.6947974005266284,1.0,40/170,15.12%,MACF1;PAWR;ABLIM1;CALD1;SORBS1;PHACTR1;CAPZB;PDLIM5;SYNE2;MYH9;MYRIP;MTSS1;PHACTR4;PARVB;NOS3;P4HB;MICAL3;ABL2;TPM1;GIPC1;MICAL2;EPS8;PFN2;EPS8L2;TMSB4X;MAEA;MAPT;PDLIM1;FXYD5;MYH10;DAG1;LIMA1;KIF18A;CAP1;SYNPO2;SHROOM2;AVIL;CEACAM1;TPM2;TMOD1
prerank,SUMO transferase activity (GO:0019789),0.47234060775764775,1.1074347487546061,0.3488372093023256,0.9246433815088646,1.0,6/16,25.93%,RANBP2;CBX4;PIAS2;MDM2;UBE2I;TOPORS
prerank,cadherin binding (GO:0045296),0.34164479527810554,1.1072531391643738,0.2316950852557673,0.9203662356613472,1.0,73/315,16.32%,DCHS1;CDH19;STXBP6;PTPRH;PRDX6;ANK3;OLFM4;TBC1D10A;EGFR;PTPRT;ACVR1;PAK4;CNN3;FMNL2;PLIN3;PACSIN2;PSEN1;BZW2;CDH10;RPL23A;CDH22;CTNNA2;SPTBN1;CDH8;YWHAZ;UBAP2;CTNNA3;GOLGA3;BAIAP2;PLEC;EPS8L1;LRRFIP1;EPS15;FLNB;ZC3H15;PPP1R13L;FLNA;FASN;CDH20;CDH7;PTPN1;SLK;VAPA;PTPRJ;CBL;GLOD4;PTPN11;UBFD1;EMD;PPP1CA;CDK5R1;RAB1A;PDXDC1;AHSA1;SCRIB;CKAP5;LYPLA2;CORO1B;NCK1;RTN4;SNX1;IQGAP1;CDC42EP1;PKP2;CLIC1;ITGB1;JUP;GCN1;CDH18;NOP56;DIAPH3;OLA1;ANLN
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),0.4699368699719332,1.1061820783777685,0.35514018691588783,0.9194415890731013,1.0,5/18,14.61%,SOSTDC1;ACVR1;TGFBR2;LTBP1;BMPR1A
prerank,phospholipase binding (GO:0043274),0.4928316968121741,1.1053464125457448,0.33434190620272314,0.917366935064742,1.0,2/13,8.06%,PRKN;FYN
prerank,sialyltransferase activity (GO:0008373),-0.36778159942748795,-1.1052632273553038,0.30272108843537415,0.694669643906452,1.0,5/20,7.55%,ST6GALNAC3;ST3GAL6;ST8SIA4;ST3GAL1;ST6GALNAC2
prerank,chemokine binding (GO:0019956),0.4183309165380576,1.1049096406968926,0.34993446920052423,0.9140036384931454,1.0,5/30,15.19%,FGF2;CCR2;ACKR3;ACKR4;ITGB1
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.46403909595720644,1.1034549114482326,0.34676258992805753,0.9143311274986257,1.0,1/18,1.35%,HSD17B7
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),0.510936388380067,1.1019778742086708,0.3703125,0.9146345750574925,1.0,3/11,16.10%,KCND3;KCNJ3;KCNH2
prerank,zinc ion transmembrane transporter activity (GO:0005385),-0.3753059887339302,-1.1019427785442124,0.3462897526501767,0.69414018284046,1.0,8/20,26.19%,SLC30A10;SLC39A8;SLC39A6;SLC30A1;SLC39A3;SLC39A10;SLC39A13;SLC39A1
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.41389835258494173,1.1019120543505123,0.31666666666666665,0.9101240351753005,1.0,6/35,10.96%,PKDCC;PEAK1;TEC;CSK;FYN;STYK1
prerank,RNA stem-loop binding (GO:0035613),0.5122964324339169,1.1003557748153217,0.36128048780487804,0.9107066447023493,1.0,5/12,25.03%,EPRS1;CPEB3;RC3H1;CSDE1;FMR1
prerank,ATPase regulator activity (GO:0060590),0.4070679570756117,1.0990222496158915,0.31695331695331697,0.9107084357603209,1.0,12/38,18.97%,HSPH1;TSC1;DNAJB4;BAG5;DNAJB6;AHSA1;KATNB1;DNAJC19;DNAJA2;DNAJA1;FNIP1;DNAJC10
prerank,acetyltransferase activity (GO:0016407),0.4184921638394651,1.0975167229211649,0.34220532319391633,0.910821571577687,1.0,9/31,18.53%,KAT2B;NAA16;PAFAH1B3;KAT8;GTF2B;DBT;SMARCE1;NAA10;NAA15
prerank,sterol transfer activity (GO:0120015),-0.37771481446100497,-1.0972619691996246,0.3047619047619048,0.696926096585281,1.0,6/17,12.31%,ABCA1;PLTP;OSBP;OSBPL2;ABCG1;STARD4
prerank,ion channel inhibitor activity (GO:0008200),0.41915869266990036,1.096194845624365,0.3592964824120603,0.910434955778084,1.0,9/35,15.55%,WNK2;WNK3;RASA1;ENSA;KCNMB2;STX8;NEDD4L;CALM1;CALM2
prerank,ATPase binding (GO:0051117),0.3764393876728148,1.0960857963217565,0.34448160535117056,0.906318766560424,1.0,14/71,12.06%,ANK1;ANK2;EGFR;PSEN1;RALB;PPP3CA;SELENOS;PIH1D1;NCSTN;ESR1;TAF9;FBL;SNX10;PDE4D
prerank,metal ion:proton antiporter activity (GO:0051139),-0.4151749648601686,-1.0949739130297655,0.3404255319148936,0.6943442237630744,1.0,6/13,11.85%,SLC9A6;SLC9A2;SLC9A8;SLC9B2;SLC9A9;SLC9A7
prerank,beta-tubulin binding (GO:0048487),0.41773565788603717,1.0928517350977913,0.36209150326797385,0.9124107965223611,1.0,7/31,14.98%,DLEC1;FGF13;PACRG;EMD;CDK5R1;ARL8A;GABARAPL2
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.3956758374233296,1.0893244118931178,0.3471376370280146,0.9195241623928148,1.0,8/42,16.03%,KAT2B;CDKN2B;CCNJ;CCNC;CKS1B;CDK5R1;CDK5R2;CCND2
prerank,transforming growth factor beta binding (GO:0050431),-0.3584013773011425,-1.0893091614049477,0.322463768115942,0.7011172831149743,1.0,8/23,11.39%,ACVRL1;ENG;TGFBR1;THBS1;CD109;TWSG1;LRRC32;VASN
prerank,potassium ion antiporter activity (GO:0022821),-0.3971097193590125,-1.0884125949292909,0.3181818181818182,0.6950842490304384,1.0,6/15,11.85%,SLC9A6;SLC9A2;SLC9A8;SLC24A3;SLC9A9;SLC9A7
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.4008669512203042,1.0880125412179122,0.3558282208588957,0.9193787818111001,1.0,11/40,16.85%,SUV39H1;METTL9;THUMPD3;SETD3;COMT;AS3MT;FBL;LRTOMT;THUMPD2;MEPCE;PCMTD2
prerank,endopeptidase activator activity (GO:0061133),-0.4361373386872273,-1.0864872819423692,0.3392857142857143,0.6916154137449236,1.0,8/10,36.49%,PSMD14;APH1B;PSENEN;ADRM1;PSME3;VSIR;PSME2;NLRC4
prerank,phosphatase inhibitor activity (GO:0019212),0.45184696213322556,1.0857383349231247,0.390625,0.9223251456413754,1.0,4/20,11.61%,LGALS3;URI1;ENSA;ANP32E
prerank,phospholipase C activity (GO:0004629),0.4284106467823683,1.0845953242415518,0.3716577540106952,0.9216883881983476,1.0,2/25,4.92%,CHRM3;PLCB1
prerank,anion transmembrane transporter activity (GO:0008509),0.4900453421701383,1.0842150331358684,0.3717201166180758,0.9185910716595899,1.0,2/12,5.59%,SLC22A3;SLCO2B1
prerank,O-acyltransferase activity (GO:0008374),0.4172012187474785,1.0819339659906357,0.37748344370860926,0.9217503168081103,1.0,2/30,2.67%,PRDX6;MBOAT2
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),0.41338745824920653,1.0818326114256052,0.35868187579214195,0.913322973029832,1.0,14/34,21.99%,NDUFS5;NDUFA4;NDUFB2;NDUFA8;NDUFS8;NDUFV3;NDUFS6;NDUFV2;NDUFA13;NDUFA6;NDUFA12;NDUFC1;NDUFA5;NDUFV1
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),0.41338745824920653,1.0818326114256052,0.35868187579214195,0.913322973029832,1.0,14/34,21.99%,NDUFS5;NDUFA4;NDUFB2;NDUFA8;NDUFS8;NDUFV3;NDUFS6;NDUFV2;NDUFA13;NDUFA6;NDUFA12;NDUFC1;NDUFA5;NDUFV1
prerank,Hsp90 protein binding (GO:0051879),0.40248233288548846,1.0809063024710037,0.36910994764397903,0.9118803864236067,1.0,9/33,13.22%,FKBP6;SLC12A2;TSC1;PACRG;PPID;HIF1A;HDAC6;AHSA1;AHR
prerank,glucose transmembrane transporter activity (GO:0005355),0.4619148597320588,1.0800438270772486,0.3815028901734104,0.9103137214720278,1.0,3/17,10.56%,SLC5A3;MFSD4A;SLC2A2
prerank,retinoid X receptor binding (GO:0046965),0.5021673568660551,1.0779003653064805,0.38769230769230767,0.9129458227338167,1.0,6/11,21.45%,TACC1;RARG;NRIP1;MED25;PPARG;NSD1
prerank,RNA polymerase II complex binding (GO:0000993),0.4151610225501022,1.0771939498045056,0.3676092544987147,0.9109371408358758,1.0,11/32,17.41%,WAC;ZNF326;ERCC5;RPRD1A;URI1;GTF2B;ELP2;ELP4;HNRNPU;CDC73;NCOA3
prerank,protein phosphatase inhibitor activity (GO:0004864),0.41911895813619576,1.077019748546295,0.37231182795698925,0.9072237094129422,1.0,4/26,8.53%,LGALS3;PPP1R14C;ENSA;PPP1R8
prerank,hexosaminidase activity (GO:0015929),0.5051270684496906,1.0767838866268986,0.40615835777126097,0.903754598071199,1.0,7/12,25.75%,NAGA;SPAM1;HYAL1;OGA;CEMIP;HEXB;CEMIP2
prerank,glutamate receptor binding (GO:0035254),-0.3810577502724895,-1.0746933804713923,0.3356164383561644,0.713820803797414,1.0,7/17,13.99%,SHANK3;SHISA6;NSF;SHANK2;CAMK2A;SQSTM1;GNAS
prerank,single-stranded telomeric DNA binding (GO:0043047),0.4977766682395648,1.0745813461496772,0.3851851851851852,0.9065817684932734,1.0,7/11,26.16%,STN1;RPA2;TERF2IP;CTC1;RAD50;HNRNPA2B1;NABP2
prerank,cGMP binding (GO:0030553),-0.4304942570712798,-1.0737197955905882,0.38202247191011235,0.7073861552686241,1.0,2/11,12.43%,PDE5A;PDE2A
prerank,small GTPase binding (GO:0031267),0.33950567848541824,1.0708209257695156,0.35360824742268043,0.914232554583812,1.0,40/169,15.05%,RTKN;DOCK7;HPS6;BICD1;AKAP13;FGD4;RHOBTB3;HACE1;RANBP2;IQGAP2;NOX1;PAK1;PKN1;MAPKAP1;ALS2;CDKL5;MTSS2;AP1G1;RAB34;BRK1;FLNA;TRIP11;SIKE1;MYO9B;RCC1;NGFR;USP33;BICD2;RIMS1;RHOH;WASF1;USP6NL;CCDC186;TBC1D20;RAB3GAP2;RAB11FIP3;IQGAP1;CYFIP1;SGSM1;ANKRD27
prerank,iron ion binding (GO:0005506),-0.2932017230071545,-1.064302337001639,0.3352601156069364,0.7233423014287393,1.0,19/48,21.72%,AOX1;PHF2;ABCE1;PHYH;FBXL5;FTH1;EGLN2;FTL;TET1;CDO1;ALKBH3;ETHE1;TYW5;FXN;CYP2R1;EGLN3;ACO2;JMJD6;DNAJC24
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.3285161838965251,1.0633024862135867,0.291,0.9337437893455944,1.0,121/597,20.67%,OSR2;ETV1;SOX6;NKX6-2;KLF15;MEOX1;ETV4;MEOX2;LHX5;TLX3;GLI2;CREB3L1;SOX8;DDX11;PRDM16;TGIF2;HOXB8;ZBTB20;SOX9;SUV39H1;HIVEP1;ZBTB37;HOXA7;MBD4;TFCP2;EGR3;KDM5B;RFX2;SOX11;ZNF276;GLI1;E2F2;PHOX2A;HOXD3;RFX3;RORC;MLX;CREB3L2;GATA6;TBX18;MEN1;CHD3;ATMIN;TFAM;RARG;BRCA1;MBD2;XPA;RARB;SOX12;SOX5;CARM1;BBX;KLF5;ARID4B;PRDM9;ERBB4;NFATC3;ATF2;ESR1;NFE2L2;MCM4;SP1;TAF9;SFPQ;TAF2;CREBZF;PER3;KLF13;NR6A1;XRCC6;ATF5;PER1;GATA3;AHR;ZNF250;ORC1;SNCA;PAX3;DHX33;TAF7;CREM;IRX5;HOXB7;POU3F1;RUNX1;ABL1;MEIS3;TP53;SP3;KCNH2;SREBF2;HNRNPU;FOXJ1;PAX2;GABPB1;GABPB2;RNF10;NFIX;NR5A1;KLF16;IRF3;ORC4;ASH2L;RFX7;BATF;EGR1;CENPC;BCOR;FOXJ3;PPARG;JUN;STAT3;ONECUT2;TFE3;ORC2;JDP2;KMT2D;PBX1;ZBED4;NR1D2
prerank,voltage-gated calcium channel activity (GO:0005245),0.39519821674587363,1.0631036171283819,0.38583638583638585,0.9301071071803,1.0,6/37,6.44%,CACNA1E;CACNA2D1;CACNG7;NCS1;CACNA1A;CACNB4
prerank,C2H2 zinc finger domain binding (GO:0070742),-0.4248561576460933,-1.0622087010928138,0.3775811209439528,0.7206038588898951,1.0,5/11,18.04%,LEF1;SRRM2;GATA2;HMGA2;THAP7
prerank,adenyl nucleotide binding (GO:0030554),0.49546793205452,1.0615275526510788,0.3977272727272727,0.9269279335179939,1.0,2/11,8.57%,HSPH1;BAG5
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),0.49546793205452,1.0615275526510788,0.3977272727272727,0.9269279335179939,1.0,2/11,8.57%,HSPH1;BAG5
prerank,fatty acid synthase activity (GO:0004312),0.5169063402501851,1.058902020819593,0.4084507042253521,0.9309422667166226,1.0,3/10,9.44%,OXSM;ELOVL6;ELOVL5
prerank,exopeptidase activity (GO:0008238),0.3761290921357709,1.058669883867015,0.3892857142857143,0.9274822576265127,1.0,9/50,9.82%,FAP;DPEP1;KDM8;NAALAD2;LTA4H;DPP10;TRHDE;DPEP2;LNPEP
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),0.4790580542511473,1.0585923282718908,0.41887905604719766,0.9235654318464839,1.0,2/13,1.40%,BMP5;PYCARD
prerank,G protein-coupled receptor activity (GO:0004930),0.3313444993122126,1.0556041833223935,0.3916581892166836,0.9288686302369341,1.0,28/239,15.46%,FFAR4;SSTR1;LGR6;MRGPRF;GPR63;RHO;HRH1;LPAR1;GPR65;GPR173;PTH2R;LGR5;P2RY14;TSHR;ADGRB3;MAS1;GRM5;GPR37;GPR88;S1PR3;ADGRL3;DRD2;GLP2R;P2RY12;P2RY1;ADGRG2;XPR1;TM2D1
prerank,galactosyltransferase activity (GO:0008378),-0.4198187909437653,-1.0550817002895776,0.3951612903225806,0.7297188749531959,1.0,5/11,19.20%,B4GALT7;B4GALT1;A4GALT;B4GALT2;B4GALT4
prerank,DNA secondary structure binding (GO:0000217),0.4034694952914095,1.0536769924265605,0.417312661498708,0.9306302722765633,1.0,8/31,17.24%,KMT2A;ERCC5;MEN1;MSH6;XRCC3;ABL1;BLM;WRN
prerank,BMP binding (GO:0036122),0.49217291390408985,1.052866355127595,0.41068702290076337,0.9291709092422369,1.0,1/11,0.48%,SOSTDC1
prerank,BMP receptor binding (GO:0070700),0.47905892508130415,1.0514869247190677,0.4234769687964339,0.9295838141877485,1.0,2/12,1.40%,BMP5;PYCARD
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),0.42877525140631806,1.0502116503095953,0.38524590163934425,0.9295992094428186,1.0,2/21,5.11%,CHRNA4;GRIK2
prerank,SH3 domain binding (GO:0017124),0.3638086418593944,1.04862048294621,0.4093567251461988,0.9306298095144279,1.0,7/62,4.43%,SGIP1;ENAH;PTPN22;CBLB;PRKN;WIPF1;NCF1
prerank,antiporter activity (GO:0015297),0.42863404744153866,1.0483505880925164,0.4094151212553495,0.927438499828193,1.0,8/20,17.17%,SLC35C2;SLC35E2B;SLC35E2A;SLC35A1;SLC25A10;SLC25A11;SLC35E1;SLC35E3
prerank,GTPase regulator activity (GO:0030695),0.3315277683237814,1.0481208835891176,0.38244197780020184,0.9241321377827273,1.0,42/212,14.96%,ARHGAP24;SIPA1L1;DLC1;ARHGAP32;RTKN;ARHGAP19;TBC1D10A;GPSM2;NPRL2;RANBP2;ELMOD2;IQGAP2;PLCB1;NF1;RGS11;RASA1;CHN1;ALS2;MTSS2;ARHGAP9;ARHGEF10L;TBCK;VAV3;ADGRB3;DOCK1;ARHGAP11A;ARL2;MYO9B;RIMS1;OPHN1;STXBP5;RHOH;ACAP2;USP6NL;ELMOD3;TBC1D20;RAB3GAP2;ARFGAP3;ARFGAP1;ARHGAP44;IQGAP1;SGSM1
prerank,solute:proton symporter activity (GO:0015295),0.4488860767100631,1.0477627392449063,0.396011396011396,0.921267107184725,1.0,2/16,5.20%,SLC17A5;SLC36A2
prerank,calmodulin-dependent protein kinase activity (GO:0004683),-0.32014507000147135,-1.047577438500657,0.341991341991342,0.740747457391295,1.0,7/24,11.48%,DAPK1;CAMK2G;CAMK1D;MKNK2;CAMK1;CAMK4;CAMK2A
prerank,GTP binding (GO:0005525),0.3330071744525092,1.0473081849923773,0.4,0.9187820685132617,1.0,41/172,18.40%,RHOJ;RASEF;RHOD;RAB38;RND3;RAP2B;ADSS1;RHOBTB3;RAB14;ARL3;RALB;ARL1;BMS1;RAB21;RAP1A;RAB39A;RABL3;LANCL2;TUBB6;RHOT2;ARL2;MRAS;ARL5C;ARF4;ANXA6;RAB22A;RHOH;RHOC;ATL3;ARL8A;GNAI1;RAB4A;TRIM23;GTPBP10;EIF2B2;RAC3;RAB7A;RHOT1;TUBA1A;NRAS;KRAS
prerank,vascular endothelial growth factor receptor binding (GO:0005172),-0.39886368416506535,-1.0460164281408828,0.3903225806451613,0.7362569979380121,1.0,3/12,2.70%,CDH5;VEGFC;VEGFD
prerank,double-stranded DNA binding (GO:0003690),0.32243197886432234,1.0446412310304285,0.35,0.9229118076486588,1.0,72/531,15.56%,OSR2;ETV1;NKX6-2;KLF15;MEOX1;ETV4;MEOX2;LHX5;TLX3;GLI2;CREB3L1;SOX8;DDX11;TGIF2;HOXB8;ZBTB20;SOX9;EGFR;HIVEP1;ZBTB37;HOXA7;SATB1;APTX;TFCP2;EGR3;KDM5B;RFX2;ERCC5;ZNF276;MBD1;E2F2;PHOX2A;HOXD3;RFX3;RORC;MLX;SETMAR;GATA6;TBX18;MEN1;RARG;XPA;RARB;SOX12;BBX;KLF5;REXO4;TDP1;NFATC3;PSIP1;ATF2;FBH1;ESR1;SP1;MSH6;KLF13;NR6A1;XRCC6;GATA3;AHR;ZNF250;PAX3;CRY1;ZNF638;POLG2;CREM;IRX5;HOXB7;CGAS;POU3F1;ABL1;MEIS3
prerank,endopeptidase inhibitor activity (GO:0004866),0.3507098092105828,1.0443116079541053,0.416204217536071,0.9199652080584788,1.0,13/82,15.40%,A2M;LXN;NGF;RECK;PRNP;CSTB;UCHL5;BIN1;SERPINE2;UBE2Z;PROS1;USP14;UBE2O
prerank,neurexin family protein binding (GO:0042043),0.49899766851171434,1.0438456753284313,0.4341692789968652,0.9175974692293895,1.0,2/10,5.72%,CEL;NLGN1
prerank,carboxylic ester hydrolase activity (GO:0052689),0.35077074471553105,1.0437483861721046,0.4059734513274336,0.9140747024972579,1.0,15/85,16.31%,PRDX6;CEL;PGAP1;H6PD;PLA2G7;PAFAH1B3;MRPL58;LYPLA1;PLA2G12A;PLAAT5;PLAAT3;LYPLA2;LIPC;PGLS;ABHD6
prerank,PDZ domain binding (GO:0030165),0.362179133502929,1.043745575682462,0.41857798165137616,0.9102627028925581,1.0,12/61,8.17%,TBC1D10A;PTEN;PRKN;GRIA1;ATP2B3;PSEN1;SDC2;GRID2;NLGN1;FZD7;ACOX1;CADM1
prerank,outward rectifier potassium channel activity (GO:0015271),0.4988701343310734,1.0433041996210923,0.4501466275659824,0.9077645347720902,1.0,6/11,21.50%,KCND1;KCND2;KCND3;KCNT2;KCNA5;PKD2
prerank,ubiquitin binding (GO:0043130),0.3564775285350837,1.037114474453747,0.4223463687150838,0.9222507565073335,1.0,19/73,19.07%,RAD23B;PRKN;MVB12B;FBXW7;FBXO7;CKS1B;UCHL1;RNFT1;USP33;UCHL3;TOLLIP;VPS36;MVB12A;PLAA;USP25;N4BP1;NBR1;MDM2;USP5
prerank,GTPase binding (GO:0051020),0.32754407475225444,1.0370380801402495,0.43398157625383826,0.9186385994621958,1.0,44/194,15.05%,RTKN;DOCK7;HPS6;BICD1;AKAP13;FGD4;EPRS1;RHOBTB3;HACE1;RANBP2;IQGAP2;NOX1;SPTBN1;PAK1;PKN1;RASA1;MAPKAP1;ALS2;CDKL5;MTSS2;AP1G1;RAB34;BNIP3;BRK1;FLNA;TRIP11;SIKE1;MYO9B;RCC1;NGFR;USP33;BICD2;RIMS1;RHOH;WASF1;USP6NL;CCDC186;TBC1D20;RAB3GAP2;RAB11FIP3;IQGAP1;CYFIP1;SGSM1;ANKRD27
prerank,NADP binding (GO:0050661),-0.3065030897777728,-1.0366402938298969,0.41517857142857145,0.7521304606754778,1.0,10/32,16.85%,CRYZL1;NOS3;LBR;ME1;PGD;GMDS;NOS1;NNT;SPR;QDPR
prerank,thyroid hormone receptor binding (GO:0046966),0.4008686653206371,1.0353118900114255,0.4421052631578947,0.9199107674934256,1.0,12/28,22.79%,TACC1;GTF2B;TRIP6;BRD8;MED13;TAF11;TAF7;MED12;NCOA3;MED30;NSD1;MED24
prerank,protein tyrosine kinase binding (GO:1990782),0.35554460291769135,1.0350771003452697,0.43507972665148065,0.9168718024099449,1.0,14/71,10.86%,SHC4;LRP4;CBLB;ACVR1;PTPN2;NRG3;PHYHIP;SOCS5;ALKAL2;GRB14;PTPN1;GRM5;CBL;PTPN11
prerank,N-acetyltransferase activity (GO:0008080),0.4299388670478398,1.0348350253070977,0.4263888888888889,0.9138167364023294,1.0,7/19,27.27%,KAT2B;SMARCE1;NAA10;NAT8L;ATAT1;SAT1;NAA50
prerank,copper ion binding (GO:0005507),0.3708328125157544,1.0337049628832342,0.44128553770086526,0.91324328146703,1.0,11/42,18.77%,CUTA;PRNP;MT3;AOC1;LOXL3;GPC1;SUMF1;SNCA;TP53;SNCB;PARK7
prerank,clathrin adaptor activity (GO:0035615),0.4622959141059622,1.0321584253666292,0.4362818590704648,0.9143219187058962,1.0,4/15,8.72%,STON2;STON1;AP1G1;HIP1
prerank,Hsp70 protein binding (GO:0030544),0.39084676398672,1.0316232579212639,0.4385510996119017,0.9122638184698818,1.0,12/31,24.28%,PRKN;TSC1;PACRG;PPID;GPR37;SNCA;FICD;DNAJA1;DNAJC10;DNAJC8;PPEF2;IQCG
prerank,hyaluronic acid binding (GO:0005540),0.48575131183707543,1.0308544731990188,0.4549689440993789,0.9107294197333862,1.0,1/10,1.24%,CHODL
prerank,neuropeptide hormone activity (GO:0005184),0.4221105931627318,1.0299049749250426,0.422554347826087,0.909944963711071,1.0,1/22,0.98%,CRH
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),0.4823398166327079,1.0292503377840536,0.41910631741140214,0.9084000850023355,1.0,5/11,18.51%,PYCARD;CASP6;CASP12;CASP2;CASP7
prerank,transforming growth factor beta receptor binding (GO:0005160),-0.3519696266062319,-1.0290765838142708,0.42996742671009774,0.7632485864640054,1.0,6/18,13.38%,SMAD6;SMAD7;ENG;TGFBR1;TGFB2;USP15
prerank,chemorepellent activity (GO:0045499),0.4147524673141185,1.0279552555552125,0.4328947368421053,0.9085060920416705,1.0,4/25,3.81%,SEMA3E;SEMA6C;NRG3;SEMA3A
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),-0.40153707124538685,-1.027770387370445,0.3988439306358382,0.7585934220908954,1.0,6/12,19.86%,PHF2;KDM1A;KDM4C;KDM4D;KDM3B;HR
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.43158740397505674,1.0271517110085606,0.4421199442119944,0.9071890738426619,1.0,5/18,16.15%,DPEP1;MT3;PRDX3;SNCA;XIAP
prerank,acylglycerol O-acyltransferase activity (GO:0016411),0.43480322702776697,1.0264901380071958,0.46511627906976744,0.9055233464370388,1.0,6/20,19.01%,AGPAT2;MOGAT3;AGPAT5;GPAT3;GPAT4;LPCAT2
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.442079078625356,1.0258620333893123,0.4388185654008439,0.9037527699532637,1.0,6/17,23.18%,DTYMK;AK1;AK3;AK5;AK8;CMPK1
prerank,general transcription initiation factor binding (GO:0140296),0.40847713242486133,1.0254843109884784,0.43283582089552236,0.9012364966543144,1.0,13/25,27.55%,DRAP1;GTF2B;ESR1;TAF11;AHR;PSMC1;TAF1;RUVBL2;YEATS2;THRA;TBP;DR1;RELA
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",-0.3260197918464537,-1.021583665056343,0.4264705882352941,0.7662584884546797,1.0,8/21,13.67%,PDE5A;PDE8B;PDE8A;PDE1A;PDE3A;PDE4A;PDE2A;PDE1C
prerank,Tat protein binding (GO:0030957),0.4910970926595405,1.0201956886552774,0.4447900466562986,0.9127208261978977,1.0,1/10,0.83%,MDFIC
prerank,cytokine receptor binding (GO:0005126),0.3428155579709134,1.018538243191094,0.4496124031007752,0.9137477305465531,1.0,13/83,13.85%,PYCARD;CRLF1;FADD;VEGFA;PXDN;SPRED2;SPRED1;IL18;TRIP6;TYK2;IL6ST;PRLR;TGFBRAP1
prerank,phosphatidylinositol kinase activity (GO:0052742),-0.36251976303778793,-1.0177364576961903,0.42443729903536975,0.7682167647917385,1.0,3/15,2.95%,PI4KA;PIK3R3;PIK3C2A
prerank,voltage-gated chloride channel activity (GO:0005247),0.48320719005381585,1.0133885625865127,0.4532258064516129,0.9250254165579997,1.0,2/10,3.47%,CLCN5;ANO6
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.3805232228252772,1.0132947942604242,0.4684796044499382,0.9217952902671233,1.0,8/37,14.04%,IARS2;EPRS1;FARSA;SARS2;FARSB;FARS2;YARS1;HARS1
prerank,damaged DNA binding (GO:0003684),0.3671365610132354,1.0109769727179307,0.46041412911084045,0.9248646365346953,1.0,9/44,13.81%,APTX;ERCC5;ERCC4;MPG;DDB2;RPA3;XPA;DDB1;RPA2
prerank,adrenergic receptor binding (GO:0031690),0.4406721496644307,1.0108722752636008,0.46397694524495675,0.9216368287119753,1.0,4/16,12.06%,SAV1;UCHL1;MAGI2;PDE4D
prerank,DNA replication origin binding (GO:0003688),0.4088584292273596,1.0108209072446028,0.46837146702557203,0.9182887529069033,1.0,8/23,24.08%,DDX11;MCM4;ORC1;ORC4;ORC2;HSPD1;KAT7;ORC3
prerank,protein kinase C binding (GO:0005080),-0.28003146396237444,-1.0107090014873772,0.4140127388535032,0.7778560497895846,1.0,12/43,18.82%,GRK5;PARD6G;PDLIM5;PRKCB;RACK1;ADCY4;CAVIN3;SQSTM1;TIRAP;TRPV4;HSPB1;DACT2
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.31755641199446133,1.0100644372810264,0.46975806451612906,0.916928811559394,1.0,49/254,21.28%,OSR2;ETV1;KLF15;ETV4;MEOX2;CREB3L1;PRDM16;MYC;SOX9;HOXA7;TFCP2;SOX11;RFXANK;E2F2;HOXD3;ZBTB16;ATMIN;SOX12;KLF5;HIF1A;NFATC3;ATF2;ESR1;SP1;ZNF112;ATF5;GATA3;SALL2;MDM4;HOXB7;RUNX1;MEIS3;TP53;NFIA;FOXJ1;MDM2;IRF3;KLF7;EGR1;PRRX1;FOXJ3;JUN;STAT3;PRDM2;ONECUT2;MEIS1;ZSCAN21;NFKB1;MITF
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),0.46684379109155777,1.0089723311041978,0.4611801242236025,0.9164301141958291,1.0,1/11,4.08%,CHRNA4
prerank,phospholipase activity (GO:0004620),0.34669517060424837,1.0088874253317057,0.48509174311926606,0.9131921235830255,1.0,16/67,21.33%,PRDX6;PLBD1;LYPLA1;PLA2G12A;PLAAT5;PLAAT3;LYPLA2;PNPLA8;SEC23IP;LIPC;GPLD1;ABHD6;GDPD3;PLA2G4E;DDHD1;ABHD16A
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.416173955835098,1.0081036135340073,0.48622589531680444,0.9119266118381171,1.0,7/20,19.22%,USP50;SENP3;UFSP2;SENP2;USP25;USP21;SENP1
prerank,ribosomal small subunit binding (GO:0043024),-0.34471821566839966,-1.007481337531546,0.4197952218430034,0.7779471271904053,1.0,5/17,15.54%,MTIF2;NPM1;ABCE1;MTIF3;NME1
prerank,protein kinase binding (GO:0019901),0.31169641182613395,1.0072258779823575,0.496,0.9109734677864469,1.0,107/479,18.71%,ROR2;SHC4;BCL2L14;DNM1;UTRN;CNKSR2;RHOD;BICD1;ANK2;KAT2B;SOX9;DUSP4;PRKN;CDKN2B;RND3;ACVR1;PTPN2;RHOBTB3;PHYHIP;MAPK7;IRAK3;GPRC5B;MAPKAPK3;NBEA;PRKCSH;MAPKAPK2;PPP1R15A;DUSP6;PRKAR1B;SLC12A2;PDE3B;SCN5A;FBXO7;SOCS1;CKS1B;PKN1;YWHAZ;MAPKAP1;NELL2;SPRED2;CSK;FAM83H;PRKAB2;UFL1;SPRED1;GATA6;FOXM1;TBL2;LAX1;BAG5;ANKRA2;HIF1A;SYN1;SV2A;PTPN1;GRM5;PIH1D1;SPRED3;SIKE1;HINT1;ATF2;PTPRJ;ESR1;PTPN11;SLC12A4;CDC25B;CDK5R1;ERCC6L2;UNC5C;RHOH;RHOC;DVL1;PRKACA;PRDX3;TPCN2;CALM1;SPAG9;PKD1;IQGAP1;TICAM1;PKP2;ITGB1;ACSL3;DACT1;ABL1;CALM2;STX1B;TP53;CCND2;FAM83F;MYH6;RAC3;TRAP1;CSPG4;SUFU;FBXO5;TPRKB;JTB;RPTOR;NBR1;DCX;USP37;DUSP16;GYS1;INKA1;MAPRE3;MAP3K11
prerank,protein kinase A catalytic subunit binding (GO:0034236),0.451775709015709,1.0071520667667815,0.44494047619047616,0.9077769699454491,1.0,3/13,6.59%,SOX9;PRKAR1B;CSK
prerank,Wnt-activated receptor activity (GO:0042813),0.4439479481355256,1.0061754990806888,0.4759825327510917,0.907146934961535,1.0,4/15,15.54%,ROR1;FZD7;PKD1;FZD9
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.44801715269881803,1.0053576553867192,0.4778761061946903,0.9060037740656197,1.0,5/14,23.18%,DTYMK;AK1;AK5;AK8;CMPK1
prerank,endopeptidase regulator activity (GO:0061135),0.3715541243960184,1.0038884211539358,0.4618181818181818,0.9066303532664555,1.0,7/40,14.93%,A2M;RECK;CSTB;UCHL5;APH1A;PROS1;USP14
prerank,UDP-galactosyltransferase activity (GO:0035250),-0.4111261664812757,-1.0010963564885802,0.4726775956284153,0.7867359805304188,1.0,4/10,16.55%,B4GALT7;B3GALT1;B4GALT1;B3GALT2
prerank,semaphorin receptor binding (GO:0030215),0.4031758545862022,1.0008411889968551,0.4634146341463415,0.9114229420976474,1.0,3/23,3.81%,SEMA3E;SEMA6C;SEMA3A
prerank,growth factor activity (GO:0008083),0.34388356545403787,0.9991160314917987,0.48085585585585583,0.9130274354001564,1.0,10/74,12.11%,FGF2;FGF10;NGF;NRG3;VEGFA;BTC;AMELX;GDNF;FGF7;GRN
prerank,insulin-like growth factor receptor binding (GO:0005159),-0.39060025047164776,-0.9988446933536529,0.43661971830985913,0.7846860752653648,1.0,3/12,5.85%,IGF1;IGF2;INSR
prerank,cyclic nucleotide binding (GO:0030551),-0.3211652350131359,-0.9974534073661275,0.4074074074074074,0.780114272762813,1.0,4/21,12.43%,PDE5A;RAPGEF4;PDE4A;PDE2A
prerank,mRNA binding (GO:0003729),0.3142651721457273,0.9952951605733673,0.5115810674723061,0.9198867101179609,1.0,86/249,26.30%,PABPC5;RBFOX1;CSTF3;RBMS3;CELF5;QKI;ELAVL4;TRA2B;DXO;PABPC1;CPSF6;ETF1;HNRNPAB;METTL3;LUC7L2;SRBD1;UNK;CPEB3;ZC3H12B;KHDRBS3;PPP1R8;DCP1B;NCBP1;EIF4G1;PCBP4;DAZAP1;ADARB1;CPEB1;RBM4B;CELF6;DHX33;NOVA1;SRSF6;YTHDC1;KHSRP;LUC7L;EIF4ENIF1;TP53;HNRNPU;RBM46;N4BP1;SRRM3;FUBP1;RC3H1;RNPS1;SSB;SF1;AUH;CLUH;RBFOX3;PARK7;MARF1;CNBP;SYNCRIP;HNRNPC;FUBP3;ZFP36;CELF4;HNRNPL;RBFOX2;EIF4G3;DDX6;RBMS1;FYTTD1;RIDA;SNIP1;PTBP2;ZC3H12C;YBX3;DENR;RBM25;XPO5;TUT1;PCBP2;G3BP2;THOC5;GNL3;FMR1;CIRBP;NSRP1;RBM4;RNF20;YTHDF3;RBM15;HNRNPA2B1;CPEB4
prerank,GTPase activator activity (GO:0005096),0.31046581318445715,0.9952727550959931,0.5130260521042084,0.9166155210095117,1.0,73/313,17.47%,ARHGAP24;SIPA1L1;DLC1;ARHGAP32;ARHGAP19;TBC1D10A;DENND2A;AKAP13;FGD4;FRMD7;NPRL2;ARHGEF28;NUCB1;RANBP2;ELMOD2;IQGAP2;DOCK5;PLCB1;NF1;ARHGEF10;RGS11;RASA1;CHN1;ALS2;MTSS2;EPS8L1;DOCK10;ITSN1;RAP1A;EIF2B5;ARHGAP9;RGL1;LAMTOR2;ARHGEF11;ARHGEF10L;TBCK;VAV3;ADGRB3;DENND1C;DOCK1;ARHGAP11A;SPATA13;MYO9B;FARP2;RCC1;OPHN1;DNMBP;STXBP5;RCC1L;ACAP2;USP6NL;ELMOD3;TBC1D20;RAB3GAP2;ARFGAP3;ARFGAP1;ARHGAP44;RAB3IL1;IQGAP1;SGSM1;ANKRD27;ELMO1;CYTH3;RIC8B;ARFGEF1;RAP1GAP;HPS1;ELMOD1;ARHGEF4;EIF2B2;DENND10;GARNL3;RALGAPB
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.4642477337499117,0.9945486199258018,0.48372093023255813,0.9153797184861362,1.0,5/11,21.67%,SLC25A23;SLC35B3;SLC25A25;SLC25A24;SLC17A9
prerank,peptide hormone receptor binding (GO:0051428),0.461191933303712,0.9930515088275614,0.4710252600297177,0.9161465221279448,1.0,1/11,3.66%,PTHLH
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),-0.40164036478333476,-0.9910234556702876,0.47109826589595377,0.7889358979381309,1.0,3/10,4.93%,PRKAG2;PKIA;PRKAR1A
prerank,protein phosphorylated amino acid binding (GO:0045309),0.3650619614866606,0.990570435964862,0.49440993788819876,0.9193075187886101,1.0,18/42,27.01%,FBXW7;RASA1;SAMSN1;PIK3R1;PTPN11;ABL1;GRB2;SH3BP2;BCAR3;YES1;VAV2;NCK2;CRK;HCK;LDLRAP1;SYK;SHC3;PIN1
prerank,tumor necrosis factor receptor binding (GO:0005164),0.45207528319939344,0.9897171055235712,0.48525073746312686,0.9182829549007884,1.0,5/12,31.22%,TRAF4;TRAP1;TRIM37;TRAF6;TRAF3
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),-0.31504406504521604,-0.9887812235571329,0.48638132295719844,0.7869652133035608,1.0,9/23,14.75%,PDE5A;PDE8B;PDE8A;PDE1A;PDE3A;PDE4A;PDE2A;PDE1C;ADPRM
prerank,ribonuclease activity (GO:0004540),0.34401826810529584,0.9886771277352636,0.4704519119351101,0.9178185344462968,1.0,8/56,10.78%,INTS11;RNASE6;NOB1;EXOSC8;ZC3H12B;PPP1R8;EXOSC2;RCL1
prerank,poly(A)-specific ribonuclease activity (GO:0004535),-0.37858760100078387,-0.9882841676645414,0.4918032786885246,0.7802452033897713,1.0,3/12,12.09%,NOCT;CNOT1;PAN2
prerank,cation transmembrane transporter activity (GO:0008324),0.3560754439002049,0.988135533235054,0.5059101654846335,0.9160530407450771,1.0,5/48,6.18%,SLC22A3;SLC25A2;SLC1A5;SLC36A2;SLC25A38
prerank,androgen receptor binding (GO:0050681),-0.30836980613309617,-0.9877697310427884,0.49159663865546216,0.7739782444885347,1.0,7/25,11.46%,FOXP1;KDM1A;PRKCB;SNW1;DDX5;KDM4C;PRMT2
prerank,myosin V binding (GO:0031489),0.4325926418306609,0.9861607912908927,0.49359886201991465,0.918036385406378,1.0,7/15,25.47%,RAB14;RAB3D;RAB3A;RAB3B;RAB39B;RAB6A;RAB27B
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.30379094447104327,0.9855016184752773,0.562,0.9165472405107654,1.0,115/831,16.06%,EBF2;RORA;OSR2;ETV1;SOX6;NKX6-2;KLF15;MEOX1;EBF4;ETV4;MEOX2;LHX5;TLX3;GLI2;SOX8;PRDM16;MYC;DMRT2;TGIF2;EBF1;HOXB8;ZNF25;ZBTB20;SOX9;HIVEP1;OTP;ZBTB37;HOXA7;SATB1;TFCP2;EGR3;NFX1;FOXP2;RFX2;SOX11;RFXANK;GLI1;E2F2;ZEB1;PHOX2A;HOXD3;PGBD1;ZFP14;RFX3;ZBTB16;RORC;MLXIPL;MLX;TRPS1;TWIST2;E2F6;LRRFIP1;GATA6;TBX18;FOXM1;ZSCAN20;GTF2B;MKX;ZBTB41;RARG;RARB;SOX12;SOX5;ZNF569;BBX;KLF5;HIF1A;ZBTB6;CHD2;ZSCAN26;ZBTB38;NFATC3;ZNF260;ATF2;ZKSCAN8;ESR1;NFE2L2;MYT1;SP1;ZNF112;HDAC6;RBAK;ZFHX4;SIX5;KLF13;ZGPAT;PATZ1;FOXP4;ZBTB1;NR6A1;NRIP1;ATF5;PER1;GATA3;ZNF83;SALL2;ZNF250;ZBTB39;NACC2;KDM6A;PAX3;ZFHX2;HIVEP3;CREM;IRX5;HOXB7;ZNF235;ZEB2;POU3F1;RUNX1;MEIS3;PURG;KLF9;TP53;SP3
prerank,mRNA 3'-UTR binding (GO:0003730),0.33603464719618814,0.9845943066407022,0.5,0.915726172695284,1.0,27/79,26.30%,PABPC5;RBMS3;ELAVL4;PABPC1;EXOSC8;CPEB3;ZFP36L2;PCBP4;DAZAP1;CPEB1;KHSRP;TP53;HNRNPU;RC3H1;RNPS1;AUH;HNRNPC;ZFP36;RBMS1;YBX3;TUT1;FMR1;CIRBP;RBM4;RNF20;HNRNPA2B1;CPEB4
prerank,histone methyltransferase activity (GO:0042054),0.3710618503837366,0.9843169950258376,0.49873417721518987,0.9132427401330285,1.0,8/32,11.16%,SUV39H1;EED;MEN1;CARM1;PRDM9;SETD2;FBL;PRMT1
prerank,ribonuclease P activity (GO:0004526),0.4598824842250837,0.9842107235495267,0.49242424242424243,0.9103121491478126,1.0,6/11,27.33%,RPP38;PRORP;POP1;RPP21;RPP30;RPP14
prerank,glycerophospholipid flippase activity (GO:0140333),-0.3989694439482554,-0.9841659156701393,0.4688427299703264,0.7755943164690271,1.0,8/11,18.40%,ATP10A;ABCA3;ABCA4;ATP11A;ATP8B2;ABCB4;ATP10B;ATP8A1
prerank,wide pore channel activity (GO:0022829),-0.309240125170693,-0.9835233283524893,0.479020979020979,0.7697313139029263,1.0,4/23,10.77%,GJA1;GJB6;GJC1;GJD3
prerank,acetylation-dependent protein binding (GO:0140033),-0.3233420849643719,-0.9830622477266684,0.48253968253968255,0.7563229388638445,1.0,10/20,21.13%,MLLT3;BRD7;ZMYND8;BRD9;BRD2;ATAD2B;BAZ2A;THAP7;YEATS4;BRDT
prerank,lysine-acetylated histone binding (GO:0070577),-0.3233420849643719,-0.9830622477266684,0.48253968253968255,0.7563229388638445,1.0,10/20,21.13%,MLLT3;BRD7;ZMYND8;BRD9;BRD2;ATAD2B;BAZ2A;THAP7;YEATS4;BRDT
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),0.4394909870951704,0.9821718150489717,0.49633967789165445,0.9125176404515956,1.0,5/15,19.01%,AGPAT2;AGPAT5;GPAT3;GPAT4;LPCAT2
prerank,nuclear receptor coactivator activity (GO:0030374),0.3480678575863301,0.9804095456474933,0.5017381228273464,0.9141183008056631,1.0,21/52,25.11%,FGF2;NCOA1;TACC1;PKN1;CARM1;ZMIZ1;NCOA2;BRD8;MED13;TMF1;MED12;NCOA3;MED30;RNF4;DCAF6;MED24;WDR77;CCDC62;ZMIZ2;NCOA7;ENY2
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",0.43565196333231904,0.9803749510324384,0.49273255813953487,0.9110249222380092,1.0,3/14,9.77%,NCF1;NOX1;NCF2
prerank,phosphoric ester hydrolase activity (GO:0042578),-0.2554484541642587,-0.9800490638852287,0.4764705882352941,0.756818508824631,1.0,15/49,15.01%,MPPED2;ATP1A2;PPP1CB;PPP1CC;PXYLP1;DUSP3;LHPP;SBF1;SAMHD1;ARMT1;ACP6;PGAM5;DUSP10;PTPRO;PRUNE1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",0.45959217750148773,0.9796255198402815,0.4899536321483771,0.9098574531755435,1.0,2/10,10.15%,APOBEC1;ADARB2
prerank,triglyceride lipase activity (GO:0004806),0.4101062733893232,0.9795080976383879,0.5020134228187919,0.9070366908242166,1.0,1/20,1.19%,CEL
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.346369912019701,0.978816847708977,0.5034965034965035,0.9057642365746952,1.0,9/53,13.82%,SLC1A3;SLC25A2;SLC1A5;SLC36A2;SLC25A38;SLC43A1;SLC7A7;SLC7A8;SLC25A15
prerank,cation:chloride symporter activity (GO:0015377),0.469057950748979,0.9776542696232569,0.5068285280728376,0.905707248146369,1.0,3/10,11.15%,SLC12A3;SLC12A2;SLC12A4
prerank,gap junction channel activity (GO:0005243),-0.31337691944676155,-0.9768749885752541,0.4948453608247423,0.7574336323631188,1.0,4/22,10.77%,GJA1;GJB6;GJC1;GJD3
prerank,calcium-dependent phospholipid binding (GO:0005544),0.34746156352197416,0.9737423772714814,0.5065710872162486,0.9125170152152505,1.0,17/49,21.13%,CPNE8;C2CD5;ANXA9;SYT1;RPH3A;SYT11;SYT12;MCTP1;ANXA6;DOC2B;DYSF;CPNE7;SYT2;CPNE1;PLA2G4E;SYT13;CPNE3
prerank,protein serine/threonine kinase activity (GO:0004674),0.30322752076733245,0.972888110842599,0.5737211634904714,0.9115877042127953,1.0,84/334,19.43%,WNK2;PRKCA;STK32B;PRKCQ;STK36;EGFR;ACVR1;ALPK1;MAP4K4;PAK4;MAPK7;ARAF;IRAK3;WNK3;SIK2;EIF2AK3;RPS6KA4;MAPKAPK3;MAST2;PAK5;MAPKAPK2;DYRK4;TESK2;TNIK;ACVR1C;PAK1;PKN1;CDKL5;CDK8;CDKL3;CDK13;TGFBR2;ATP23;PRKAB2;DYRK1B;PDK3;LIMK1;CDK6;GAK;CDK15;CDK19;PASK;STK39;TLK2;MAPK9;AKT3;SGK3;SGK2;SLK;MAPK14;PKMYT1;STK32A;MAPK1;TAOK3;TBK1;STK33;CSNK1G1;PRKACA;CSNK1A1;NEK7;CDK16;TRIO;TTBK1;RPS6KA2;MAP3K4;BMPR1A;ATM;PIM2;CSNK1E;CSNK1G2;HTATIP2;SGK1;RIPK1;CHUK;PKN2;TP53RK;VRK3;MAP3K11;TAF1;CSNK2A2;TESK1;BCKDK;CSNK1G3;TOP1
prerank,Toll-like receptor binding (GO:0035325),0.45624859121903705,0.9724653212340322,0.4946564885496183,0.9096792586981135,1.0,3/11,14.85%,TLR1;TOLLIP;UNC93B1
prerank,CoA hydrolase activity (GO:0016289),0.41803851781161144,0.9711346853257268,0.5200553250345782,0.9097915161661694,1.0,6/16,25.89%,ACOT11;HIBCH;ACAA2;ACOT8;NUDT7;ACOT9
prerank,kinase binding (GO:0019900),0.301165570271685,0.9709010668732955,0.6146146146146146,0.9073085290381429,1.0,104/434,19.56%,SHC4;BCL2L14;DNM1;UTRN;CNKSR2;RHOD;PTPN22;BICD1;ANK2;KAT2B;GSN;PRKN;CDKN2B;EGFR;RND3;PTPN2;RHOBTB3;IRAK3;GPRC5B;NBEA;PPP1R15A;SLC12A2;DLG2;SCN5A;FBXO7;SOCS1;CKS1B;YWHAZ;MAPKAP1;LAPTM4B;SPRED2;FAM83H;PRKAB2;UFL1;SPRED1;GATA6;FOXM1;TBL2;LAX1;FLNA;BAG5;ANKRA2;TRIP6;HIF1A;SYN1;SV2A;PTPN1;PIH1D1;SPRED3;SIKE1;ATF2;PTPRJ;ESR1;PTPN11;SLC12A4;CDC25B;TOLLIP;CDK5R1;ERCC6L2;UNC5C;TAX1BP1;SGO1;RHOH;RHOC;DVL1;PRKACA;PRDX3;TPCN2;ATF5;PER1;CALM1;PKD1;IQGAP1;TICAM1;ACSL3;EIF4ENIF1;CALM2;STX1B;TP53;CCND2;FAM83F;MYH6;RAC3;TRAP1;CSPG4;PIP5K1A;SUFU;FBXO5;TPRKB;JTB;RPTOR;DCX;USP37;PIK3IP1;GYS1;INKA1;HTT;MAPRE3;PARK7;POLR2A;KCNA5;GRB2;CAB39;BCL10
prerank,metalloexopeptidase activity (GO:0008235),0.34730009777009474,0.9691477090736058,0.5369047619047619,0.9084903421527591,1.0,12/51,15.60%,DPEP1;AGBL3;LTA4H;MMP15;AGBL2;TRHDE;LNPEP;AGBL4;MMP16;AGBL1;CPD;RNPEPL1
prerank,secondary active transmembrane transporter activity (GO:0015291),0.3422101588223125,0.9686685303146869,0.5154130702836005,0.9066841440044519,1.0,13/51,17.17%,SLC28A1;ANKH;SLC16A10;SLC35C2;SLCO2B1;SLC35E2B;SLC35E2A;SLC35A1;SLC7A8;SLC25A10;SLC25A11;SLC35E1;SLC35E3
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),-0.3545434956168089,-0.9685329321934062,0.5029761904761905,0.770874443789145,1.0,1/15,0.65%,PLA2G4A
prerank,3'-5' DNA helicase activity (GO:0043138),-0.3427768284225531,-0.9680792276138953,0.49830508474576274,0.765058173698437,1.0,4/16,9.74%,NAV2;RECQL5;ERCC3;MCM6
prerank,nuclear receptor binding (GO:0016922),0.3182391266079249,0.9673159120639367,0.5319829424307037,0.907017232886195,1.0,35/111,20.24%,NCOA1;RNF6;TACC1;PKN1;WIPI1;DDX54;GTF2B;PPID;TRIP6;NCOA2;BRD8;HIF1A;MED13;ESR1;TAF11;DCAF1;TMF1;NRIP1;PRPF6;STRN;LCOR;CRY1;NCOR2;TAF7;MED12;MED25;JUP;SMARCE1;NCOA3;MED30;TACC2;PARK7;TAF1;PHB2;SMARCA4
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.29790082661390493,0.9652546579758619,0.6506506506506506,0.9091111845334527,1.0,127/731,19.77%,EBF2;RORA;ETV1;SOX6;NKX6-2;KLF15;MEOX1;EBF4;ETV4;MEOX2;TLX3;GLI2;CREB3L1;SOX8;PRDM16;MYC;DMRT2;TGIF2;EBF1;ZBTB20;SOX9;HIVEP1;ZBTB37;HOXA7;SATB1;TFCP2;EGR3;FOXP2;RFX2;SOX11;GLI1;E2F2;ZEB1;HOXD3;PGBD1;ZFP14;RFX3;ZBTB16;RORC;MLXIPL;MLX;CREB3L2;E2F6;LRRFIP1;GATA6;TBX18;ZSCAN20;MKX;ZBTB41;RARG;RARB;SOX12;SOX5;ZNF569;KLF5;HIF1A;ZBTB6;CHD2;ZSCAN26;ZBTB38;NFATC3;ZNF260;ATF2;ZKSCAN8;ESR1;NFE2L2;MYT1;SP1;ZNF112;HDAC6;ZFHX4;SIX5;KLF13;ZGPAT;PATZ1;FOXP4;ZBTB1;NR6A1;NRIP1;PER1;GATA3;AHR;ZNF83;SALL2;ZNF250;ZBTB39;NACC2;KDM6A;PAX3;ZFHX2;HIVEP3;CREM;IRX5;HOXB7;ZNF235;ZEB2;POU3F1;RUNX1;MEIS3;KLF9;TP53;SP3;SREBF2;HNRNPU;NFIA;FOXJ1;PAX2;NFIX;ZKSCAN1;HEYL;NR5A1;KLF16;IRF3;ZNF697;ZNF496;KLF7;RFX7;BATF;EGR1;MED8;RUVBL2;TOP1;PRRX1;FOXJ3;PPARG;JUN;STAT3
prerank,deubiquitinase activity (GO:0101005),0.3211353809579691,0.9633362178812469,0.5317982456140351,0.9108583706058664,1.0,24/88,19.07%,USP50;USP35;USP11;MINDY4;OTUD7B;UCHL5;OTULIN;UCHL1;USP46;MYSM1;USP33;UCHL3;USP32;USP48;USP40;USP14;USP1;USP25;USP21;USP2;OTUD4;USP37;OTUD7A;USP5
prerank,5'-nucleotidase activity (GO:0008253),0.4293977577734624,0.9608393853084148,0.5157894736842106,0.9137343822887112,1.0,6/13,26.68%,NT5DC2;NT5C2;NT5C3B;NT5C;NT5C3A;NT5E
prerank,Lys48-specific deubiquitinase activity (GO:1990380),-0.34868948070890937,-0.9601599678854758,0.4984984984984985,0.7776065935485372,1.0,6/14,15.56%,USP7;USP9X;OTUD5;MINDY2;USP15;MINDY3
prerank,nucleotidyltransferase activity (GO:0016779),0.4021599381236918,0.9596125276503891,0.5251396648044693,0.9137321915441037,1.0,9/19,23.77%,PAPSS2;TUT4;CGAS;PNPT1;REV1;NUDT5;TENT2;TUT1;MOCS3
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),0.3867522378825712,0.9594518310995844,0.521970705725699,0.9110921302126052,1.0,4/24,9.31%,PLEKHA5;SESTD1;OSBPL5;LANCL2
prerank,C-C chemokine receptor activity (GO:0016493),0.3929640247761541,0.9586384787596443,0.5202898550724637,0.9099856270606242,1.0,3/21,14.06%,CCR2;ACKR3;ACKR4
prerank,nuclear import signal receptor activity (GO:0061608),0.421695318515375,0.9571280927948799,0.5330396475770925,0.9105664592392206,1.0,7/15,19.85%,IPO9;KPNB1;KPNA6;KPNA1;TNPO3;IPO5;KPNA3
prerank,acyl-CoA hydrolase activity (GO:0047617),0.4083774758933435,0.9562613052623401,0.5351123595505618,0.9096821761217733,1.0,4/17,20.98%,THEM4;ACOT11;ACAA2;ACOT8
prerank,calcium-release channel activity (GO:0015278),-0.33504966207754755,-0.9550712322621501,0.5067114093959731,0.7824918048956567,1.0,3/17,9.86%,ITPR1;RASA3;MCOLN1
prerank,calcium channel activity (GO:0005262),0.3213344463466658,0.9548107490053508,0.569247546346783,0.9101152264096032,1.0,17/84,18.11%,CACNA1E;CACNA2D1;CACNG7;ANXA9;NCS1;CACNA1A;PSEN1;CACNB4;SLC24A5;ANXA6;TPCN2;TRPC5;PKD1;CACNA2D4;CACNA2D2;SLC24A4;SLC24A2
prerank,microtubule motor activity (GO:0003777),0.33457644287156413,0.9543107279442373,0.5330188679245284,0.9083771375316438,1.0,12/51,19.17%,DNAH2;KIF20B;KIF19;STARD9;KIF21A;DYNC1I1;KIF5C;DYNC1I2;KIF22;KIF21B;KIF3A;KIF2A
prerank,hydro-lyase activity (GO:0016836),0.3502974717361778,0.9522525918308195,0.5277777777777778,0.9101596855192592,1.0,10/41,20.13%,CYP2S1;CBS;HADHA;UROS;CDYL;PCBD2;AUH;EHHADH;PARK7;HACD2
prerank,cardiolipin binding (GO:1901612),-0.390966130910393,-0.9501774709775119,0.5070422535211268,0.7869917536559417,1.0,5/10,29.59%,STOML2;GSDMD;GSDME;UQCC3;MME
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",0.40170146268051726,0.9499291344587399,0.5246376811594203,0.9126235282578649,1.0,5/16,22.15%,BST1;NEIL1;SMUG1;CD38;TDG
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.4361443699844779,0.9466254717621253,0.5446153846153846,0.9175344374530274,1.0,5/12,21.67%,SLC25A23;SLC35B3;SLC25A25;SLC25A24;SLC17A9
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.29183612470611653,0.9466041993719341,0.716,0.9146720799090431,1.0,125/732,19.77%,EBF2;RORA;ETV1;SOX6;NKX6-2;KLF15;MEOX1;EBF4;ETV4;MEOX2;TLX3;GLI2;SOX8;PRDM16;MYC;DMRT2;TGIF2;EBF1;ZBTB20;SOX9;HIVEP1;ZBTB37;HOXA7;SATB1;TFCP2;EGR3;FOXP2;RFX2;SOX11;GLI1;E2F2;ZEB1;HOXD3;PGBD1;ZFP14;RFX3;ZBTB16;RORC;MLXIPL;MLX;E2F6;LRRFIP1;GATA6;TBX18;ZSCAN20;MKX;ZBTB41;RARG;RARB;SOX12;SOX5;ZNF569;KLF5;HIF1A;ZBTB6;CHD2;ZSCAN26;ZBTB38;NFATC3;ZNF260;ATF2;ZKSCAN8;ESR1;NFE2L2;MYT1;SP1;ZNF112;HDAC6;ZFHX4;SIX5;KLF13;ZGPAT;PATZ1;FOXP4;ZBTB1;NR6A1;NRIP1;PER1;GATA3;AHR;ZNF83;SALL2;ZNF250;ZBTB39;NACC2;KDM6A;PAX3;ZFHX2;HIVEP3;CREM;IRX5;HOXB7;ZNF235;ZEB2;POU3F1;RUNX1;MEIS3;KLF9;TP53;SP3;SREBF2;HNRNPU;NFIA;FOXJ1;PAX2;NFIX;ZKSCAN1;HEYL;NR5A1;KLF16;IRF3;ZNF697;ZNF496;KLF7;RFX7;BATF;EGR1;MED8;RUVBL2;TOP1;PRRX1;FOXJ3;PPARG;JUN;STAT3
prerank,GTPase activity (GO:0003924),0.2980747572220879,0.9461474224721934,0.5985699693564862,0.9127984298480061,1.0,41/192,18.88%,RHOJ;GNA14;DNM1;RHOD;GNG3;RAB38;RND3;RAP2B;RHOBTB3;RAB14;RALB;ARL1;BMS1;RAB21;RAP1A;RABL3;RHOT2;ARL2;MRAS;GSPT2;TBCC;RAB22A;MTG1;RAB1A;RHOH;RHOC;ATL3;ARL8A;RAB3A;GNAI1;RAB4A;TRIM23;OPA1;GTPBP10;RAP1GAP;RAC3;RAB7A;RHOT1;NRAS;KRAS;RAB3B
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",0.43711366007969843,0.9446472856158313,0.5368098159509203,0.913256272945493,1.0,4/12,12.06%,PDE7B;PDE4B;PDE3B;PDE4D
prerank,N-acyltransferase activity (GO:0016410),0.35653992623932684,0.9435926198489255,0.5462610899873257,0.9128660748260609,1.0,10/32,21.94%,CERS3;CERS6;PLAAT5;PLAAT3;SMARCE1;NAA10;GLYAT;PLA2G4E;CERS2;NAT8L
prerank,thiol-dependent deubiquitinase (GO:0004843),0.3149198692877044,0.942273700935605,0.5594713656387665,0.9131078635613072,1.0,23/83,19.07%,USP50;USP35;USP11;OTUD7B;UCHL5;OTULIN;UCHL1;USP46;MYSM1;USP33;UCHL3;USP32;USP48;USP40;USP14;USP1;USP25;USP21;USP2;OTUD4;USP37;OTUD7A;USP5
prerank,phospholipase inhibitor activity (GO:0004859),0.44058102157609447,0.9417802729749913,0.5367892976588629,0.9114653851026437,1.0,3/10,18.64%,ANXA9;SNCA;SNCB
prerank,O-methyltransferase activity (GO:0008171),0.44152127466016267,0.9400405992872544,0.553680981595092,0.9126749361553843,1.0,4/10,19.19%,COMT;LRTOMT;MEPCE;CMTR2
prerank,nucleoside-diphosphatase activity (GO:0017110),0.43269877495723186,0.939777404577036,0.5529953917050692,0.9105133569437954,1.0,2/12,5.19%,NUDT15;ENTPD2
prerank,R-SMAD binding (GO:0070412),-0.31298018737635724,-0.9386302934430062,0.526813880126183,0.8069969258555957,1.0,4/18,12.68%,SMAD6;DDX5;RGCC;RANBP3
prerank,protein phosphatase regulator activity (GO:0019888),0.3298781926183925,0.9384720623510043,0.5688836104513064,0.9107594221078726,1.0,8/53,9.16%,LGALS3;PPP1R15A;RCAN1;ENSA;PPP2R3A;SHOC2;PPP2R2A;RCAN3
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",0.35059905769100386,0.9381533955393853,0.5548628428927681,0.9086540455435658,1.0,6/34,8.26%,RAG2;IQGAP2;MAPKAP1;GBF1;ARHGAP9;GAB2
prerank,endoribonuclease activity (GO:0004521),0.35791783857698645,0.9378871854785986,0.55,0.9064232358458806,1.0,5/32,10.78%,INTS11;NOB1;ZC3H12B;ENDOV;RCL1
prerank,lipase activity (GO:0016298),0.3398052999097757,0.9365957688722178,0.5559610705596107,0.9066489012210457,1.0,7/43,16.31%,PLBD1;CEL;LYPLA1;PNPLA8;SEC23IP;LIPC;ABHD6
prerank,SUMO binding (GO:0032183),0.4296248909373068,0.936231886297174,0.5398496240601504,0.9047647658804455,1.0,6/13,22.15%,UBA2;CBX4;RNF111;USP25;RNF4;TDG
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.41803231905969257,0.9332952969580538,0.5436746987951807,0.9086832909852584,1.0,4/13,22.39%,IDI1;SREBF2;EHHADH;ECH1
prerank,protein-arginine N-methyltransferase activity (GO:0016274),-0.38139922687671757,-0.9328621829433744,0.5470085470085471,0.8138047693746263,1.0,5/11,13.03%,NDUFAF7;PRMT7;PRMT5;PRMT2;PRMT8
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.287563051398282,0.9326071862679892,0.6816816816816816,0.907466512597268,1.0,92/431,18.40%,WNK2;PYGL;RHOJ;RASEF;RHOD;PEAK1;STK36;RAB38;RND3;RAP2B;ADSS1;ACVR1;MAP4K4;RHOBTB3;PDXK;IRAK3;WNK3;RAB14;SIK2;ARL3;RPS6KA4;MAST2;GSS;UBA2;KSR1;CDKL5;RALB;ARL1;PDK3;BMS1;RAB21;RAP1A;SARS2;CDK6;RAB39A;RABL3;TBCK;ACLY;TLK2;AKT3;LANCL2;TUBB6;SYN1;RHOT2;ARL2;MRAS;ARL5C;EIF4G1;MYO9B;PXK;HSPA4;PI4K2A;ARF4;MSH6;ANXA6;RAB22A;DDX25;RHOH;RHOC;ATL3;ARL8A;GNAI1;SRR;PNPLA8;RAB4A;P2RY1;HARS1;AK6;RTEL1;TRIM23;BMPR1A;GTPBP10;ABCB9;ABL1;PAPOLA;BLM;OLA1;NDUFA13;HNRNPU;ABCD2;FICD;ABCF1;EIF2B2;RAC3;SMC4;HSPA9;RAB7A;PEX1;RHOT1;TUBA1A;NRAS;KRAS
prerank,metalloaminopeptidase activity (GO:0070006),0.40795264282193505,0.932452327182586,0.5539772727272727,0.9051125050191013,1.0,6/16,15.60%,LTA4H;MMP15;TRHDE;LNPEP;MMP16;RNPEPL1
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.33586328959536027,0.9324027177341073,0.5836341756919374,0.9024949419428028,1.0,16/49,23.06%,ZFAND2B;RAD23B;ZRANB3;OTUD7B;EPS15;HDAC6;ZBTB1;ZFAND6;OTUD7A;TAB3;TNIP2;WDR81;UBQLN4;TAB2;UBQLN1;UBQLN2
prerank,histone acetyltransferase binding (GO:0035035),0.382455070631499,0.9319295532888533,0.5343007915567283,0.9008231302613239,1.0,8/21,24.09%,HIF1A;CITED2;TAF7;KANSL1;TP53;EGR1;KANSL1L;MEF2A
prerank,histone deacetylase activity (GO:0004407),-0.3128970848776936,-0.9317609844386381,0.5655430711610487,0.8094687774810444,1.0,10/19,25.72%,HDAC8;SIRT3;HDAC4;HDAC11;HDAC3;HDAC5;SUDS3;MIER2;SIRT7;HDAC10
prerank,zinc ion binding (GO:0008270),0.28953473310725525,0.9315345877163383,0.6690140845070423,0.8989722793190932,1.0,57/293,19.04%,RAG2;GLI2;CSRP1;DHH;DPEP1;CBLB;PRKN;EPRS1;KMT2A;SEC24D;PDXK;KDM5B;ITGB1BP2;MT3;MBD1;GRIN2B;HHIP;LTA4H;ZEB1;AOC1;TRIM2;RPH3A;CHD3;GTF2B;TRHDE;SEC24C;PTPN1;LNPEP;MMP16;USP33;MYT1;RBAK;SIRT6;PHF8;ZFPM2;KPNB1;HPF1;SNCA;MDM4;ADAM33;GRIN2A;TRAF7;BAZ1B;PAPPA2;RCHY1;BLM;TP53;TET3;RBSN;RC3H1;ADH5;SEC24A;MDM2;KLF7;ZMYND11;TAB3;EGR1
prerank,protein heterodimerization activity (GO:0046982),0.29570051343812864,0.9295175546757815,0.6278350515463917,0.9007346509264667,1.0,32/178,17.47%,TENM2;TENM3;ERBB3;BCL2;ERBB2;IRAK3;EXT1;UBA2;FBXO7;METTL3;MLXIPL;MLX;PAFAH1B3;NAE1;MTTP;HIP1;HIF1A;RCC1;VAPA;UBA3;KATNB1;ZBTB1;TRMT112;AHR;SNX1;TAF7;ITGB1;FZD9;TP53;ABCG4;CHUK;RALGAPB
prerank,microtubule binding (GO:0008017),0.2916487339137543,0.9270225831581473,0.6802030456852792,0.9035633712223032,1.0,50/222,19.60%,SGIP1;SAXO2;DNM1;FGF13;KIF20B;KIF19;MAP4K4;MAP1B;GAS2L3;ARL3;MAST2;STARD9;PRNP;EML1;NDE1;MACO1;KIF21A;CCDC170;CEP57;CAPN6;DYNC1I1;TUBGCP5;VAPA;MID2;KIF5C;CLASP1;HDAC6;CEP295NL;APC2;KATNB1;RMDN2;CKAP5;MDM1;KIF22;TPGS1;OPA1;GABARAPL2;MAP6D1;EML5;NAV3;DCX;KIF21B;KIF3A;MAPRE3;CAMSAP1;MID1;KIF2A;HOOK2;MAP6;CCDC66
prerank,double-stranded RNA binding (GO:0003725),-0.22209271094059252,-0.9267246126037555,0.6764705882352942,0.8142548412791684,1.0,13/70,14.23%,DDX60;SIDT1;RFTN1;DGCR8;STRBP;AGO1;ACTN1;IFIH1;TFRC;ELAVL1;OAS2;AGO3;MSN
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.2957163929903528,0.9250852097366347,0.6288981288981289,0.9051321375548282,1.0,36/147,17.28%,DENND2A;AKAP13;FGD4;FRMD7;ARHGEF28;NUCB1;DOCK5;ARHGEF10;ALS2;EPS8L1;DOCK10;ITSN1;RAP1A;EIF2B5;RGL1;LAMTOR2;ARHGEF11;VAV3;DENND1C;DOCK1;SPATA13;FARP2;RCC1;DNMBP;RCC1L;RAB3GAP2;RAB3IL1;ANKRD27;ELMO1;CYTH3;RIC8B;ARFGEF1;HPS1;ARHGEF4;EIF2B2;DENND10
prerank,phosphotyrosine residue binding (GO:0001784),0.3456527729410375,0.924087075743217,0.5977443609022557,0.904642610685153,1.0,16/37,26.26%,RASA1;SAMSN1;PIK3R1;PTPN11;ABL1;GRB2;SH3BP2;BCAR3;YES1;VAV2;NCK2;CRK;HCK;LDLRAP1;SYK;SHC3
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),0.413551478765778,0.9214614359335057,0.5783132530120482,0.9076712930222696,1.0,3/14,11.44%,PTEN;MTMR14;MTMR12
prerank,protein kinase A regulatory subunit binding (GO:0034237),0.373101607733391,0.9206805759566155,0.5794520547945206,0.906737949432682,1.0,8/21,23.03%,PRRC1;AKAP6;WASF1;PRKACA;ARFGEF1;AKAP1;PJA2;WASF3
prerank,phosphatidic acid binding (GO:0070300),0.3814825954125435,0.9198335946815029,0.5625,0.9058835598859953,1.0,5/19,14.92%,SESTD1;PACSIN2;MAPKAP1;GRAMD1B;OPA1
prerank,adenylate cyclase binding (GO:0008179),0.44046646214727886,0.9195429342559213,0.5585585585585585,0.9038326202203408,1.0,5/10,27.63%,AKAP6;CALM1;CALM2;ADCY5;AKAP12
prerank,guanyl ribonucleotide binding (GO:0032561),0.28951972279052657,0.9191384720894419,0.6591606960081884,0.9020244819142005,1.0,54/196,22.96%,RHOJ;RASEF;RHOD;RAB38;RND3;RAP2B;ADSS1;RHOBTB3;RAB14;ARL3;RALB;ARL1;BMS1;RAB21;RAP1A;RAB39A;RABL3;LANCL2;TUBB6;RHOT2;ARL2;MRAS;ARL5C;ARF4;ANXA6;RAB22A;RHOH;RHOC;ATL3;ARL8A;GNAI1;RAB4A;TRIM23;GTPBP10;EIF2B2;RAC3;RAB7A;RHOT1;TUBA1A;NRAS;KRAS;RAB3B;PDE11A;RRAGA;RHOU;RABL6;GLUD1;AGAP2;PDE10A;RAB18;GBP2;RAP2A;RAB6A;RAP2C
prerank,syntaxin binding (GO:0019905),0.318139171042672,0.9191241900144601,0.5969802555168409,0.899425626226264,1.0,12/61,13.45%,SNAP23;STXBP4;PTPN2;SYNPR;CACNA1A;SYT1;SNAP29;TMED10;VPS11;SYT12;STXBP5;STX8
prerank,alanine transmembrane transporter activity (GO:0022858),-0.3593740031980839,-0.916313402057787,0.5697674418604651,0.8322651888030819,1.0,4/12,14.60%,SLC6A6;SLC38A7;SLC38A5;SLC36A4
prerank,estrogen receptor binding (GO:0030331),0.3546459822949134,0.9131946180702403,0.5803108808290155,0.909470383659213,1.0,10/32,14.17%,NCOA1;TACC1;WIPI1;DDX54;PPID;ESR1;DCAF1;NRIP1;STRN;LCOR
prerank,lysophospholipase activity (GO:0004622),-0.30330530779867176,-0.9101284853597635,0.5661764705882353,0.8392827762201366,1.0,6/20,17.80%,PLA2G4A;PNPLA6;ASPG;MGLL;ABHD12;LYPLAL1
prerank,ribosomal large subunit binding (GO:0043023),0.43207470755611976,0.9082338045361561,0.5954887218045113,0.917206326262299,1.0,3/11,14.37%,CPSF6;EIF6;DHX33
prerank,histone demethylase activity (GO:0032452),0.36023318510790453,0.9076482402271534,0.5852348993288591,0.9157675321790832,1.0,6/27,13.89%,KDM8;KDM5B;KDM4B;PHF8;JARID2;KDM6A
prerank,vitamin D receptor binding (GO:0042809),0.4014098235164337,0.9060650617990919,0.5783132530120482,0.9164999423985254,1.0,6/14,22.79%,MED13;TAF11;TAF7;MED12;MED30;MED24
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.3051737157722988,0.9049590855368064,0.6200676437429538,0.91624312069495,1.0,24/69,25.43%,CERS3;KAT2B;CERS6;NAA16;KAT8;GTF2B;ZDHHC8;MOGAT3;PLAAT5;HHAT;PLAAT3;DBT;NAA10;GLYAT;NAA15;PLA2G4E;CERS2;ZDHHC21;PORCN;SCP2;ZDHHC13;DGAT2;ZDHHC15;ZDHHC17
prerank,pyrophosphatase activity (GO:0016462),0.3256501215531204,0.9035540227064929,0.6135552913198573,0.9164430815143154,1.0,11/50,12.51%,NUDT15;DXO;RNGTT;ENTPD2;BNIPL;NUDT1;NUDT22;PLPP4;NUDT10;NUDT9;NUDT3
prerank,ephrin receptor activity (GO:0005003),0.3864169070862104,0.9023543118109799,0.5977653631284916,0.9137445300417872,1.0,3/17,3.35%,EFNA4;EPHB6;EPHB2
prerank,transmembrane-ephrin receptor activity (GO:0005005),0.3864169070862104,0.9023543118109799,0.5977653631284916,0.9137445300417872,1.0,3/17,3.35%,EFNA4;EPHB6;EPHB2
prerank,disordered domain specific binding (GO:0097718),0.3712471914322186,0.9012627155873971,0.6089828269484808,0.9134586742871041,1.0,7/23,18.13%,KCNA1;FYN;CALM1;CALM2;TP53;NCOA3;MDM2
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.3516607168717917,0.900137730756272,0.6113924050632912,0.9130979895458207,1.0,5/29,7.08%,KAT2B;CDKN2B;PRKAR1B;SPRED2;SPRED1
prerank,omega peptidase activity (GO:0008242),0.29923805312664475,0.9001065269544778,0.6405228758169934,0.9105738783532578,1.0,23/89,19.07%,USP50;USP35;USP11;OTUD7B;UCHL5;OTULIN;UCHL1;USP46;MYSM1;USP33;UCHL3;USP32;USP48;USP40;USP14;USP1;USP25;USP21;USP2;OTUD4;USP37;OTUD7A;USP5
prerank,MAP-kinase scaffold activity (GO:0005078),0.42035445050082915,0.8999803203482013,0.57847533632287,0.908291991151378,1.0,4/11,14.88%,AKAP13;KSR1;SPAG9;IQGAP1
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",0.3402632489336889,0.8994071523452037,0.6264009962640099,0.9068932023483331,1.0,11/35,23.75%,DTWD1;ELAC1;GATB;TRMT12;MRPL58;DTWD2;MTFMT;TRIT1;LCMT2;ALKBH1;NT5C3A
prerank,myosin binding (GO:0017022),0.3197404954967359,0.8993295818532875,0.6404230317273796,0.9045083612241032,1.0,18/55,22.82%,PYCARD;GSN;RAB14;SPATA6;RAB3D;STXBP5;MYOC;RAB3A;KIRREL1;MOBP;ARFGEF1;TRAK2;RAB3B;NKD2;RAB39B;TRIOBP;LLGL1;RAB6A
prerank,protein phosphatase activator activity (GO:0072542),-0.3384854548650994,-0.897022028744658,0.56875,0.8628338132173778,1.0,3/13,5.07%,PHACTR4;IGFBP3;PTPA
prerank,GABA receptor binding (GO:0050811),-0.35752238229312594,-0.8961874114648556,0.5949008498583569,0.8579024737055272,1.0,6/11,20.12%,TRAK1;GABARAP;PLCL2;JAKMIP1;SHISA7;ARFGEF2
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.2781744539753958,0.8959348215125642,0.7386018237082067,0.9087953119566434,1.0,45/232,18.13%,PDZRN3;RNF157;CBLB;PRKN;DTX4;HACE1;NFX1;TRIM44;RNF6;ZNRF2;NEURL4;UFL1;TRIM2;TRIM11;CBX4;PELI1;RNFT1;VPS11;FBXO27;NEURL1B;PIAS2;CUL3;UHRF2;HUWE1;CBL;TRIM41;RNF121;FBXO17;MEX3C;MYLIP;RNF24;NEDD4L;AREL1;NEURL3;UBE2O;RNF19A;RCHY1;XIAP;RNF111;KCMF1;RNF10;RC3H1;RNF167;TRIM9;MDM2
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.3316595439977151,-0.8933698981320958,0.6053511705685619,0.856950981506563,1.0,3/14,11.53%,SLC26A7;SLC26A2;SLC25A30
prerank,ATPase activator activity (GO:0001671),0.37437898717138934,0.8906209667758336,0.6344086021505376,0.9167696133021005,1.0,7/20,18.97%,DNAJB4;DNAJB6;AHSA1;DNAJC19;DNAJA2;DNAJA1;DNAJC10
prerank,RNA polymerase binding (GO:0070063),0.37292105635413025,0.8902159022135175,0.6176470588235294,0.9150269003673198,1.0,8/18,27.47%,BIN1;BRCA1;TCERG1L;PKN2;ZFP36;CCNT2;TCERG1;ANP32B
prerank,NF-kappaB binding (GO:0051059),-0.283504796124922,-0.8890695109939979,0.6224066390041494,0.8596642770399968,1.0,10/24,27.29%,NFKBIA;NPM1;GSK3B;ANXA4;COMMD7;COMMD6;HDAC3;RNF25;BRMS1;SETD6
prerank,C-C chemokine binding (GO:0019957),0.3567995132724863,0.8878903190519866,0.6073968705547653,0.9169623294842537,1.0,4/22,20.39%,CCR2;ACKR3;ACKR4;ZFP36
prerank,cell adhesion mediator activity (GO:0098631),0.3509696511877622,0.8876220054061728,0.6196808510638298,0.915029890880909,1.0,6/24,10.12%,LRRC4C;NTNG1;CNTN6;CNTN2;DSCAM;PALLD
prerank,glycine binding (GO:0016594),0.4092298118925085,0.8856455192825197,0.572289156626506,0.9164810794980527,1.0,3/11,20.40%,GRIN2B;SRR;GLRB
prerank,carboxypeptidase activity (GO:0004180),0.33172452462347857,0.8854639155444349,0.6228070175438597,0.9143326356278009,1.0,6/35,13.52%,NAALAD2;AGBL3;AGBL2;AGBL4;AGBL1;CPD
prerank,kinase activator activity (GO:0019209),-0.2660710918800718,-0.8849465883052342,0.6826923076923077,0.8616050273145323,1.0,9/30,13.20%,PRKAG2;WNK1;MADD;GPRC5C;RGCC;RPLP1;MARK2;SPDYA;NCKAP1L
prerank,3'-5' exonuclease activity (GO:0008408),0.3161115044111379,0.8846675655250862,0.6273809523809524,0.9134117951452343,1.0,10/45,17.24%,USB1;REV3L;XRN2;REXO4;PNLDC1;EXOSC2;EXD2;POLG;PNPT1;WRN
prerank,1-phosphatidylinositol binding (GO:0005545),0.3943137377056086,0.8846289712124057,0.61212976022567,0.9109884779262883,1.0,4/15,12.36%,SESTD1;WDFY3;SNX10;ZFYVE9
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",-0.35371586860544624,-0.8835228175371999,0.5807365439093485,0.8580647784698555,1.0,5/11,22.98%,ITPR1;TRPC6;TRPC3;TRPC7;CYTH2
prerank,protein phosphatase 1 binding (GO:0008157),-0.28619846539532967,-0.8815069088759014,0.6061776061776062,0.8553846347564762,1.0,5/21,10.93%,PHACTR4;PPP1R16B;PPP1R3B;SH3RF2;PPP1R11
prerank,protein homodimerization activity (GO:0042803),0.2729075515661776,0.8813482375726062,0.858,0.9147689554765647,1.0,111/589,18.85%,SOX6;TENM2;AADAT;TENM3;PDGFRA;GLIPR2;FAP;PYCARD;KIF20B;KYNU;BCL2;CBS;HM13;PSPH;PTPRT;ACVR1;EPRS1;KMT2A;VEGFA;PDXK;IRAK3;FOXP2;ERCC5;NTRK2;GSS;EXT1;HSPB6;AOC1;NAGA;CADM3;ALS2;ZBTB16;MLXIPL;MLX;SETMAR;MKLN1;CARD9;PNPO;PAFAH1B3;S100A6;LRRFIP1;TBX18;BNIP3;FGFR1;ACOX1;CADM1;RABL3;PDLIM4;FLNA;CEP57;S100A16;RPE;XPA;HIP1;CRYAB;PRDM9;SNX6;ERBB4;ZBTB38;SLK;MYO9B;MID2;GDNF;GLCE;GALM;SP1;MSH6;SFPQ;PHETA2;ZBTB1;NR6A1;GGCT;AHR;SRR;SYNDIG1;EXD2;NACC2;HARS1;NFS1;RAB11FIP3;BMPR1A;SNX1;PDCD6IP;CHMP4C;ABCB9;JUP;FZD9;RCHY1;BLM;FECH;KCNH2;PPCS;RAP1GAP;ALDH1A3;ABCG4;ABCD2;FICD;RIPK1;ACSL6;WRN;GSTZ1;CHUK;TRIM9;CAT;IRF3;PGRMC1;NUDT5;MAP3K11;MID1;PARK7;PEX11A
prerank,RNA methyltransferase activity (GO:0008173),0.37203839139770145,0.8809633787728732,0.6515580736543909,0.9130015425955881,1.0,5/19,15.74%,METTL3;TRMT12;TGS1;FBL;MEPCE
prerank,RNA binding (GO:0003723),0.26884504163502837,0.8805899137112817,0.941,0.911224721515033,1.0,356/1321,23.18%,DCN;LGALS3;PABPC5;RBFOX1;DNM1;CSTF3;CSRP1;DDX11;RBMS3;S100A4;NQO1;DHX8;DHX34;CELF5;HNRNPDL;LRP1;C1D;QKI;GPATCH4;EPRS1;APTX;TRMT10B;WDR36;FNDC3B;TRA2B;NFX1;PRRC2B;ZNF326;DXO;PABPC1;CCDC9;FARSA;ANKHD1;CPSF6;RBM33;RPL23A;CSTB;ETF1;GOLGB1;ZNFX1;LTA4H;NOP2;SPTBN1;ZMAT3;HNRNPAB;TUFM;RP9;MRPL14;MRPL32;YWHAZ;ATXN2;POLR2B;UBAP2;NGRN;METTL3;UCHL5;MRPL16;CDK13;PLEC;BRIX1;NUDT1;EIF1B;XRN2;NOL8;DHX35;SON;BMS1;LUC7L2;LRRFIP1;SRP9;EIF3C;SARS2;SAMSN1;TUT4;ZC3H8;IBA57;MRTO4;SRBD1;DHX30;DDX54;UNK;CHD3;TBL2;CPEB3;UTP6;ZC3H12B;GDI2;FLNB;ADK;GOT2;SRSF11;ZC3H15;KHDRBS3;MRPS35;MRPS28;TFAM;PPP1R8;FLNA;BRCA1;HEATR1;S100A16;PEG10;DDX24;ANXA11;RBM10;FASN;FARS2;NSUN5;TRIP6;DCP1B;RCAN3;CASC3;CKAP4;APOBEC1;REXO4;PTPN1;CHD2;ALKBH5;NCBP1;ZFP36L2;PNLDC1;R3HDM1;HDAC2;ADARB2;FIP1L1;HUWE1;EIF4G1;RSRC2;EXOSC2;PSIP1;ENDOV;DUSP11;PCBP4;UBFD1;CLNS1A;RIMS1;FKBP4;RPP38;FBL;PRMT1;SFPQ;GSPT2;MRPL28;UPF1;COL14A1;CCDC137;RBM27;ZC3H18;EBNA1BP2;MEX3C;SNRNP40;HNRNPA3;DDX25;RCC1L;GRN;LSM3;SPATS2;YARS1;XRCC6;PRPF6;CCDC86;DAZAP1;HSP90B1;CFAP20;DHX57;ADARB1;DALRD3;KPNB1;SPOUT1;CCDC47;POLRMT;RBM4B;POLR2G;DDX42;PUS7;CELF6;MSI1;GLRX3;DHX32;RBM7;EIF1;EIF1AX;SUMO1;DHX33;NOVA1;SRSF6;YTHDC1;RBM45;NDUFV3;RTN4;ZNF638;WDR46;ELP5;SEC23IP;DDX10;KHSRP;RNMT;SLTM;TNS1;GTPBP10;DDX27;LUC7L;EIF4ENIF1;PSMC1;UBE2O;GTF2E2;XPOT;NIP7;GCN1;PURG;CSNK1E;PUS1;KYAT3;MEPCE;NIFK;NOP56;RPS27L;SNRPA;SLC25A11;SEC63;SMG6;PNPT1;NOC4L;SF3A1;HNRNPU;RAVER2;POP1;FSCN1;DDX56;RBM46;EIF4A2;ZYX;ABCF1;N4BP1;NXF1;SRRM3;FUBP1;AKAP1;RPP21;RC3H1;RNPS1;SSB;TRAP1;UBA1;SF1;PCID2;PKN2;POLR1G;CAST;FUS;BOP1;HSPA9;OTUD4;MRPS30;SART1;CLUH;NUDT5;NAA15;AATF;RBFOX3;DDX23;RPSA;PARK7;ACAA2;POLR2A;PNISR;RDX;GIGYF2;GRB2;IPO5;UBAP2L;CNBP;TOP1;RPN1;BZW1;SYNCRIP;FAM120A;ZNF106;VIRMA;PSTK;SRRM1;UBE2L3;HNRNPUL1;JUN;STAT3;MCRS1;TENT5A;UBTF;CSDE1;MRPS14;BCCIP;NSUN2;DBR1;HNRNPC;FUBP3;ZFP36;CELF4;R3HDM2;DDX31;HNRNPH2;ZBED4;MRPS9;SREK1;PEF1;ZCCHC9;MRPS31;HSPD1;SSBP1;DHX40;HNRNPL;MRPL1;CPNE3;MYO5A;SSRP1;PYM1;RBFOX2;MKRN1;PTCD3;DAP3;FDPS;EIF4G3;HARS2;NPM3;NOL10;DDX6;SRSF3;RBMS1;FYTTD1;VIM;HNRNPUL2;ALKBH8;ALDH6A1;RIDA;SNIP1;AHNAK;RPS11;PTBP2;DDX4;EDF1;NUP42;ZC3H12C;RBMX2;YBX3;SNRNP200;DYNC1H1;SF3B2;ALKBH1;DENR;WDR75;AFF2;DDX50;EXOSC3;RBM25;DHX29;WBP4;TBL3
prerank,cytochrome-c oxidase activity (GO:0004129),-0.3144241245375644,-0.8797551859096105,0.627906976744186,0.8524964766347444,1.0,5/15,17.38%,COX6B1;COX6A1;COX4I1;COX5B;COX5A
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),0.4189400802087496,0.8790645170044125,0.6261980830670927,0.9116997444730273,1.0,2/10,2.56%,PRDM16;SUV39H1
prerank,5'-3' RNA polymerase activity (GO:0034062),0.35016884764200634,0.8788738512475013,0.6095979247730221,0.909653078086541,1.0,12/27,26.15%,POLR2B;POLRMT;POLR1B;POLR2G;MED21;POLR1D;POLR1C;TENT2;POLR2A;POLR3K;POLR2F;POLR3F
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),0.33392902923243317,0.8777742667874698,0.6446700507614214,0.9091489981821819,1.0,5/32,11.78%,SLC1A5;SLC36A2;SLC25A38;SLC43A1;SLC7A8
prerank,chemokine receptor activity (GO:0004950),0.3503464040491864,0.8770953294984772,0.6046831955922864,0.9080768048410702,1.0,3/24,14.06%,CCR2;ACKR3;ACKR4
prerank,aminopeptidase activity (GO:0004177),0.34651033878590226,0.8754642037083814,0.6297262059973925,0.9087609538804193,1.0,6/26,10.52%,KDM8;LTA4H;MMP15;TRHDE;LNPEP;MMP16
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),0.37841161675946317,0.8752655775016485,0.6339677891654466,0.9067678668744134,1.0,3/16,11.44%,PTEN;MTMR14;MTMR12
prerank,nuclear localization sequence binding (GO:0008139),-0.29964105631146687,-0.8746236684996491,0.6544117647058824,0.8567523173992244,1.0,5/18,10.96%,NFKBIA;KPNA4;BRAP;RANBP6;NUP214
prerank,core promoter sequence-specific DNA binding (GO:0001046),0.32736258375729976,0.8745666633027503,0.620253164556962,0.9056945703963867,1.0,18/35,27.55%,MYC;DRAP1;GTF2B;PIH1D1;TAF4;TP53;PARK7;TAF1;RUVBL2;UBTF;SMARCA4;SNAPC3;RRN3;TBP;SMARCB1;DR1;HDAC1;RELA
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",-0.30329326674399115,-0.872086134069287,0.6643598615916955,0.8557766924396512,1.0,9/16,39.45%,CDO1;ETHE1;ALOX12;BCO2;HGD;ALOXE3;HAAO;ALOX5;PIR
prerank,high voltage-gated calcium channel activity (GO:0008331),-0.356991932879075,-0.8681459097264353,0.6428571428571429,0.8573140204489365,1.0,2/10,1.46%,CACNA1C;CACNB2
prerank,manganese ion binding (GO:0030145),-0.23422591213359106,-0.8667756353292698,0.7071428571428572,0.8535517400076615,1.0,11/48,16.28%,MPPED2;ABL2;MTPAP;ME1;PRIMPOL;MGAT1;IMPA1;B4GALT7;ADPRM;MPPE1;B4GALT1
prerank,telomeric DNA binding (GO:0042162),0.3274776220254216,0.8663892045703718,0.6645161290322581,0.9184704156997847,1.0,14/32,28.36%,UPF3A;STN1;UPF1;XRCC6;BLM;SMG6;TERF2IP;WRN;CTC1;RAD50;ACD;HNRNPA2B1;SMG1;TELO2
prerank,metallocarboxypeptidase activity (GO:0004181),0.33872430757589195,0.8638641724596933,0.6479791395045632,0.9205347281164804,1.0,5/26,13.52%,AGBL3;AGBL2;AGBL4;AGBL1;CPD
prerank,phosphatase activity (GO:0016791),0.29310066382946803,0.8637458809061223,0.6759776536312849,0.9183100838960424,1.0,20/73,21.09%,ACP5;PTPN22;DUSP4;PSPH;APTX;ACP2;BPNT2;DUSP11;PTPRJ;PLPP4;PPP1CA;PLPPR4;HDHD2;MDP1;MINPP1;DUSP16;NT5C;DUSP12;PLPPR2;PTPMT1
prerank,fibroblast growth factor binding (GO:0017134),-0.2808226042478592,-0.8598907602575243,0.678082191780822,0.8609432258891655,1.0,7/21,15.46%,KL;RPS19;THBS1;RPS2;FGFR2;API5;FGFR4
prerank,neuropeptide receptor binding (GO:0071855),0.3806287018958483,0.8594112977089862,0.6461769115442278,0.9236732989498389,1.0,3/14,25.35%,NMU;NPY;SHANK1
prerank,phospholipase activator activity (GO:0016004),0.4048800171779423,0.8569477847954244,0.6309148264984227,0.9258074811950788,1.0,1/10,8.06%,FYN
prerank,pre-mRNA binding (GO:0036002),0.33513342174171806,0.8552392107848704,0.6723237597911227,0.926501701524499,1.0,8/28,21.10%,CELF5;TRA2B;RNPC3;RBM7;SRSF6;HNRNPU;CELF4;HNRNPL
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",-0.3403562113991695,-0.8545878909778001,0.6647727272727273,0.8655803629416708,1.0,2/11,13.96%,DDAH2;PADI2
prerank,MAP kinase activity (GO:0004707),0.3861495583458031,0.8545458554848421,0.6552262090483619,0.9252608566779309,1.0,4/14,11.41%,MAPK7;MAPK9;MAPK14;MAPK1
prerank,platelet-derived growth factor receptor binding (GO:0005161),0.39222279918934844,0.854385564035966,0.6777456647398844,0.9231543564917859,1.0,3/13,10.54%,PDGFRA;VEGFA;PTPRJ
prerank,inorganic cation transmembrane transporter activity (GO:0022890),0.305067351163798,0.8537090041797086,0.6833333333333333,0.921889664624119,1.0,4/48,5.24%,PIEZO2;CALHM6;ATP6V1B2;SLC12A2
prerank,histone deacetylase binding (GO:0042826),0.28541231970535497,0.8527474721510511,0.7390829694323144,0.9211520652137997,1.0,16/88,16.16%,KAT2B;PRKN;PKN1;MTA2;ANKRA2;HDAC2;SP1;SFPQ;HDAC6;RBBP4;NACC2;LCOR;NCOR2;DACT1;TP53;MTA3
prerank,ribonuclease P RNA binding (GO:0033204),0.40457418390791733,0.8511732248647776,0.650381679389313,0.9214876956520188,1.0,5/10,27.33%,RPP38;POP1;RPP21;RPP30;RPP14
prerank,ubiquitin protein ligase activity (GO:0061630),0.2641716942267487,0.850754724999372,0.8109201213346815,0.9198376813150788,1.0,44/228,18.13%,PDZRN3;RNF157;CBLB;PRKN;DTX4;HACE1;NFX1;TRIM44;RNF6;ZNRF2;NEURL4;TRIM2;TRIM11;PELI1;UBE2K;RNFT1;VPS11;FBXO27;NEURL1B;CUL3;UHRF2;HUWE1;CBL;TRIM41;RNF121;FBXO17;MEX3C;MYLIP;RNF24;NEDD4L;AREL1;NEURL3;UBE2O;RNF19A;RCHY1;UBOX5;XIAP;RNF111;KCMF1;RNF10;RC3H1;RNF167;TRIM9;MDM2
prerank,store-operated calcium channel activity (GO:0015279),-0.3409323903457098,-0.8501244256502911,0.6559766763848397,0.8684511833826518,1.0,5/10,25.36%,TRPC6;ORAI2;TRPC3;TRPC7;ORAI3
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.3007141210368598,0.8494611446984964,0.6835294117647058,0.9195941606874367,1.0,11/55,18.11%,ANXA9;ATP2B3;PSEN1;SLC8A2;SLC24A5;ANXA6;ATP2B1;TRPC5;PKD1;SLC24A4;SLC24A2
prerank,nucleoside-triphosphatase activity (GO:0017111),0.265368827209665,0.8493205824037511,0.801829268292683,0.9174755213375406,1.0,51/248,19.24%,RHOJ;GNA14;DNM1;KIF20B;RHOD;GNG3;RAB38;RND3;RAP2B;RHOBTB3;RAB14;RALB;ARL1;BMS1;RAB21;RAP1A;CHD3;RABL3;RHOT2;ARL2;DYNC1I1;MRAS;MYO19;GSPT2;GPR88;TBCC;RAB22A;MTG1;RAB1A;RHOH;RHOC;ATL3;ARL8A;RAB3A;GNAI1;ATP2B1;RAB4A;TRIM23;OPA1;GTPBP10;RAP1GAP;ABCG4;ABCD2;RAC3;RAB7A;RHOT1;NRAS;KRAS;RAB3B;KIF2A;RUVBL2
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.35069655820711215,0.8488531441669503,0.6556927297668038,0.9159225170041904,1.0,6/21,17.26%,POLN;POLE2;REV3L;POLE3;POLG;REV1
prerank,GDP binding (GO:0019003),0.29121064844396133,0.8475901117367362,0.7004662004662005,0.9157112199171535,1.0,16/63,18.88%,RASEF;RAP2B;RAB14;ARL3;RALB;RAB21;RAP1A;MRAS;RAB22A;GNAI1;RAB4A;TRIM23;RAB7A;NRAS;KRAS;RAB3B
prerank,ATP binding (GO:0005524),0.26375404022189425,0.8474076701232156,0.8190954773869347,0.9137533900563286,1.0,54/266,18.30%,WNK2;PYGL;PEAK1;STK36;ACVR1;MAP4K4;RHOBTB3;PDXK;IRAK3;WNK3;SIK2;RPS6KA4;MAST2;GSS;UBA2;KSR1;CDKL5;PDK3;SARS2;CDK6;TBCK;ACLY;TLK2;AKT3;LANCL2;SYN1;EIF4G1;MYO9B;PXK;HSPA4;PI4K2A;MSH6;DDX25;SRR;PNPLA8;P2RY1;HARS1;AK6;RTEL1;BMPR1A;ABCB9;ABL1;PAPOLA;BLM;OLA1;NDUFA13;HNRNPU;ABCD2;FICD;ABCF1;EIF2B2;SMC4;HSPA9;PEX1
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.2837426437006003,0.8464856501866651,0.710989010989011,0.9130665518201824,1.0,15/75,19.49%,HSD17B7;HSD17B11;H6PD;AKR1B10;HADHA;PHGDH;RDH10;DHRS3;HIBADH;CBR3;KCNAB2;UGDH;ADH5;EHHADH;LDHB
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),0.3745541039820639,0.8463667757657732,0.6651851851851852,0.9109860848801365,1.0,4/14,19.16%,KCND3;KCNJ3;KCNH2;KCNA5
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",0.3994753440926031,0.8443749761576432,0.6393188854489165,0.9121879787125069,1.0,5/10,21.57%,RPE;GLCE;GALM;GNE;DSEL
prerank,myosin II binding (GO:0045159),0.40925070352459625,0.8433876387513468,0.662015503875969,0.9115178056095925,1.0,4/10,22.42%,GSN;STXBP5;TRIOBP;LLGL1
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),0.3912448984352841,0.842281181845856,0.669683257918552,0.9111348414429185,1.0,2/12,5.98%,PYCARD;APAF1
prerank,adenylyltransferase activity (GO:0070566),-0.2739085126430516,-0.8419306340894198,0.730909090909091,0.8781868000330805,1.0,8/21,19.33%,NMNAT2;MTPAP;NMNAT1;OAS2;KARS1;FLAD1;TENT4A;TENT4B
prerank,AMP binding (GO:0016208),0.3905490399290902,0.8394235128449744,0.6529680365296804,0.91357516992435,1.0,2/11,2.63%,PYGL;ACSS2
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),-0.35140100680601294,-0.8353097001182626,0.6790830945558739,0.8845006671137134,1.0,2/10,2.53%,CD200;CXADR
prerank,MAP kinase kinase kinase activity (GO:0004709),-0.32541601249580066,-0.8331527060987123,0.6819484240687679,0.8821327010559021,1.0,5/11,18.07%,MAP3K5;MAP3K20;MAP3K7;MAP3K1;TAOK2
prerank,exoribonuclease activity (GO:0004532),0.3726848751592241,0.8316460212059624,0.6656671664167916,0.9244688478488889,1.0,2/12,10.32%,EXOSC8;EXOSC2
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.3313096203312672,0.8308110792245678,0.6828309305373526,0.9236227086219378,1.0,4/25,14.24%,POR;SQLE;MTRR;CYP27A1
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",-0.3088672278898116,-0.8301523611361586,0.6925373134328359,0.8812022990150241,1.0,6/14,27.50%,SDHB;CIAO3;ACO1;ACO2;RSAD2;EXO5
prerank,phosphatidylinositol binding (GO:0035091),0.2769333348796166,0.8297752864270588,0.7532751091703057,0.9231960995273439,1.0,14/91,12.36%,RAG2;SESTD1;DPEP1;PITPNB;NCF1;WDFY3;SH3YL1;RPH3A;HIP1;DENND1C;PASK;SNX10;MREG;ZFYVE9
prerank,miRNA binding (GO:0035198),-0.2474717427781737,-0.8295272957674862,0.7610619469026548,0.876220142701211,1.0,7/30,12.43%,YBX1;AGO1;ZC3H7B;DDX21;ELAVL1;TUT7;AGO3
prerank,lipase activator activity (GO:0060229),0.39127228956427407,0.8289121938979039,0.6656394453004623,0.9223002397970299,1.0,1/10,8.06%,FYN
prerank,tRNA methyltransferase activity (GO:0008175),-0.2909176934458056,-0.8279872889565205,0.7021276595744681,0.8730753991571949,1.0,4/16,8.47%,TRMT9B;FTSJ1;METTL2A;METTL2B
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),0.3718945827374154,0.8279630465952753,0.6891117478510028,0.9215622373266088,1.0,2/13,4.40%,TRMT10B;THUMPD3
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),-0.2622580289359685,-0.8276424539285913,0.7410358565737052,0.8676017633394428,1.0,6/24,15.14%,ZDHHC14;ZDHHC3;ZDHHC18;ZDHHC7;ZDHHC20;ZDHHC4
prerank,5'-3' exonuclease activity (GO:0008409),0.3606713887425978,0.8271138038233377,0.6722306525037937,0.9206822208934262,1.0,2/14,6.69%,DXO;XRN2
prerank,calcium-activated potassium channel activity (GO:0015269),0.3891723645703795,0.8248936377270227,0.6677367576243981,0.9218997126719564,1.0,3/11,17.39%,KCNMB2;KCNMB3;KCNMA1
prerank,E-box binding (GO:0070888),0.30920507380378925,0.8246340064405224,0.7155727155727156,0.9200454825761186,1.0,9/34,22.55%,MYC;ZEB1;PER1;GATA3;AHR;SREBF2;PPARG;MITF;SNAI1
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),0.3511511314486303,0.8206203596209001,0.6925329428989752,0.9242065619862754,1.0,2/15,14.06%,CCR2;ACKR4
prerank,translation initiation factor activity (GO:0003743),0.3092236938126421,0.8195202232584491,0.7083854818523154,0.9237784787778373,1.0,8/36,17.19%,EIF1B;EIF3C;EIF2B5;EIF3M;EIF4G1;EIF1;EIF4A2;EIF2B2
prerank,exonuclease activity (GO:0004527),0.2951053626434647,0.8186168603697478,0.7332535885167464,0.9230476533775906,1.0,10/46,17.24%,DXO;REV3L;XRN2;EXOSC8;REXO4;EXOSC2;EXD2;AEN;POLG;WRN
prerank,ubiquitin-protein transferase activity (GO:0004842),0.25317054791673627,0.8180807054428024,0.9007021063189569,0.9215930032663204,1.0,90/346,23.52%,UBE2T;PDZRN3;RNF157;CBLB;PRKN;DTX4;UBE2E2;HACE1;NFX1;TRIM44;RNF6;KLHL13;FBXO7;ZNRF2;DDB2;NEURL4;TRIM2;HECTD3;TRIM11;PELI1;BRCA1;UBE2K;RNFT1;VPS11;FBXO27;NEURL1B;CUL3;UHRF2;UBE2Z;HUWE1;CBL;RSPRY1;UBE2J2;TSPAN17;TRIM41;RNF121;FBXO17;MEX3C;MYLIP;AKTIP;MALT1;RNF24;TRIM23;NEDD4L;TRAF7;AREL1;NEURL3;UBE2O;RNF19A;RCHY1;CDC23;XIAP;RNF111;UBE2Q1;RNF182;MIB1;KCMF1;CUL4B;RNF10;RC3H1;RNF167;TRIM9;FBXO22;MDM2;ANKRD39;RNF4;TAF1;FBXO11;BCOR;UBE2L3;TRAIP;TRIM35;UBE2G1;RNF13;UBE2E1;ANAPC4;MKRN1;RNF114;UBE2D3;RNFT2;TTC3;UBR3;FBXO44;RNF123;SIAH1;PJA2;RNF187;COP1;UBE3C;RNF2
prerank,hormone receptor binding (GO:0051427),0.35930976244582186,0.816288949817194,0.6963746223564955,0.9222324397557846,1.0,3/14,17.10%,PTHLH;TYK2;NPPC
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),0.37918453558211607,0.8139340565202662,0.6973058637083994,0.923907366811199,1.0,6/12,27.55%,GTF2B;TAF1;RUVBL2;TBP;HDAC1;RELA
prerank,motor activity (GO:0003774),0.27987121132719167,0.8139216069724032,0.7591743119266054,0.9216979896854033,1.0,13/60,19.17%,DNAH2;KIF20B;KIF19;STARD9;KIF21A;DYNC1I1;KIF5C;GPR88;DYNC1I2;KIF22;KIF21B;KIF3A;KIF2A
prerank,DNA polymerase activity (GO:0034061),0.33283981699849197,0.8124595554830132,0.6894664842681258,0.9218193831915944,1.0,6/22,17.26%,POLN;POLE2;REV3L;POLE3;POLG;REV1
prerank,nuclear export signal receptor activity (GO:0005049),0.3757901232662877,0.8121781229743746,0.7014446227929374,0.9200870845890778,1.0,5/11,23.26%,XPO1;EIF4ENIF1;CSE1L;NUP42;XPO5
prerank,acylglycerol lipase activity (GO:0047372),-0.3210389270032994,-0.8120874735677552,0.7021276595744681,0.889934145949856,1.0,5/11,25.43%,MGLL;ABHD2;ABHD12;FAAH;LIPE
prerank,SH2 domain binding (GO:0042169),0.3111962549907737,0.8114041112458866,0.7278562259306803,0.9190680173278465,1.0,1/31,0.33%,DLC1
prerank,adenyl ribonucleotide binding (GO:0032559),0.25189921487428696,0.8108797206016909,0.886317907444668,0.917611286552993,1.0,54/291,17.19%,WNK2;PYGL;PEAK1;STK36;ACSS2;ACVR1;MAP4K4;RHOBTB3;PDXK;IRAK3;WNK3;SIK2;RPS6KA4;MAST2;PDE4B;GSS;UBA2;KSR1;CDKL5;PDK3;SARS2;CDK6;TBCK;ACLY;TLK2;AKT3;LANCL2;SYN1;EIF4G1;MYO9B;PXK;HSPA4;PI4K2A;MSH6;DDX25;PDE4D;SRR;PNPLA8;P2RY1;HARS1;AK6;RTEL1;BMPR1A;ABCB9;ABL1;PAPOLA;BLM;OLA1;NDUFA13;HNRNPU;ABCD2;FICD;ABCF1;EIF2B2
prerank,transition metal ion binding (GO:0046914),0.25113179891486515,0.8107166255688341,0.9228456913827655,0.915708086698448,1.0,73/397,19.04%,RAG2;GLI2;CSRP1;DHH;DPEP1;CBLB;PRKN;CUTA;EPRS1;KMT2A;SEC24D;PDXK;KDM5B;ITGB1BP2;PRNP;MT3;MBD1;GRIN2B;HHIP;LTA4H;ZEB1;AOC1;AGMO;LOXL3;TRIM2;GALNT1;RPH3A;CHD3;GTF2B;SCD5;TRHDE;SEC24C;PTPN1;LNPEP;MMP16;USP33;MYT1;RBAK;GPC1;SIRT6;PHF8;SOD2;ZFPM2;KPNB1;HPF1;EXD2;SNCA;MDM4;ADAM33;GRIN2A;TRAF7;BAZ1B;GALNT3;PAPPA2;ABL1;RCHY1;PAPOLA;BLM;TP53;TET3;RBSN;RC3H1;WRN;ADH5;SEC24A;PCK2;MDM2;KLF7;ZMYND11;SNCB;PARK7;TAB3;EGR1
prerank,carboxy-lyase activity (GO:0016831),-0.25434052903205384,-0.8104435227448327,0.7836879432624113,0.8866761397023473,1.0,7/23,20.15%,ECHDC1;AZIN1;AMD1;DDC;ODC1;PPCDC;BCKDHA
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),0.3755373086476779,0.808843999349224,0.6991150442477876,0.9166469356152334,1.0,4/12,14.61%,ACVR1;TGFBR2;LTBP1;BMPR1A
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),0.3714577498752917,0.800861351919043,0.6929133858267716,0.9269437312761083,1.0,5/11,20.92%,NUDT1;NUDT10;NUDT3;NUDT5;NUDT11
prerank,proton transmembrane transporter activity (GO:0015078),0.29763927904308246,0.7992864800417449,0.7535853976531942,0.9271312749861716,1.0,8/39,18.80%,CLCN5;ATP6V1B2;UQCRQ;NDUFA4;COX10;DMAC2L;SLC9A1;CYB5A
prerank,glutathione transferase activity (GO:0004364),-0.2539189580537986,-0.7982830348484979,0.7712177121771218,0.9011523746098902,1.0,5/23,13.58%,LANCL1;GSTA4;GSTM1;HPGDS;MGST1
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.3199836202451842,0.7976030158445615,0.7503250975292588,0.9274739471066309,1.0,3/26,8.61%,B3GNT9;CSGALNACT1;CHSY1
prerank,diacylglycerol kinase activity (GO:0004143),0.37304676440482204,0.7951688718952276,0.6911076443057722,0.928984709632096,1.0,7/11,28.53%,DGKI;AGK;DGKA;DGKK;DGKD;DGKZ;DGKQ
prerank,calcium channel regulator activity (GO:0005246),0.2919620000580552,0.792316339956359,0.7624521072796935,0.9310436251393387,1.0,9/37,20.90%,CACNG7;NRXN1;SGK3;CALM1;CALM2;SGK1;STIMATE;NPY;STIM2
prerank,organic anion transmembrane transporter activity (GO:0008514),0.25531865335344434,0.7905543782422343,0.8423280423280424,0.9314545330112207,1.0,19/134,14.66%,SLC22A3;SLC1A3;SLC27A1;SLC25A2;SLC1A5;MPC1;SLC25A21;SLC36A2;SLCO2B1;SLC25A38;MPC2;SLC2A2;SLC35A1;SLC7A8;SLC25A23;SLC16A1;SLC35B3;SLC25A15;SLC25A25
prerank,Lys63-specific deubiquitinase activity (GO:0061578),-0.31506768784031736,-0.7898684775173967,0.7228260869565217,0.9084295330299358,1.0,2/10,9.84%,OTUD5;STAMBPL1
prerank,GABA receptor activity (GO:0016917),-0.25144456554338873,-0.7884782701193682,0.796875,0.9042955726169069,1.0,7/21,28.63%,GPR156;GABRG1;GABRA5;GABRB1;GABRE;GABRB2;GABBR2
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),0.3534506402746512,0.788266722872318,0.7136363636363636,0.9327674332388142,1.0,2/11,8.53%,PPP1R14C;PPP1R8
prerank,amino acid:sodium symporter activity (GO:0005283),0.36789612249216636,0.788128989089898,0.7291361639824304,0.9308221059689896,1.0,1/11,1.03%,SLC1A3
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.3021976028347201,0.785800763095817,0.7666666666666667,0.9320814225867439,1.0,10/28,27.33%,ELAC1;ENDOV;RPP38;PRORP;POP1;RPP21;DBR1;RPP30;DROSHA;RPP14
prerank,cholesterol transfer activity (GO:0120020),0.34183355008868566,0.7852436304106741,0.7303703703703703,0.9307815597944737,1.0,4/16,13.10%,GRAMD1A;MTTP;GRAMD1C;GRAMD1B
prerank,magnesium ion binding (GO:0000287),0.25320127345002824,0.78505849519926,0.8459937565036421,0.9289309006310561,1.0,22/135,15.66%,IDH2;PSPH;PDXK;IRAK3;SIK2;MAST2;DXO;GSS;PGM1;UBA2;ENDOV;PI4K2A;MSH6;NUDT3;GNAI1;SRR;EXD2;SNCA;IDH3A;OPA1;ABL1;PAPOLA
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.31353351056990864,0.7849606804349583,0.73342175066313,0.9269475927683055,1.0,11/27,26.15%,POLR2B;POLRMT;POLR1B;POLR2G;MED21;POLR1D;POLR1C;POLR2A;POLR3K;POLR2F;POLR3F
prerank,regulatory RNA binding (GO:0061980),-0.22318581569552354,-0.7846903182379589,0.8631578947368421,0.9042914545063531,1.0,15/38,30.18%,YBX1;AGO1;ZC3H7B;DDX21;ELAVL1;TUT7;AGO3;MATR3;TARBP2;HNRNPA1;ZC3H10;AGO2;DICER1;PIWIL2;AGO4
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.24951981572722698,0.784215077912129,0.8730808597748209,0.9259479778166192,1.0,38/181,20.33%,MDFIC;NCOA1;PTPRT;TACC1;MTA2;BBS5;NCOA2;LDB2;HIF1A;PIAS2;HDAC2;ATF2;NFE2L2;MAPK14;SP1;NRIP1;ZFPM2;CRY1;NCOR2;DACT1;JUP;TAF4;TP53;TAF4B;MTA3;SMARCE1;NCOA3;DNAJA1;TACC2;TAF1;CPNE1;BCL10;PRRX1;PPARG;JUN;STAT3;SMARCA4;BBS7
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.31280104994870517,0.7828580809621994,0.7462887989203779,0.9257662916170654,1.0,4/24,14.11%,DTYMK;AK1;AK3;AK5
prerank,enoyl-CoA hydratase activity (GO:0004300),-0.30878468145783655,-0.779366200289539,0.7834757834757835,0.9064748215720715,1.0,4/10,12.95%,ECHDC1;ECHDC2;ECHDC3;ECI1
prerank,U6 snRNA binding (GO:0017070),-0.2888650542086749,-0.7787823455375374,0.7537091988130564,0.9012508666307526,1.0,5/14,23.14%,PRPF4;LARP7;EIF5A;SART3;RBM22
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),0.340088275764462,0.7765434298050036,0.7319587628865979,0.9327208347175889,1.0,3/15,10.37%,SOCS5;SOCS1;PIK3R1
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),0.34676113906207373,0.774217380779959,0.7816593886462883,0.933886828875817,1.0,2/14,5.98%,PYCARD;APAF1
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.35365981649876244,0.7737557384443202,0.7243401759530792,0.9323656373274389,1.0,1/12,2.07%,NQO1
prerank,phosphatidate phosphatase activity (GO:0008195),-0.29359484630813093,-0.7722713005085313,0.7951070336391437,0.9056432404904611,1.0,3/13,9.59%,PLPP1;LPIN2;PLPP5
prerank,vinculin binding (GO:0017166),0.3664303991720817,0.770750179075806,0.7331240188383046,0.9344905820932979,1.0,1/11,1.32%,UTRN
prerank,hexosyltransferase activity (GO:0016758),0.2546291714910978,0.7696875004838112,0.8571428571428571,0.9338655825952781,1.0,21/101,20.64%,HAS2;TMTC2;GBA2;EXT1;ALG9;B3GNT9;CSGALNACT1;CHSY1;POMGNT2;ALG5;TMTC3;RFNG;ALG1;DPY19L2;HYAL1;MTAP;POGLUT2;CHSY3;DPY19L3;ALG6;B4GALT6
prerank,ferrous iron binding (GO:0008198),-0.2574185019571179,-0.7685140550827743,0.8109965635738832,0.905123908537824,1.0,9/21,21.72%,PHYH;FTH1;EGLN2;FTL;CDO1;ALKBH3;FXN;EGLN3;DNAJC24
prerank,protein kinase regulator activity (GO:0019887),0.254577280046601,0.7656169275124795,0.8471760797342193,0.9373456613550532,1.0,8/95,5.68%,CXCL10;FGF13;CCNJ;CCNC;GPRC5B;MT3;PRKAR1B;SOCS1
prerank,ribosome binding (GO:0043022),0.2780525959379794,0.7651474688200987,0.812200956937799,0.9358553540961599,1.0,11/46,18.60%,ETF1;NAA16;EIF3C;CPEB3;EIF6;GTPBP6;CCDC47;CPEB1;NAA10;NAA15;RPSA
prerank,L-glutamate transmembrane transporter activity (GO:0005313),0.3329777108789474,0.7637251738396875,0.7740112994350282,0.9357088834476419,1.0,1/14,1.03%,SLC1A3
prerank,dynactin binding (GO:0034452),0.349262674718468,0.7618612911655984,0.7526555386949925,0.9361138672177035,1.0,3/12,10.81%,BICD1;SNX6;BICD2
prerank,Notch binding (GO:0005112),-0.24042734960997947,-0.7598867765222934,0.8458646616541353,0.9111382066047714,1.0,8/22,21.27%,SNW1;JAG1;JAG2;NOTCH4;KCTD10;DTX1;DNER;TCIM
prerank,water transmembrane transporter activity (GO:0005372),0.3526956916573792,0.7527579656501587,0.7738461538461539,0.9463730185200606,1.0,1/11,5.26%,AQP4
prerank,calcium:sodium antiporter activity (GO:0005432),-0.3163231298957939,-0.7520557526585004,0.7853107344632768,0.9154901730347798,1.0,3/10,10.27%,SLC8A3;SLC8B1;SLC24A3
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),0.34418042772740176,0.7519662061122133,0.7507374631268436,0.945314046855743,1.0,2/12,10.37%,GAB2;PIK3R1
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.2826007322524937,0.7466405171047777,0.8050632911392405,0.9503160091636601,1.0,9/34,20.30%,SUV39H1;SETD3;MEN1;PRDM9;SETD2;SETD4;KMT2E;N6AMT1;SETDB1
prerank,ligand-gated calcium channel activity (GO:0099604),-0.24794510121523772,-0.7453668283292564,0.8277027027027027,0.9182508818012403,1.0,3/19,9.86%,ITPR1;RASA3;MCOLN1
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),0.2840606735723668,0.7434302816751169,0.8082368082368082,0.952293318708959,1.0,6/32,12.17%,KDM8;KDM4B;P4HTM;ALKBH5;HSPBAP1;PHF8
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.33988199849359785,0.7399101111896375,0.7954545454545454,0.9546412976145463,1.0,11/11,66.04%,HCN1;HCN2;KCNA10;CNGA1;CNGA3;CNGA4;CNGA2;AQP1;CNGB3;HCN4;CNGB1
prerank,death domain binding (GO:0070513),0.34958724225554655,0.739737924782491,0.8071216617210683,0.9527425982105143,1.0,3/11,17.22%,BCL2;CRADD;RIPK1
prerank,mRNA methyltransferase activity (GO:0008174),0.3327111202148352,0.7354411656950159,0.7886056971514243,0.956030320939409,1.0,4/12,20.18%,METTL3;RNMT;CMTR2;NSUN2
prerank,alpha-actinin binding (GO:0051393),-0.2266063138413285,-0.7330329602336475,0.896414342629482,0.9283438787773098,1.0,2/24,0.90%,CACNA1C;PDLIM5
prerank,protein kinase activator activity (GO:0030295),0.25446916190754604,0.7314098307569296,0.8582857142857143,0.9588777550581401,1.0,14/60,19.42%,ERBB3;FGF13;GPRC5B;MT3;CAB39L;ALS2;GRM5;CDK5R1;CALM1;IQGAP1;CALM2;RPTOR;DBF4;CAB39
prerank,ubiquitin conjugating enzyme binding (GO:0031624),-0.2175133927647303,-0.7301291498413904,0.8697478991596639,0.9262570023896266,1.0,9/27,25.31%,DCUN1D3;RNF144B;DCUN1D1;AUP1;SIAH2;SIAH3;RNF125;ANKIB1;ZMYM2
prerank,amino acid binding (GO:0016597),-0.21831555013762055,-0.7298245244211662,0.9078341013824884,0.9206482383209087,1.0,11/31,24.12%,NOS3;AARS1;DDAH2;NOS1;ASS1;GCLC;GLRA2;GRIN3A;GRM7;AGXT;CASTOR1
prerank,protein serine/threonine kinase activator activity (GO:0043539),0.2787613713752494,0.728662914915562,0.8349875930521092,0.9603607759643416,1.0,10/34,19.42%,CKS1B;CAB39L;ALS2;CDK5R1;CALM1;CDK5R2;IQGAP1;CALM2;DBF4;CAB39
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.25617648884315447,0.7263486828692725,0.8518957345971564,0.9611639354883784,1.0,7/60,8.41%,PTEN;DUSP4;LRRC40;PPP3CB;PPP3CA;PPM1B;PPM1J
prerank,phosphatase activator activity (GO:0019211),0.32507815036812376,0.7262268328175534,0.7951289398280802,0.9591946680867997,1.0,7/14,26.58%,PPP1R15A;CALM1;CALM2;BMP2;PPP2R5A;PPP2R5E;PPP2R5C
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),0.34188583456959165,0.724912628540916,0.7861538461538462,0.958792385085058,1.0,4/10,18.51%,CASP6;CASP12;CASP2;CASP7
prerank,MAP kinase kinase activity (GO:0004708),0.3153597032743315,0.7230826138133484,0.7982708933717579,0.9591090198867517,1.0,3/15,11.14%,MAPKAPK3;MAPK14;MAP2K4
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.2923031286083942,0.7229170411726091,0.8120713305898491,0.9572140355090033,1.0,2/22,5.17%,DUSP4;DUSP6
prerank,DNA polymerase binding (GO:0070182),0.305602285661591,0.7168063737597411,0.815406976744186,0.9624610813566239,1.0,8/18,27.60%,RTEL1;POLG2;SMG6;FANCI;SMARCA4;ACD;NABP2;LONP1
prerank,retinoic acid receptor binding (GO:0042974),0.30560056599170715,0.715179152488912,0.814404432132964,0.962382021327572,1.0,6/17,21.45%,TACC1;RARG;NRIP1;MED25;PPARG;NSD1
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",-0.2706865911698161,-0.7129667789114795,0.8343373493975904,0.9344752614878364,1.0,8/13,35.02%,DNASE1L1;DNA2;DICER1;GEN1;ZGRF1;DNASE1L2;EXO1;FAN1
prerank,thioesterase binding (GO:0031996),0.3311912885628982,0.7127078911071666,0.8183206106870229,0.9632120831317142,1.0,1/11,4.68%,TRAF4
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.32677062101995047,0.7119073548902446,0.8200589970501475,0.9621359823694603,1.0,6/12,23.44%,PAPOLA;TENT2;TENT5D;TENT5A;TENT5C;TUT1
prerank,P-type ion transporter activity (GO:0015662),0.3243417362396097,0.6989037994043781,0.8421052631578947,0.9750161545388262,1.0,2/12,12.92%,ATP2B3;ATP2B1
prerank,mannosyltransferase activity (GO:0000030),0.286252811552827,0.6983207033714002,0.8208333333333333,0.9735650032640836,1.0,8/21,19.09%,TMTC2;ALG9;TMTC3;ALG1;DPY19L2;ALG8;DPM1;DPY19L3
prerank,rRNA binding (GO:0019843),0.2547981286819809,0.6977302224338272,0.8784596871239471,0.972098539400028,1.0,4/42,6.28%,TST;MRPS18A;NGRN;MRPL16
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.2591636056734422,0.6938722052616898,0.8925518925518926,0.9743119095951861,1.0,2/38,8.22%,A2M;SERPINE2
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),0.2828261137481196,0.6935313102456374,0.8787465940054496,0.9725196151316977,1.0,7/22,22.72%,ZRANB3;OTUD7B;ZBTB1;OTUD7A;TAB3;WDR81;TAB2
prerank,peptidoglycan binding (GO:0042834),-0.2803307043199922,-0.6864926416072645,0.8446866485013624,0.9562102945383024,1.0,6/10,41.57%,PGLYRP1;NOD1;NOD2;JCHAIN;NLRP3;TLR2
prerank,GABA-gated chloride ion channel activity (GO:0022851),-0.25863468366864295,-0.6851408657801278,0.8881987577639752,0.9515559995299095,1.0,5/12,24.31%,GABRG1;GABRA5;GABRB1;GABRE;GABRB2
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),0.2881764375029637,0.6837581266585544,0.839541547277937,0.9809675127683268,1.0,3/18,10.37%,SOCS5;SOCS1;PIK3R1
prerank,ATP hydrolysis activity (GO:0140603),0.24941976884950526,0.6817861609292917,0.8982843137254902,0.9808462364866818,1.0,13/41,25.24%,KIF20B;RHOBTB3;CHD3;MYO19;ATP2B1;ABCG4;ABCD2;RUVBL2;DDX4;CHD1L;HSPA1A;MYO18A;SMCHD1
prerank,palmitoyltransferase activity (GO:0016409),-0.20918864928131087,-0.6816384228927336,0.9230769230769231,0.9488531324888737,1.0,6/28,15.14%,ZDHHC14;ZDHHC3;ZDHHC18;ZDHHC7;ZDHHC20;ZDHHC4
prerank,carboxylic acid binding (GO:0031406),-0.19068880686795742,-0.6797425731198509,0.9548022598870056,0.9447553353094544,1.0,10/38,24.12%,NOS3;EPDR1;PHYH;SESN2;NOS1;GCLC;GLRA2;GRIN3A;GRM7;CASTOR1
prerank,peptide N-acetyltransferase activity (GO:0034212),0.3212458581209061,0.6747440481061363,0.8526645768025078,0.9859138004145672,1.0,3/10,18.53%,NAA16;NAA10;NAA15
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.2532813529025285,0.6740430422682898,0.8886043533930857,0.9845610926620614,1.0,6/34,16.29%,USB1;XRN2;PNLDC1;EXOSC2;EXD2;PNPT1
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),0.30335855315058025,0.6707995556144062,0.8510948905109489,0.9858132124114581,1.0,7/13,27.62%,GABRG2;GABRA3;GLRB;GABRA2;GABRG3;GABRA4;GLRA3
prerank,channel activity (GO:0015267),0.2466799446583623,0.6701662000826192,0.8991494532199271,0.9843456565849609,1.0,2/41,5.26%,BCL2;AQP4
prerank,kinesin binding (GO:0019894),0.259211357779848,0.6696825599927937,0.8777633289986996,0.9827997135967188,1.0,6/27,17.58%,ARHGEF10;AP1G1;SNCA;CLSTN1;SPAG9;AP1AR
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.3141271506859446,0.6672021000007545,0.8482003129890454,0.9830960085209761,1.0,1/11,6.69%,AKR1B10
prerank,UDP-glycosyltransferase activity (GO:0008194),0.23004948086660454,0.6667713057963682,0.9426321709786277,0.981430744795134,1.0,10/70,18.15%,HAS2;EXT1;B3GNT9;CSGALNACT1;CHSY1;POMGNT2;RFNG;HYAL1;POGLUT2;CHSY3
prerank,inward rectifier potassium channel activity (GO:0005242),0.26781312358036724,0.6641302624235543,0.888121546961326,0.9817769946231377,1.0,7/24,25.26%,KCNK1;KCNJ3;KCNJ10;KCNH2;KCNK6;KCNJ13;KCNN2
prerank,tRNA binding (GO:0000049),0.2426411289623713,0.6640888981863255,0.9146341463414634,0.9797629068676543,1.0,15/43,25.21%,TRMT10B;SARS2;FARS2;DALRD3;ELP5;XPOT;PUS1;SSB;PSTK;NSUN2;ALKBH8;ALKBH1;DARS2;PTCD1;CARS1
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.2520851106274699,0.6633900569879358,0.8921694480102695,0.9784477248379563,1.0,7/29,17.89%,GBA2;GALC;CTBS;GANC;MOGS;PGGHG;ABHD10
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.3078224576448567,0.6618557962523292,0.8630769230769231,0.9778897219768825,1.0,5/11,27.27%,NAA16;NAA10;NAA15;NAA40;NAA50
prerank,pseudouridine synthase activity (GO:0009982),0.3002910663910612,0.6612993846236572,0.8517940717628705,0.9764067872819456,1.0,3/13,15.72%,PUSL1;PUS7;PUS1
prerank,DNA-binding transcription factor binding (GO:0140297),0.21019189853546377,0.6594423719531999,0.9794871794871794,0.9761797188315074,1.0,32/189,20.33%,PRDM16;MYC;BCL2;CRTC1;TLE1;YWHAZ;MTA2;BBS5;LDB2;PIAS2;HDAC2;ATF2;NFE2L2;SP1;TAF9;ZFPM2;CREM;DACT1;TP53;MTA3;TLE3;CTBP1;TLE4;PSMD9;PARK7;TAF1;CGGBP1;PRRX1;PPARG;JUN;STAT3;BBS7
prerank,methyltransferase activity (GO:0008168),0.23974922250883524,0.6571293404498818,0.9221411192214112,0.9764059589739161,1.0,11/46,20.18%,SUV39H1;COMT;METTL3;AS3MT;PRMT1;COQ5;LRTOMT;MEPCE;AMT;N6AMT1;NSUN2
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),0.25608302451039133,0.6557603785777448,0.9059278350515464,0.9755979366294918,1.0,2/29,3.13%,SLC1A5;SLC25A21
prerank,ligand-gated anion channel activity (GO:0099095),-0.21990240155150945,-0.6519263296518678,0.9084745762711864,0.9612697706578455,1.0,6/17,24.31%,GABRG1;GABRA5;GLRA2;GABRB1;GABRE;GABRB2
prerank,MHC class II protein complex binding (GO:0023026),0.3093237179867327,0.65091627537598,0.8712715855572999,0.9779860307516657,1.0,3/11,18.23%,ANXA11;CD74;MS4A1
prerank,actinin binding (GO:0042805),0.2747888426587192,0.6504432278207227,0.8861788617886179,0.976412978394469,1.0,7/21,21.50%,CSRP1;PDLIM4;MAGI1;KCNA5;PPARG;NFKB1;PKD2
prerank,RNA cap binding (GO:0000339),-0.22909795757039397,-0.646999463235613,0.9195046439628483,0.9589143776030545,1.0,4/16,21.09%,LSM1;NCBP3;EIF3D;EIF4E3
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.23201294740718745,0.6442803171869831,0.9153567110036276,0.9796951293123536,1.0,7/46,14.03%,EXT1;B3GNT9;MGAT3;PIGP;POMGNT2;PIGA;RFNG
prerank,signaling receptor complex adaptor activity (GO:0030159),0.23921715445234804,0.6389523506535054,0.9270959902794653,0.9820827386951598,1.0,7/38,14.56%,SAV1;GAB2;PIK3R1;PTPN11;MAGI2;NCK1;SPAG9
prerank,mannose binding (GO:0005537),-0.23864236711038542,-0.638088540084529,0.9382716049382716,0.959013023643415,1.0,9/12,55.04%,CLN5;ACR;COLEC11;LMAN1L;CLEC4D;LMAN2L;LMAN2;CLEC6A;CD207
prerank,hormone activity (GO:0005179),0.2280475624241552,0.6377822874925714,0.9396449704142011,0.9810766551942748,1.0,2/54,3.66%,CRH;PTHLH
prerank,nuclease activity (GO:0004518),0.22678164737931392,0.6358910026059689,0.9327830188679245,0.9806105834676714,1.0,8/52,17.24%,RNASE6;ERCC5;SETMAR;XRN2;REXO4;AEN;N4BP1;WRN
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),0.2718205400143707,0.6324991679689536,0.9069111424541608,0.9812446157481102,1.0,3/16,16.03%,SLC1A5;SLC25A10;SLC25A11
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",0.29387173615152296,0.6322468804824934,0.8940298507462686,0.9794355945268296,1.0,1/12,6.45%,B3GNT9
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.23890123606414632,0.6302317324683592,0.940337224383917,0.9790285454837055,1.0,6/33,16.29%,USB1;XRN2;PNLDC1;EXOSC2;EXD2;PNPT1
prerank,extracellular ligand-gated ion channel activity (GO:0005230),0.300463549474134,0.6255082584393784,0.8970814132104454,0.9806641955297214,1.0,5/10,26.56%,GABRG2;GABRA3;GABRA2;GABRG3;GABRA4
prerank,cAMP binding (GO:0030552),0.28421829265919313,0.6231481531295482,0.9125188536953243,0.9803960188653557,1.0,4/11,21.64%,PDE4B;PDE4D;HCN1;PDE10A
prerank,kinase inhibitor activity (GO:0019210),0.23662087260309211,0.618505067497316,0.9323979591836735,0.9818283296439485,1.0,5/33,14.00%,SOCS1;TAOK3;RHOH;SNCA;NCK1
prerank,signal sequence binding (GO:0005048),0.23136938998240822,0.6098045242162586,0.9505703422053232,0.9859430458562596,1.0,14/35,26.01%,TOMM20;KDELR2;KPNB1;KPNA6;KDELR3;KPNA1;POM121;CAT;IPO5;KPNA3;PEX5L;CEMIP;TNPO2;SEC61A2
prerank,protein kinase inhibitor activity (GO:0004860),0.2218333794737277,0.6084334554960259,0.9568434032059187,0.984848776466027,1.0,8/42,18.45%,SOCS1;SPRED2;SPRED1;TAOK3;SNCA;NCK1;RPTOR;INKA1
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.23657181170358893,0.6054600276727774,0.9425587467362925,0.9848575689068703,1.0,6/28,16.80%,MAPKAPK3;MAPK14;MAP2K4;PRKACA;RPS6KA2;SGK1
prerank,single-stranded RNA binding (GO:0003727),0.21672987195431076,0.6031558942385788,0.969437652811736,0.9843832341307938,1.0,7/43,16.44%,DDX11;ADARB2;ENDOV;POLR2G;RBM7;PUS1;HNRNPU
prerank,death receptor activity (GO:0005035),0.28535758995295185,0.6012428636533371,0.9280125195618153,0.9836747303365697,1.0,2/11,10.58%,TNFRSF10B;NGFR
prerank,GABA-A receptor activity (GO:0004890),-0.19983519930503058,-0.5998737647479992,0.974169741697417,0.9755259845351555,1.0,5/18,24.31%,GABRG1;GABRA5;GABRB1;GABRE;GABRB2
prerank,N-methyltransferase activity (GO:0008170),0.2521264816872756,0.5984702975670008,0.9281842818428184,0.9834082891964265,1.0,5/20,19.53%,SETD3;FDXACB1;PRMT1;RNMT;N6AMT1
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),-0.19427470223426546,-0.5976377603145324,0.9857142857142858,0.9707786683068227,1.0,5/22,15.44%,ATP6V0C;ATP6V0D1;ATP6V0A4;ATP6V0A2;ATP2A3
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",0.2472515236700686,0.5855849357655649,0.9406657018813314,0.9871700258383757,1.0,7/16,27.66%,ATP6V1B2;ATP6V1C1;ATP6V0E2;ATP6V0E1;TCIRG1;ATP6V1D;ATP5F1B
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",0.2472515236700686,0.5855849357655649,0.9406657018813314,0.9871700258383757,1.0,7/16,27.66%,ATP6V1B2;ATP6V1C1;ATP6V0E2;ATP6V0E1;TCIRG1;ATP6V1D;ATP5F1B
prerank,kinase activity (GO:0016301),0.19133833143292775,0.5850219952393723,0.9915343915343915,0.9855248444855238,1.0,21/109,19.81%,MAP4K4;PDXK;NEK1;PAPSS2;PI4KB;CDKL5;STK39;PKMYT1;DGKI;CDK5R1;RFK;ETNK1;SHPK;TRRAP;ABL1;PKN2;AGK;TAF1;BCKDK;PSTK;CERKL
prerank,snoRNA binding (GO:0030515),0.2260616154343113,0.5840861363177223,0.9629629629629629,0.9840307614641733,1.0,4/30,8.61%,NUDT1;BMS1;UTP6;HEATR1
prerank,CARD domain binding (GO:0050700),0.25242639237261627,0.5708841417024824,0.9462989840348331,0.9887953657057408,1.0,6/14,25.62%,CARD9;BCL10;CARD11;CARD16;MAVS;CARD10
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.19025100604652154,0.554755147738777,0.9921875,0.9943540727870981,1.0,25/74,27.87%,PDXK;PAPSS2;PI4KB;ADK;DGKI;RFK;ETNK1;SHPK;FGGY;GNE;GALK2;AGK;HK2;FAM20C;HYKK;HK1;NT5C3A;DGKA;FCSK;DGKK;PIK3CA;DGKD;GK;PIK3C3;DGKZ
prerank,RNA 7-methylguanosine cap binding (GO:0000340),0.2589223104443027,0.5543196869285089,0.9535603715170279,0.9925836535992925,1.0,2/12,14.94%,NCBP1;CYFIP1
prerank,NADPH binding (GO:0070402),0.24932519120601782,0.55208111106499,0.9537037037037037,0.9915610677280396,1.0,4/13,24.10%,MTRR;CBR3;DECR1;HMGCR
prerank,muscle alpha-actinin binding (GO:0051371),0.24237713950702805,0.5499504660763613,0.948301329394387,0.990454222007731,1.0,3/15,14.47%,PDLIM4;PALLD;LDB3
prerank,MHC class I protein binding (GO:0042288),-0.2020364612998875,-0.5393183883961993,0.9702380952380952,0.9872969237054324,1.0,2/13,17.92%,TAPBP;TUBB4B
prerank,histone methyltransferase binding (GO:1990226),0.2494327984261131,0.5346619049878759,0.9620853080568721,0.9943532404429554,1.0,3/11,15.98%,LCOR;NOP56;LCORL
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),0.2014575048937523,0.5290636336956842,0.9849056603773585,0.994358895587727,1.0,13/33,30.11%,PRKN;UBA2;TOLLIP;RNF19A;PARK7;SIAH1;PPARA;UBE3D;DCUN1D5;TCERG1;TRAF6;ARIH1;RNF217
prerank,transferrin receptor binding (GO:1990459),0.24538138175000643,0.520730733891461,0.9624413145539906,0.9950255560783602,1.0,3/10,22.73%,SNX1;CHUK;SNX4
prerank,lipid phosphatase activity (GO:0042577),-0.18504528146537635,-0.5083630656567865,0.9876543209876543,0.9891232812316371,1.0,1/14,2.38%,PLPP1
prerank,nucleotide diphosphatase activity (GO:0004551),0.22723516244644854,0.5061190167045405,0.9835082458770614,0.9972445989762969,1.0,5/14,24.95%,NUDT10;NUDT3;NUDT6;NUDT11;FHIT
prerank,lysine N-methyltransferase activity (GO:0016278),0.19965637523659963,0.4794759598151467,0.989100817438692,1.0,1.0,2/20,9.87%,SETD3;SETD2
prerank,single-stranded DNA helicase activity (GO:0017116),0.19301991894155152,0.4677455604368184,0.9871977240398293,1.0,1.0,3/19,19.86%,CHTF18;HELQ;WRNIP1
prerank,snRNA binding (GO:0017069),0.16933265690788588,0.46344828126268445,0.9987546699875467,0.9997541892284797,1.0,11/42,25.41%,RNPC3;SNRPB2;RBM7;MEPCE;SNRPA;HNRNPU;SF3B3;CDK9;TUT1;CCNT2;SNRPA1
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),0.20641039281484574,0.43965737391122944,0.9920508744038156,1.0,1.0,3/11,22.94%,NEIL1;HMCES;ALKBH1
prerank,titin binding (GO:0031432),0.19319529356206241,0.42157982883714534,0.9970501474926253,1.0,1.0,3/13,22.66%,CALM1;CALM2;CAMK2D
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.18615452206113112,0.39088363899095585,0.9968304278922345,1.0,1.0,10/10,81.40%,EXD2;MGME1;DCLRE1A;TATDN1;FEN1;APEX1;EXO1;POLD1;DCLRE1C;DCLRE1B
prerank,MHC protein binding (GO:0042287),0.15902973743326793,0.3829848725488069,0.9971590909090909,0.9988902115894167,1.0,3/20,20.96%,ABCB9;CD74;TAP1
